compound_id,iupac_name,smiles_raw,provenance_file,provenance_sheet,provenance_row,variable,value
1,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=CC2=CC=CC=C12,data/bronze/artifacts/2018_raw.xlsx,Sheet1,2,KRAS-SOS1 Interaction,1.33e-07
1,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=CC2=CC=CC=C12,data/bronze/artifacts/2018_raw.xlsx,Sheet1,2,KRAS-Activation by SOS high GTP,3.03e-07
1,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=CC2=CC=CC=C12,data/bronze/artifacts/2018_raw.xlsx,Sheet1,2,KRAS-Activation by SOS no GTP,3.7e-07
1,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=CC2=CC=CC=C12,data/bronze/artifacts/2018_raw.xlsx,Sheet1,2,EGFR kinase inhibition IC50,>2.00E-5
2,"N-[(1R)-1-(3-chlorophenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,3,KRAS-SOS1 Interaction,1.27e-07
2,"N-[(1R)-1-(3-chlorophenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,3,KRAS-Activation by SOS high GTP,2.07e-07
2,"N-[(1R)-1-(3-chlorophenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,3,KRAS-Activation by SOS no GTP,5.37e-07
2,"N-[(1R)-1-(3-chlorophenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,3,EGFR kinase inhibition IC50,1.83e-05
3,"methyl4-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-1-benzothiophene-2-carboxylate",COC(=O)C=1SC2=C(C1)C(=CC=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,4,KRAS-SOS1 Interaction,1.13e-07
3,"methyl4-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-1-benzothiophene-2-carboxylate",COC(=O)C=1SC2=C(C1)C(=CC=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,4,KRAS-Activation by SOS high GTP,1.15e-07
3,"methyl4-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-1-benzothiophene-2-carboxylate",COC(=O)C=1SC2=C(C1)C(=CC=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,4,KRAS-Activation by SOS no GTP,2.31e-07
3,"methyl4-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-1-benzothiophene-2-carboxylate",COC(=O)C=1SC2=C(C1)C(=CC=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,4,EGFR kinase inhibition IC50,>2.00E-5
4,"N-[1-(1-benzofuran-7-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1C=CC2=C1C(=CC=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,5,KRAS-SOS1 Interaction,1.61e-07
4,"N-[1-(1-benzofuran-7-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1C=CC2=C1C(=CC=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,5,KRAS-Activation by SOS high GTP,2.43e-07
4,"N-[1-(1-benzofuran-7-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1C=CC2=C1C(=CC=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,5,KRAS-Activation by SOS no GTP,4.79e-07
4,"N-[1-(1-benzofuran-7-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1C=CC2=C1C(=CC=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,5,EGFR kinase inhibition IC50,>2.00E-5
5,"N-[1-(7-fluoro-1H-indazol-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC=1C=CC(=C2C=NNC12)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,6,KRAS-SOS1 Interaction,1.71e-06
5,"N-[1-(7-fluoro-1H-indazol-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC=1C=CC(=C2C=NNC12)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,6,KRAS-Activation by SOS high GTP,1.3e-06
5,"N-[1-(7-fluoro-1H-indazol-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC=1C=CC(=C2C=NNC12)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,6,KRAS-Activation by SOS no GTP,5.06e-06
5,"N-[1-(7-fluoro-1H-indazol-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC=1C=CC(=C2C=NNC12)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,6,EGFR kinase inhibition IC50,>2.00E-5
6,"N-[1-(6-fluoro-1H-indazol-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1=CC(=C2C=NNC2=C1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,7,KRAS-SOS1 Interaction,2.28e-06
6,"N-[1-(6-fluoro-1H-indazol-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1=CC(=C2C=NNC2=C1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,7,KRAS-Activation by SOS high GTP,1.86e-06
6,"N-[1-(6-fluoro-1H-indazol-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1=CC(=C2C=NNC2=C1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,7,KRAS-Activation by SOS no GTP,4.98e-06
6,"N-[1-(6-fluoro-1H-indazol-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1=CC(=C2C=NNC2=C1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,7,EGFR kinase inhibition IC50,>2.00E-5
7,"6,7-dimethoxy-2-methyl-N-[1-(5-methyl-1H-indazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C=NNC2=CC=C1C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,8,KRAS-SOS1 Interaction,0.44
7,"6,7-dimethoxy-2-methyl-N-[1-(5-methyl-1H-indazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C=NNC2=CC=C1C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,8,KRAS-Activation by SOS high GTP,0.18
7,"6,7-dimethoxy-2-methyl-N-[1-(5-methyl-1H-indazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C=NNC2=CC=C1C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,8,KRAS-Activation by SOS no GTP,0.33
7,"6,7-dimethoxy-2-methyl-N-[1-(5-methyl-1H-indazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C=NNC2=CC=C1C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,8,EGFR kinase inhibition IC50,>2.00E-5
8,"6,7-dimethoxy-2-methyl-N-[1-(2-methyl-2H-indazol-7-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=CC2=CN(N=C12)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,9,KRAS-SOS1 Interaction,1.82e-05
8,"6,7-dimethoxy-2-methyl-N-[1-(2-methyl-2H-indazol-7-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=CC2=CN(N=C12)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,9,KRAS-Activation by SOS high GTP,1.98e-05
8,"6,7-dimethoxy-2-methyl-N-[1-(2-methyl-2H-indazol-7-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=CC2=CN(N=C12)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,9,KRAS-Activation by SOS no GTP,0.14
8,"6,7-dimethoxy-2-methyl-N-[1-(2-methyl-2H-indazol-7-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=CC2=CN(N=C12)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,9,EGFR kinase inhibition IC50,>2.00E-5
9,"6,7-dimethoxy-2-methyl-N-[1-(2-methyl-2H-indazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C2=CN(N=C2C=CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,10,KRAS-SOS1 Interaction,1.52e-06
9,"6,7-dimethoxy-2-methyl-N-[1-(2-methyl-2H-indazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C2=CN(N=C2C=CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,10,KRAS-Activation by SOS high GTP,1.37e-06
9,"6,7-dimethoxy-2-methyl-N-[1-(2-methyl-2H-indazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C2=CN(N=C2C=CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,10,KRAS-Activation by SOS no GTP,5.96e-06
9,"6,7-dimethoxy-2-methyl-N-[1-(2-methyl-2H-indazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C2=CN(N=C2C=CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,10,EGFR kinase inhibition IC50,>2.00E-5
10,"6,7-dimethoxy-2-methyl-N-[1-(1-methyl-1H-indazol-7-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C=CC=C2C=NN(C12)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,11,KRAS-SOS1 Interaction,1.18e-06
10,"6,7-dimethoxy-2-methyl-N-[1-(1-methyl-1H-indazol-7-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C=CC=C2C=NN(C12)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,11,KRAS-Activation by SOS high GTP,1.27e-06
10,"6,7-dimethoxy-2-methyl-N-[1-(1-methyl-1H-indazol-7-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C=CC=C2C=NN(C12)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,11,KRAS-Activation by SOS no GTP,8.14e-06
10,"6,7-dimethoxy-2-methyl-N-[1-(1-methyl-1H-indazol-7-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C=CC=C2C=NN(C12)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,11,EGFR kinase inhibition IC50,>2.00E-5
11,"6,7-dimethoxy-2-methyl-N-[1-(5,6,7,8-tetrahydronaphthalen-1-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=CC=2CCCCC12,data/bronze/artifacts/2018_raw.xlsx,Sheet1,12,KRAS-SOS1 Interaction,2.83e-07
11,"6,7-dimethoxy-2-methyl-N-[1-(5,6,7,8-tetrahydronaphthalen-1-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=CC=2CCCCC12,data/bronze/artifacts/2018_raw.xlsx,Sheet1,12,KRAS-Activation by SOS high GTP,2.21e-07
11,"6,7-dimethoxy-2-methyl-N-[1-(5,6,7,8-tetrahydronaphthalen-1-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=CC=2CCCCC12,data/bronze/artifacts/2018_raw.xlsx,Sheet1,12,KRAS-Activation by SOS no GTP,5.4e-07
11,"6,7-dimethoxy-2-methyl-N-[1-(5,6,7,8-tetrahydronaphthalen-1-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=CC=2CCCCC12,data/bronze/artifacts/2018_raw.xlsx,Sheet1,12,EGFR kinase inhibition IC50,>2.00E-5
12,"N-[(1R)-1-(4-fluorophenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1=CC=C(C=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,13,KRAS-SOS1 Interaction,3.35e-07
12,"N-[(1R)-1-(4-fluorophenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1=CC=C(C=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,13,KRAS-Activation by SOS high GTP,5.78e-07
12,"N-[(1R)-1-(4-fluorophenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1=CC=C(C=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,13,KRAS-Activation by SOS no GTP,1.29e-06
12,"N-[(1R)-1-(4-fluorophenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1=CC=C(C=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,13,EGFR kinase inhibition IC50,>2.00E-5
13,"6,7-dimethoxy-2-methyl-N-[1-(3-methyl-1H-indazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C(=NNC2=CC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,14,KRAS-SOS1 Interaction,2.82e-06
13,"6,7-dimethoxy-2-methyl-N-[1-(3-methyl-1H-indazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C(=NNC2=CC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,14,KRAS-Activation by SOS high GTP,2.65e-06
13,"6,7-dimethoxy-2-methyl-N-[1-(3-methyl-1H-indazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C(=NNC2=CC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,14,KRAS-Activation by SOS no GTP,7.73e-06
13,"6,7-dimethoxy-2-methyl-N-[1-(3-methyl-1H-indazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C(=NNC2=CC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,14,EGFR kinase inhibition IC50,>2.00E-5
14,"N-[1-(1,3-benzothiazol-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=NC2=C1C=CC=C2C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,15,KRAS-SOS1 Interaction,6.66e-07
14,"N-[1-(1,3-benzothiazol-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=NC2=C1C=CC=C2C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,15,KRAS-Activation by SOS high GTP,6.08e-07
14,"N-[1-(1,3-benzothiazol-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=NC2=C1C=CC=C2C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,15,KRAS-Activation by SOS no GTP,1.83e-06
14,"N-[1-(1,3-benzothiazol-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=NC2=C1C=CC=C2C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,15,EGFR kinase inhibition IC50,>2.00E-5
15,"N-[1-(1-benzothiophen-7-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=CC2=C1C(=CC=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,16,KRAS-SOS1 Interaction,1.26e-07
15,"N-[1-(1-benzothiophen-7-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=CC2=C1C(=CC=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,16,KRAS-Activation by SOS high GTP,9.11e-06
15,"N-[1-(1-benzothiophen-7-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=CC2=C1C(=CC=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,16,KRAS-Activation by SOS no GTP,3.24e-07
15,"N-[1-(1-benzothiophen-7-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=CC2=C1C(=CC=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,16,EGFR kinase inhibition IC50,>2.00E-5
16,"6,7-dimethoxy-2-methyl-N-[1-(6-methyl-1H-indazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C=NNC2=CC(=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,17,KRAS-SOS1 Interaction,3.25e-06
16,"6,7-dimethoxy-2-methyl-N-[1-(6-methyl-1H-indazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C=NNC2=CC(=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,17,KRAS-Activation by SOS high GTP,3.02e-06
16,"6,7-dimethoxy-2-methyl-N-[1-(6-methyl-1H-indazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C=NNC2=CC(=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,17,KRAS-Activation by SOS no GTP,8.17e-06
16,"6,7-dimethoxy-2-methyl-N-[1-(6-methyl-1H-indazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C=NNC2=CC(=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,17,EGFR kinase inhibition IC50,>2.00E-5
17,"6,7-dimethoxy-2-methyl-N-[1-(1-methyl-1H-indazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C=NN(C2=CC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,18,KRAS-SOS1 Interaction,2.7e-07
17,"6,7-dimethoxy-2-methyl-N-[1-(1-methyl-1H-indazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C=NN(C2=CC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,18,KRAS-Activation by SOS high GTP,2.97e-07
17,"6,7-dimethoxy-2-methyl-N-[1-(1-methyl-1H-indazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C=NN(C2=CC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,18,KRAS-Activation by SOS no GTP,7.12e-07
17,"6,7-dimethoxy-2-methyl-N-[1-(1-methyl-1H-indazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C=NN(C2=CC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,18,EGFR kinase inhibition IC50,>2.00E-5
18,"N-[1-(5-fluoro-1H-indazol-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC=1C(=C2C=NNC2=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,19,KRAS-SOS1 Interaction,8.5e-06
18,"N-[1-(5-fluoro-1H-indazol-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC=1C(=C2C=NNC2=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,19,KRAS-Activation by SOS high GTP,7.88e-06
18,"N-[1-(5-fluoro-1H-indazol-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC=1C(=C2C=NNC2=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,19,KRAS-Activation by SOS no GTP,1.05e-05
18,"N-[1-(5-fluoro-1H-indazol-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC=1C(=C2C=NNC2=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,19,EGFR kinase inhibition IC50,>2.00E-5
19,"N-[1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCOC2=C1C=CC(=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,20,KRAS-SOS1 Interaction,7.78e-06
19,"N-[1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCOC2=C1C=CC(=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,20,KRAS-Activation by SOS high GTP,6.55e-06
19,"N-[1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCOC2=C1C=CC(=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,20,KRAS-Activation by SOS no GTP,0.44
19,"N-[1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCOC2=C1C=CC(=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,20,EGFR kinase inhibition IC50,>2.00E-5
20,"N-[1-(1-benzofuran-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1C(=CC2=C1C=CC=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,21,KRAS-SOS1 Interaction,8.42e-06
20,"N-[1-(1-benzofuran-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1C(=CC2=C1C=CC=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,21,KRAS-Activation by SOS high GTP,8.2e-06
20,"N-[1-(1-benzofuran-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1C(=CC2=C1C=CC=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,21,KRAS-Activation by SOS no GTP,0.41
20,"N-[1-(1-benzofuran-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1C(=CC2=C1C=CC=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,21,EGFR kinase inhibition IC50,>2.00E-5
21,"N-[1-(2,3-dimethoxyphenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",COC1=C(C=CC=C1OC)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,22,KRAS-SOS1 Interaction,3.16e-06
21,"N-[1-(2,3-dimethoxyphenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",COC1=C(C=CC=C1OC)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,22,KRAS-Activation by SOS high GTP,3.23e-06
21,"N-[1-(2,3-dimethoxyphenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",COC1=C(C=CC=C1OC)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,22,KRAS-Activation by SOS no GTP,1.11e-05
21,"N-[1-(2,3-dimethoxyphenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",COC1=C(C=CC=C1OC)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,22,EGFR kinase inhibition IC50,>2.00E-5
22,"N-[1-(2,3-dihydro-1-benzofuran-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCC2=C1C=CC=C2C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,23,KRAS-SOS1 Interaction,1.77e-07
22,"N-[1-(2,3-dihydro-1-benzofuran-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCC2=C1C=CC=C2C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,23,KRAS-Activation by SOS high GTP,2.19e-07
22,"N-[1-(2,3-dihydro-1-benzofuran-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCC2=C1C=CC=C2C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,23,KRAS-Activation by SOS no GTP,5.89e-07
22,"N-[1-(2,3-dihydro-1-benzofuran-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCC2=C1C=CC=C2C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,23,EGFR kinase inhibition IC50,>2.00E-5
23,"N-[1-(1,3-benzodioxol-5-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1COC2=C1C=CC(=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,24,KRAS-SOS1 Interaction,2.72e-06
23,"N-[1-(1,3-benzodioxol-5-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1COC2=C1C=CC(=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,24,KRAS-Activation by SOS high GTP,1.85e-06
23,"N-[1-(1,3-benzodioxol-5-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1COC2=C1C=CC(=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,24,KRAS-Activation by SOS no GTP,8.62e-06
23,"N-[1-(1,3-benzodioxol-5-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1COC2=C1C=CC(=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,24,EGFR kinase inhibition IC50,>2.00E-5
24,"N-[1-(2,3-dihydro-1-benzofuran-5-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCC2=C1C=CC(=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,25,KRAS-SOS1 Interaction,7.01e-07
24,"N-[1-(2,3-dihydro-1-benzofuran-5-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCC2=C1C=CC(=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,25,KRAS-Activation by SOS high GTP,1.22e-06
24,"N-[1-(2,3-dihydro-1-benzofuran-5-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCC2=C1C=CC(=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,25,KRAS-Activation by SOS no GTP,2.45e-06
24,"N-[1-(2,3-dihydro-1-benzofuran-5-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCC2=C1C=CC(=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,25,EGFR kinase inhibition IC50,>2.00E-5
25,"6,7-dimethoxy-2-methyl-N-[1-(5,6,7,8-tetrahydronaphthalen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=2CCCCC2C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,26,KRAS-SOS1 Interaction,5.41e-07
25,"6,7-dimethoxy-2-methyl-N-[1-(5,6,7,8-tetrahydronaphthalen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=2CCCCC2C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,26,KRAS-Activation by SOS high GTP,8.5e-07
25,"6,7-dimethoxy-2-methyl-N-[1-(5,6,7,8-tetrahydronaphthalen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=2CCCCC2C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,26,KRAS-Activation by SOS no GTP,1.5e-06
25,"6,7-dimethoxy-2-methyl-N-[1-(5,6,7,8-tetrahydronaphthalen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=2CCCCC2C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,26,EGFR kinase inhibition IC50,>2.00E-5
26,"6,7-dimethoxy-2-methyl-N-[1-(2-methylimidazo[1,2-a]pyridin-3-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C(N=C2N1C=CC=C2)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,27,KRAS-SOS1 Interaction,9.55e-06
26,"6,7-dimethoxy-2-methyl-N-[1-(2-methylimidazo[1,2-a]pyridin-3-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C(N=C2N1C=CC=C2)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,27,KRAS-Activation by SOS high GTP,0.52
26,"6,7-dimethoxy-2-methyl-N-[1-(2-methylimidazo[1,2-a]pyridin-3-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C(N=C2N1C=CC=C2)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,27,KRAS-Activation by SOS no GTP,6.96e-06
26,"6,7-dimethoxy-2-methyl-N-[1-(2-methylimidazo[1,2-a]pyridin-3-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C(N=C2N1C=CC=C2)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,27,EGFR kinase inhibition IC50,>2.00E-5
27,"N-[1-(1-benzothiophen-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=C(C2=C1C=CC=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,28,KRAS-SOS1 Interaction,3.68e-07
27,"N-[1-(1-benzothiophen-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=C(C2=C1C=CC=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,28,KRAS-Activation by SOS high GTP,4.02e-07
27,"N-[1-(1-benzothiophen-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=C(C2=C1C=CC=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,28,KRAS-Activation by SOS no GTP,4.98e-07
27,"N-[1-(1-benzothiophen-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=C(C2=C1C=CC=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,28,EGFR kinase inhibition IC50,>2.00E-5
28,"2-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-1-benzofuran-7-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1OC2=C(C1)C=CC=C2O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,29,KRAS-SOS1 Interaction,0.4
28,"2-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-1-benzofuran-7-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1OC2=C(C1)C=CC=C2O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,29,KRAS-Activation by SOS high GTP,0.08
28,"2-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-1-benzofuran-7-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1OC2=C(C1)C=CC=C2O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,29,KRAS-Activation by SOS no GTP,0.46
28,"2-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-1-benzofuran-7-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1OC2=C(C1)C=CC=C2O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,29,EGFR kinase inhibition IC50,>2.00E-5
29,6-bromo-2-methyl-N-[(1R)-1-phenylethyl]quinazolin-4-amine,BrC=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,30,KRAS-SOS1 Interaction,1.02e-05
29,6-bromo-2-methyl-N-[(1R)-1-phenylethyl]quinazolin-4-amine,BrC=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,30,KRAS-Activation by SOS high GTP,1.09e-05
29,6-bromo-2-methyl-N-[(1R)-1-phenylethyl]quinazolin-4-amine,BrC=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,30,KRAS-Activation by SOS no GTP,0.44
29,6-bromo-2-methyl-N-[(1R)-1-phenylethyl]quinazolin-4-amine,BrC=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,30,EGFR kinase inhibition IC50,>2.00E-5
30,6-{[dimethyl(oxido)-lambda6-sulfanylidene]amino}-2-methyl-N-[(1R)-1-phenylethyl]quinazolin-4-amine,CS(=O)(C)=NC=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,31,KRAS-SOS1 Interaction,1.34e-06
30,6-{[dimethyl(oxido)-lambda6-sulfanylidene]amino}-2-methyl-N-[(1R)-1-phenylethyl]quinazolin-4-amine,CS(=O)(C)=NC=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,31,KRAS-Activation by SOS high GTP,1.1e-06
30,6-{[dimethyl(oxido)-lambda6-sulfanylidene]amino}-2-methyl-N-[(1R)-1-phenylethyl]quinazolin-4-amine,CS(=O)(C)=NC=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,31,KRAS-Activation by SOS no GTP,2.91e-06
30,6-{[dimethyl(oxido)-lambda6-sulfanylidene]amino}-2-methyl-N-[(1R)-1-phenylethyl]quinazolin-4-amine,CS(=O)(C)=NC=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,31,EGFR kinase inhibition IC50,>2.00E-5
31,6-bromo-N-[(1R)-1-(4-fluorophenyl)ethyl]-2-methylquinazolin-4-amine,BrC=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,32,KRAS-SOS1 Interaction,8.59e-06
31,6-bromo-N-[(1R)-1-(4-fluorophenyl)ethyl]-2-methylquinazolin-4-amine,BrC=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,32,KRAS-Activation by SOS high GTP,9.51e-06
31,6-bromo-N-[(1R)-1-(4-fluorophenyl)ethyl]-2-methylquinazolin-4-amine,BrC=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,32,KRAS-Activation by SOS no GTP,0.49
31,6-bromo-N-[(1R)-1-(4-fluorophenyl)ethyl]-2-methylquinazolin-4-amine,BrC=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,32,EGFR kinase inhibition IC50,>2.00E-5
32,6-{[dimethyl(oxido)-lambda6-sulfanylidene]amino}-N-[(1R)-1-(4-fluorophenyl)ethyl]-2-methylquinazolin-4-amine,CS(=O)(C)=NC=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,33,KRAS-SOS1 Interaction,1.07e-06
32,6-{[dimethyl(oxido)-lambda6-sulfanylidene]amino}-N-[(1R)-1-(4-fluorophenyl)ethyl]-2-methylquinazolin-4-amine,CS(=O)(C)=NC=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,33,KRAS-Activation by SOS high GTP,1.48e-06
32,6-{[dimethyl(oxido)-lambda6-sulfanylidene]amino}-N-[(1R)-1-(4-fluorophenyl)ethyl]-2-methylquinazolin-4-amine,CS(=O)(C)=NC=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,33,KRAS-Activation by SOS no GTP,2.59e-06
32,6-{[dimethyl(oxido)-lambda6-sulfanylidene]amino}-N-[(1R)-1-(4-fluorophenyl)ethyl]-2-methylquinazolin-4-amine,CS(=O)(C)=NC=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,33,EGFR kinase inhibition IC50,>2.00E-5
33,"6,7-dimethoxy-N-[1-(7-methoxy-1-benzofuran-2-yl)ethyl]-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1OC2=C(C1)C=CC=C2OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,34,KRAS-SOS1 Interaction,0.53
33,"6,7-dimethoxy-N-[1-(7-methoxy-1-benzofuran-2-yl)ethyl]-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1OC2=C(C1)C=CC=C2OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,34,KRAS-Activation by SOS high GTP,0.24
33,"6,7-dimethoxy-N-[1-(7-methoxy-1-benzofuran-2-yl)ethyl]-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1OC2=C(C1)C=CC=C2OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,34,KRAS-Activation by SOS no GTP,0.09
33,"6,7-dimethoxy-N-[1-(7-methoxy-1-benzofuran-2-yl)ethyl]-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1OC2=C(C1)C=CC=C2OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,34,EGFR kinase inhibition IC50,>2.00E-5
34,"6-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2H-1,4-benzoxazin-3(4H)-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C=CC2=C(NC(CO2)=O)C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,35,KRAS-SOS1 Interaction,4.23e-06
34,"6-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2H-1,4-benzoxazin-3(4H)-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C=CC2=C(NC(CO2)=O)C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,35,KRAS-Activation by SOS high GTP,3.76e-06
34,"6-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2H-1,4-benzoxazin-3(4H)-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C=CC2=C(NC(CO2)=O)C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,35,KRAS-Activation by SOS no GTP,1.68e-05
34,"6-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2H-1,4-benzoxazin-3(4H)-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C=CC2=C(NC(CO2)=O)C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,35,EGFR kinase inhibition IC50,>2.00E-5
35,"6,7-dimethoxy-N-[1-(6-methoxy-2-naphthyl)ethyl]-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC2=CC=C(C=C2C=C1)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,36,KRAS-SOS1 Interaction,4.72e-06
35,"6,7-dimethoxy-N-[1-(6-methoxy-2-naphthyl)ethyl]-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC2=CC=C(C=C2C=C1)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,36,KRAS-Activation by SOS high GTP,4.78e-06
35,"6,7-dimethoxy-N-[1-(6-methoxy-2-naphthyl)ethyl]-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC2=CC=C(C=C2C=C1)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,36,KRAS-Activation by SOS no GTP,0.48
35,"6,7-dimethoxy-N-[1-(6-methoxy-2-naphthyl)ethyl]-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC2=CC=C(C=C2C=C1)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,36,EGFR kinase inhibition IC50,>2.00E-5
36,"N-[(1R)-1-(5'-amino-2'-methylbiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NC=1C=CC(=C(C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,37,KRAS-SOS1 Interaction,5.42e-07
36,"N-[(1R)-1-(5'-amino-2'-methylbiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NC=1C=CC(=C(C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,37,KRAS-Activation by SOS high GTP,1e-06
36,"N-[(1R)-1-(5'-amino-2'-methylbiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NC=1C=CC(=C(C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,37,KRAS-Activation by SOS no GTP,6.96e-07
36,"N-[(1R)-1-(5'-amino-2'-methylbiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NC=1C=CC(=C(C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,37,EGFR kinase inhibition IC50,
37,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(pyrimidin-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NC=NC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,38,KRAS-SOS1 Interaction,1.54e-06
37,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(pyrimidin-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NC=NC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,38,KRAS-Activation by SOS high GTP,1.85e-06
37,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(pyrimidin-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NC=NC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,38,KRAS-Activation by SOS no GTP,2.69e-06
37,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(pyrimidin-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NC=NC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,38,EGFR kinase inhibition IC50,
38,"N-{(1R)-1-[3'-(cyclopropylmethoxy)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)COC=1C=C(C=CC1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,39,KRAS-SOS1 Interaction,
38,"N-{(1R)-1-[3'-(cyclopropylmethoxy)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)COC=1C=C(C=CC1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,39,KRAS-Activation by SOS high GTP,
38,"N-{(1R)-1-[3'-(cyclopropylmethoxy)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)COC=1C=C(C=CC1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,39,KRAS-Activation by SOS no GTP,
38,"N-{(1R)-1-[3'-(cyclopropylmethoxy)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)COC=1C=C(C=CC1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,39,EGFR kinase inhibition IC50,
39,"N-{(1R)-1-[3-(isoquinolin-5-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1=NC=CC2=C(C=CC=C12)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,40,KRAS-SOS1 Interaction,1.46e-06
39,"N-{(1R)-1-[3-(isoquinolin-5-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1=NC=CC2=C(C=CC=C12)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,40,KRAS-Activation by SOS high GTP,1.83e-06
39,"N-{(1R)-1-[3-(isoquinolin-5-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1=NC=CC2=C(C=CC=C12)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,40,KRAS-Activation by SOS no GTP,3.05e-06
39,"N-{(1R)-1-[3-(isoquinolin-5-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1=NC=CC2=C(C=CC=C12)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,40,EGFR kinase inhibition IC50,
40,"N-[(1R)-1-(2'-chloro-6'-fluoro-3'-methylbiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC1=C(C(=CC=C1C)F)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,41,KRAS-SOS1 Interaction,3.85e-06
40,"N-[(1R)-1-(2'-chloro-6'-fluoro-3'-methylbiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC1=C(C(=CC=C1C)F)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,41,KRAS-Activation by SOS high GTP,1.75e-06
40,"N-[(1R)-1-(2'-chloro-6'-fluoro-3'-methylbiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC1=C(C(=CC=C1C)F)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,41,KRAS-Activation by SOS no GTP,4.55e-06
40,"N-[(1R)-1-(2'-chloro-6'-fluoro-3'-methylbiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC1=C(C(=CC=C1C)F)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,41,EGFR kinase inhibition IC50,
41,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(5-methylpyridin-3-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NC=C(C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,42,KRAS-SOS1 Interaction,9.72e-07
41,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(5-methylpyridin-3-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NC=C(C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,42,KRAS-Activation by SOS high GTP,1.4e-06
41,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(5-methylpyridin-3-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NC=C(C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,42,KRAS-Activation by SOS no GTP,1.87e-06
41,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(5-methylpyridin-3-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NC=C(C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,42,EGFR kinase inhibition IC50,
42,"6,7-dimethoxy-2-methyl-N-{1-[5-(pyrimidin-5-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=NC=NC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,43,KRAS-SOS1 Interaction,4.27e-06
42,"6,7-dimethoxy-2-methyl-N-{1-[5-(pyrimidin-5-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=NC=NC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,43,KRAS-Activation by SOS high GTP,5.58e-06
42,"6,7-dimethoxy-2-methyl-N-{1-[5-(pyrimidin-5-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=NC=NC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,43,KRAS-Activation by SOS no GTP,0.48
42,"6,7-dimethoxy-2-methyl-N-{1-[5-(pyrimidin-5-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=NC=NC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,43,EGFR kinase inhibition IC50,
43,"6,7-dimethoxy-2-methyl-N-[1-{5-[4-(morpholin-4-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC=C(C=C1)N1CCOCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,44,KRAS-SOS1 Interaction,0.3
43,"6,7-dimethoxy-2-methyl-N-[1-{5-[4-(morpholin-4-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC=C(C=C1)N1CCOCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,44,KRAS-Activation by SOS high GTP,0.14
43,"6,7-dimethoxy-2-methyl-N-[1-{5-[4-(morpholin-4-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC=C(C=C1)N1CCOCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,44,KRAS-Activation by SOS no GTP,0.16
43,"6,7-dimethoxy-2-methyl-N-[1-{5-[4-(morpholin-4-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC=C(C=C1)N1CCOCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,44,EGFR kinase inhibition IC50,
44,"6,7-dimethoxy-2-methyl-N-[1-{5-[3-(morpholin-4-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)N1CCOCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,45,KRAS-SOS1 Interaction,0.55
44,"6,7-dimethoxy-2-methyl-N-[1-{5-[3-(morpholin-4-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)N1CCOCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,45,KRAS-Activation by SOS high GTP,0.47
44,"6,7-dimethoxy-2-methyl-N-[1-{5-[3-(morpholin-4-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)N1CCOCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,45,KRAS-Activation by SOS no GTP,0.25
44,"6,7-dimethoxy-2-methyl-N-[1-{5-[3-(morpholin-4-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)N1CCOCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,45,EGFR kinase inhibition IC50,
45,"N-{1-[5-(isoquinolin-5-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1=NC=CC2=C(C=CC=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,46,KRAS-SOS1 Interaction,1.51e-06
45,"N-{1-[5-(isoquinolin-5-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1=NC=CC2=C(C=CC=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,46,KRAS-Activation by SOS high GTP,2.17e-06
45,"N-{1-[5-(isoquinolin-5-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1=NC=CC2=C(C=CC=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,46,KRAS-Activation by SOS no GTP,1.1e-06
45,"N-{1-[5-(isoquinolin-5-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1=NC=CC2=C(C=CC=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,46,EGFR kinase inhibition IC50,
46,"6,7-dimethoxy-2-methyl-N-(1-[5-(5-methylpyridin-3-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=NC=C(C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,47,KRAS-SOS1 Interaction,2.37e-06
46,"6,7-dimethoxy-2-methyl-N-(1-[5-(5-methylpyridin-3-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=NC=C(C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,47,KRAS-Activation by SOS high GTP,3.82e-06
46,"6,7-dimethoxy-2-methyl-N-(1-[5-(5-methylpyridin-3-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=NC=C(C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,47,KRAS-Activation by SOS no GTP,4.1e-06
46,"6,7-dimethoxy-2-methyl-N-(1-[5-(5-methylpyridin-3-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=NC=C(C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,47,EGFR kinase inhibition IC50,
47,"6,7-dimethoxy-2-methyl-N-{1-[5-(2-propoxyphenyl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)OCCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,48,KRAS-SOS1 Interaction,0.4
47,"6,7-dimethoxy-2-methyl-N-{1-[5-(2-propoxyphenyl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)OCCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,48,KRAS-Activation by SOS high GTP,0.22
47,"6,7-dimethoxy-2-methyl-N-{1-[5-(2-propoxyphenyl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)OCCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,48,KRAS-Activation by SOS no GTP,0.17
47,"6,7-dimethoxy-2-methyl-N-{1-[5-(2-propoxyphenyl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)OCCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,48,EGFR kinase inhibition IC50,
48,"2-(5-(1-[(6J-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N,N-dimethylbenzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C(=O)N(C)C)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,49,KRAS-SOS1 Interaction,2.12e-06
48,"2-(5-(1-[(6J-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N,N-dimethylbenzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C(=O)N(C)C)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,49,KRAS-Activation by SOS high GTP,3.27e-06
48,"2-(5-(1-[(6J-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N,N-dimethylbenzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C(=O)N(C)C)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,49,KRAS-Activation by SOS no GTP,4.52e-06
48,"2-(5-(1-[(6J-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N,N-dimethylbenzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C(=O)N(C)C)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,49,EGFR kinase inhibition IC50,
49,"6,7-dimethoxy-2-methyl-N-{1-[5-(1-methyl-1H-indol-5-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=C2C=CN(C2=CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,50,KRAS-SOS1 Interaction,1.96e-05
49,"6,7-dimethoxy-2-methyl-N-{1-[5-(1-methyl-1H-indol-5-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=C2C=CN(C2=CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,50,KRAS-Activation by SOS high GTP,0.35
49,"6,7-dimethoxy-2-methyl-N-{1-[5-(1-methyl-1H-indol-5-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=C2C=CN(C2=CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,50,KRAS-Activation by SOS no GTP,0.36
49,"6,7-dimethoxy-2-methyl-N-{1-[5-(1-methyl-1H-indol-5-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=C2C=CN(C2=CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,50,EGFR kinase inhibition IC50,
50,"6,7-dimethoxy-N-[1-{5-[2-(methoxymethyl)phenyl]thiophen-2-yl}ethyl]-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)COC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,51,KRAS-SOS1 Interaction,9.85e-06
50,"6,7-dimethoxy-N-[1-{5-[2-(methoxymethyl)phenyl]thiophen-2-yl}ethyl]-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)COC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,51,KRAS-Activation by SOS high GTP,2e-05
50,"6,7-dimethoxy-N-[1-{5-[2-(methoxymethyl)phenyl]thiophen-2-yl}ethyl]-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)COC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,51,KRAS-Activation by SOS no GTP,0.23
50,"6,7-dimethoxy-N-[1-{5-[2-(methoxymethyl)phenyl]thiophen-2-yl}ethyl]-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)COC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,51,EGFR kinase inhibition IC50,
51,"3-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N,N-dimethylbenzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C(=O)N(C)C)C=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,52,KRAS-SOS1 Interaction,5.63e-06
51,"3-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N,N-dimethylbenzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C(=O)N(C)C)C=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,52,KRAS-Activation by SOS high GTP,5.9e-06
51,"3-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N,N-dimethylbenzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C(=O)N(C)C)C=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,52,KRAS-Activation by SOS no GTP,0.52
51,"3-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N,N-dimethylbenzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C(=O)N(C)C)C=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,52,EGFR kinase inhibition IC50,
52,"(5'-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2,2'-bithiophen-5-yl)methanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1SC(=CC1)CO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,53,KRAS-SOS1 Interaction,4.29e-06
52,"(5'-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2,2'-bithiophen-5-yl)methanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1SC(=CC1)CO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,53,KRAS-Activation by SOS high GTP,5.46e-06
52,"(5'-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2,2'-bithiophen-5-yl)methanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1SC(=CC1)CO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,53,KRAS-Activation by SOS no GTP,0.43
52,"(5'-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2,2'-bithiophen-5-yl)methanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1SC(=CC1)CO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,53,EGFR kinase inhibition IC50,
53,"6,7-dimethoxy-2-methyl-N-(1-[5-(3-methylpyridin-4-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=NC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,54,KRAS-SOS1 Interaction,6.69e-07
53,"6,7-dimethoxy-2-methyl-N-(1-[5-(3-methylpyridin-4-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=NC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,54,KRAS-Activation by SOS high GTP,1.28e-06
53,"6,7-dimethoxy-2-methyl-N-(1-[5-(3-methylpyridin-4-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=NC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,54,KRAS-Activation by SOS no GTP,1.08e-06
53,"6,7-dimethoxy-2-methyl-N-(1-[5-(3-methylpyridin-4-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=NC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,54,EGFR kinase inhibition IC50,
54,"N-{1-[5-(1H-indol-6-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=CC=C(C=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,55,KRAS-SOS1 Interaction,4.19e-06
54,"N-{1-[5-(1H-indol-6-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=CC=C(C=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,55,KRAS-Activation by SOS high GTP,4.13e-06
54,"N-{1-[5-(1H-indol-6-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=CC=C(C=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,55,KRAS-Activation by SOS no GTP,4.97e-06
54,"N-{1-[5-(1H-indol-6-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=CC=C(C=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,55,EGFR kinase inhibition IC50,
55,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)C=1OC(=NN1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,56,KRAS-SOS1 Interaction,6.74e-07
55,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)C=1OC(=NN1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,56,KRAS-Activation by SOS high GTP,6.29e-07
55,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)C=1OC(=NN1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,56,KRAS-Activation by SOS no GTP,7.24e-07
55,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)C=1OC(=NN1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,56,EGFR kinase inhibition IC50,
56,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{3-[5-(methylsulfonyl)pyridin-3-yl]phenyl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NC=C(C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,57,KRAS-SOS1 Interaction,1.47e-06
56,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{3-[5-(methylsulfonyl)pyridin-3-yl]phenyl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NC=C(C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,57,KRAS-Activation by SOS high GTP,1.79e-06
56,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{3-[5-(methylsulfonyl)pyridin-3-yl]phenyl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NC=C(C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,57,KRAS-Activation by SOS no GTP,2.56e-06
56,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{3-[5-(methylsulfonyl)pyridin-3-yl]phenyl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NC=C(C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,57,EGFR kinase inhibition IC50,
57,"5-(3-((1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)-1,3-dihydro-2H-indol-2-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C=1C=C2CC(NC2=CC1)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,58,KRAS-SOS1 Interaction,4.14e-07
57,"5-(3-((1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)-1,3-dihydro-2H-indol-2-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C=1C=C2CC(NC2=CC1)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,58,KRAS-Activation by SOS high GTP,4.01e-07
57,"5-(3-((1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)-1,3-dihydro-2H-indol-2-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C=1C=C2CC(NC2=CC1)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,58,KRAS-Activation by SOS no GTP,8.29e-07
57,"5-(3-((1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)-1,3-dihydro-2H-indol-2-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C=1C=C2CC(NC2=CC1)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,58,EGFR kinase inhibition IC50,
58,"N-{(1R)-1-[3-(2,2-dimethylcyclopropyl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1(C(C1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,59,KRAS-SOS1 Interaction,1.77e-06
58,"N-{(1R)-1-[3-(2,2-dimethylcyclopropyl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1(C(C1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,59,KRAS-Activation by SOS high GTP,1.64e-06
58,"N-{(1R)-1-[3-(2,2-dimethylcyclopropyl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1(C(C1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,59,KRAS-Activation by SOS no GTP,3.11e-06
58,"N-{(1R)-1-[3-(2,2-dimethylcyclopropyl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1(C(C1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,59,EGFR kinase inhibition IC50,
59,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)C=1OC(=NN1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,60,KRAS-SOS1 Interaction,1.59e-06
59,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)C=1OC(=NN1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,60,KRAS-Activation by SOS high GTP,7.7e-07
59,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)C=1OC(=NN1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,60,KRAS-Activation by SOS no GTP,9.65e-07
59,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)C=1OC(=NN1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,60,EGFR kinase inhibition IC50,
60,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrrolo[2,3-b]pyridin-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=C2C(=NC1)NC=C2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,61,KRAS-SOS1 Interaction,5.85e-07
60,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrrolo[2,3-b]pyridin-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=C2C(=NC1)NC=C2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,61,KRAS-Activation by SOS high GTP,4.48e-07
60,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrrolo[2,3-b]pyridin-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=C2C(=NC1)NC=C2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,61,KRAS-Activation by SOS no GTP,1.94e-06
60,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrrolo[2,3-b]pyridin-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=C2C(=NC1)NC=C2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,61,EGFR kinase inhibition IC50,
61,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-3-sulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)S(=O)(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,62,KRAS-SOS1 Interaction,3.74e-07
61,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-3-sulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)S(=O)(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,62,KRAS-Activation by SOS high GTP,7.17e-07
61,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-3-sulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)S(=O)(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,62,KRAS-Activation by SOS no GTP,8.95e-07
61,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-3-sulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)S(=O)(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,62,EGFR kinase inhibition IC50,
62,"N-{(1R)-1-[3-(2-aminopyrimidin-5-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NC1=NC=C(C=N1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,63,KRAS-SOS1 Interaction,1.28e-06
62,"N-{(1R)-1-[3-(2-aminopyrimidin-5-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NC1=NC=C(C=N1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,63,KRAS-Activation by SOS high GTP,2.77e-06
62,"N-{(1R)-1-[3-(2-aminopyrimidin-5-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NC1=NC=C(C=N1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,63,KRAS-Activation by SOS no GTP,2.83e-06
62,"N-{(1R)-1-[3-(2-aminopyrimidin-5-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NC1=NC=C(C=N1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,63,EGFR kinase inhibition IC50,
63,"N-[(1R)-1-{3-[(E)-2-cyclopropylethenyl]phenyl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)/C=C/C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,64,KRAS-SOS1 Interaction,1.13e-06
63,"N-[(1R)-1-{3-[(E)-2-cyclopropylethenyl]phenyl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)/C=C/C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,64,KRAS-Activation by SOS high GTP,1.87e-06
63,"N-[(1R)-1-{3-[(E)-2-cyclopropylethenyl]phenyl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)/C=C/C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,64,KRAS-Activation by SOS no GTP,1.88e-06
63,"N-[(1R)-1-{3-[(E)-2-cyclopropylethenyl]phenyl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)/C=C/C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,64,EGFR kinase inhibition IC50,
64,"N-{(1R)-1-[2'-(ethoxymethyl)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C)OCC1=C(C=CC=C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,65,KRAS-SOS1 Interaction,1.4e-06
64,"N-{(1R)-1-[2'-(ethoxymethyl)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C)OCC1=C(C=CC=C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,65,KRAS-Activation by SOS high GTP,1.98e-06
64,"N-{(1R)-1-[2'-(ethoxymethyl)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C)OCC1=C(C=CC=C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,65,KRAS-Activation by SOS no GTP,2.21e-06
64,"N-{(1R)-1-[2'-(ethoxymethyl)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C)OCC1=C(C=CC=C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,65,EGFR kinase inhibition IC50,
65,"N-[(1R)-1-(3'-fluoro-5'-methoxybiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC=1C=C(C=C(C1)OC)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,66,KRAS-SOS1 Interaction,5.78e-06
65,"N-[(1R)-1-(3'-fluoro-5'-methoxybiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC=1C=C(C=C(C1)OC)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,66,KRAS-Activation by SOS high GTP,8.34e-06
65,"N-[(1R)-1-(3'-fluoro-5'-methoxybiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC=1C=C(C=C(C1)OC)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,66,KRAS-Activation by SOS no GTP,1.35e-05
65,"N-[(1R)-1-(3'-fluoro-5'-methoxybiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC=1C=C(C=C(C1)OC)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,66,EGFR kinase inhibition IC50,
66,"6,7-dimethoxy-N-{(1R)-1-[3-(5-methoxy-1-benzofuran-2-yl)phenyl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1OC2=C(C1)C=C(C=C2)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,67,KRAS-SOS1 Interaction,3.48e-06
66,"6,7-dimethoxy-N-{(1R)-1-[3-(5-methoxy-1-benzofuran-2-yl)phenyl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1OC2=C(C1)C=C(C=C2)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,67,KRAS-Activation by SOS high GTP,4.55e-06
66,"6,7-dimethoxy-N-{(1R)-1-[3-(5-methoxy-1-benzofuran-2-yl)phenyl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1OC2=C(C1)C=C(C=C2)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,67,KRAS-Activation by SOS no GTP,8.8e-06
66,"6,7-dimethoxy-N-{(1R)-1-[3-(5-methoxy-1-benzofuran-2-yl)phenyl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1OC2=C(C1)C=C(C=C2)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,67,EGFR kinase inhibition IC50,
67,"N-[(1R)-1-(2'-butoxy-6'-fluorobiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(CCC)OC1=C(C(=CC=C1)F)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,68,KRAS-SOS1 Interaction,9.98e-06
67,"N-[(1R)-1-(2'-butoxy-6'-fluorobiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(CCC)OC1=C(C(=CC=C1)F)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,68,KRAS-Activation by SOS high GTP,1.98e-05
67,"N-[(1R)-1-(2'-butoxy-6'-fluorobiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(CCC)OC1=C(C(=CC=C1)F)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,68,KRAS-Activation by SOS no GTP,0.54
67,"N-[(1R)-1-(2'-butoxy-6'-fluorobiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(CCC)OC1=C(C(=CC=C1)F)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,68,EGFR kinase inhibition IC50,
68,"5-(3-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)pyridin-2-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C=1C=CC(=NC1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,69,KRAS-SOS1 Interaction,1.37e-07
68,"5-(3-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)pyridin-2-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C=1C=CC(=NC1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,69,KRAS-Activation by SOS high GTP,4.86e-07
68,"5-(3-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)pyridin-2-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C=1C=CC(=NC1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,69,KRAS-Activation by SOS no GTP,4.71e-07
68,"5-(3-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)pyridin-2-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C=1C=CC(=NC1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,69,EGFR kinase inhibition IC50,6.92e-06
69,"2-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-4-yl)-2-methylpropanenitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)C(C#N)(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,70,KRAS-SOS1 Interaction,3.92e-06
69,"2-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-4-yl)-2-methylpropanenitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)C(C#N)(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,70,KRAS-Activation by SOS high GTP,5.41e-06
69,"2-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-4-yl)-2-methylpropanenitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)C(C#N)(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,70,KRAS-Activation by SOS no GTP,9.97e-06
69,"2-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-4-yl)-2-methylpropanenitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)C(C#N)(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,70,EGFR kinase inhibition IC50,
70,"6,7-dimethoxy-2-methyl-N-[1-(5-phenylthiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,71,KRAS-SOS1 Interaction,6.82e-06
70,"6,7-dimethoxy-2-methyl-N-[1-(5-phenylthiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,71,KRAS-Activation by SOS high GTP,8.82e-06
70,"6,7-dimethoxy-2-methyl-N-[1-(5-phenylthiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,71,KRAS-Activation by SOS no GTP,0.47
70,"6,7-dimethoxy-2-methyl-N-[1-(5-phenylthiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,71,EGFR kinase inhibition IC50,
71,"N-[(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-3-yl)methyl]methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)CNS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,72,KRAS-SOS1 Interaction,3.93e-07
71,"N-[(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-3-yl)methyl]methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)CNS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,72,KRAS-Activation by SOS high GTP,8.43e-07
71,"N-[(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-3-yl)methyl]methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)CNS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,72,KRAS-Activation by SOS no GTP,6.8e-07
71,"N-[(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-3-yl)methyl]methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)CNS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,72,EGFR kinase inhibition IC50,
72,"N-[(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-4-yl)methyl]methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)CNS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,73,KRAS-SOS1 Interaction,7.37e-07
72,"N-[(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-4-yl)methyl]methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)CNS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,73,KRAS-Activation by SOS high GTP,8.68e-07
72,"N-[(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-4-yl)methyl]methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)CNS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,73,KRAS-Activation by SOS no GTP,8.82e-07
72,"N-[(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-4-yl)methyl]methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)CNS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,73,EGFR kinase inhibition IC50,
73,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N-propylbiphenyl-4-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)C(=O)NCCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,74,KRAS-SOS1 Interaction,4.27e-07
73,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N-propylbiphenyl-4-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)C(=O)NCCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,74,KRAS-Activation by SOS high GTP,5.54e-07
73,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N-propylbiphenyl-4-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)C(=O)NCCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,74,KRAS-Activation by SOS no GTP,4.95e-07
73,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N-propylbiphenyl-4-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)C(=O)NCCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,74,EGFR kinase inhibition IC50,
74,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N-[2-(dimethylamino)ethyl]biphenyl-4-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)C(=O)NCCN(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,75,KRAS-SOS1 Interaction,1.49e-07
74,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N-[2-(dimethylamino)ethyl]biphenyl-4-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)C(=O)NCCN(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,75,KRAS-Activation by SOS high GTP,2.23e-07
74,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N-[2-(dimethylamino)ethyl]biphenyl-4-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)C(=O)NCCN(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,75,KRAS-Activation by SOS no GTP,2.61e-07
74,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N-[2-(dimethylamino)ethyl]biphenyl-4-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)C(=O)NCCN(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,75,EGFR kinase inhibition IC50,
75,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-3-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C1=NNC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,76,KRAS-SOS1 Interaction,5.88e-07
75,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-3-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C1=NNC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,76,KRAS-Activation by SOS high GTP,1.15e-06
75,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-3-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C1=NNC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,76,KRAS-Activation by SOS no GTP,1.01e-06
75,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-3-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C1=NNC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,76,EGFR kinase inhibition IC50,
76,"N-[(1R)-1-{3-[(2E)-but-2-en-2-yl]phenyl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C/C(=C\C)/C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,77,KRAS-SOS1 Interaction,4.71e-07
76,"N-[(1R)-1-{3-[(2E)-but-2-en-2-yl]phenyl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C/C(=C\C)/C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,77,KRAS-Activation by SOS high GTP,1.19e-06
76,"N-[(1R)-1-{3-[(2E)-but-2-en-2-yl]phenyl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C/C(=C\C)/C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,77,KRAS-Activation by SOS no GTP,9.52e-07
76,"N-[(1R)-1-{3-[(2E)-but-2-en-2-yl]phenyl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C/C(=C\C)/C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,77,EGFR kinase inhibition IC50,
77,"N-[(1R)-1-(5'-chloro-2'-propoxybiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=CC(=C(C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)OCCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,78,KRAS-SOS1 Interaction,7.88e-06
77,"N-[(1R)-1-(5'-chloro-2'-propoxybiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=CC(=C(C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)OCCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,78,KRAS-Activation by SOS high GTP,9.83e-06
77,"N-[(1R)-1-(5'-chloro-2'-propoxybiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=CC(=C(C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)OCCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,78,KRAS-Activation by SOS no GTP,1.99e-05
77,"N-[(1R)-1-(5'-chloro-2'-propoxybiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=CC(=C(C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)OCCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,78,EGFR kinase inhibition IC50,
78,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{3-[(1E)-3-phenylprop-1-en-1-yl]phenyl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)\C=C\CC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,79,KRAS-SOS1 Interaction,8.55e-06
78,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{3-[(1E)-3-phenylprop-1-en-1-yl]phenyl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)\C=C\CC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,79,KRAS-Activation by SOS high GTP,0.45
78,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{3-[(1E)-3-phenylprop-1-en-1-yl]phenyl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)\C=C\CC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,79,KRAS-Activation by SOS no GTP,0.31
78,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{3-[(1E)-3-phenylprop-1-en-1-yl]phenyl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)\C=C\CC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,79,EGFR kinase inhibition IC50,
79,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4'-(morpholin-4-yl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)N1CCOCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,80,KRAS-SOS1 Interaction,1.55e-06
79,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4'-(morpholin-4-yl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)N1CCOCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,80,KRAS-Activation by SOS high GTP,9.37e-07
79,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4'-(morpholin-4-yl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)N1CCOCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,80,KRAS-Activation by SOS no GTP,1.85e-06
79,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4'-(morpholin-4-yl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)N1CCOCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,80,EGFR kinase inhibition IC50,
80,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3'-(morpholin-4-yl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)N1CCOCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,81,KRAS-SOS1 Interaction,7.21e-07
80,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3'-(morpholin-4-yl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)N1CCOCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,81,KRAS-Activation by SOS high GTP,7.11e-07
80,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3'-(morpholin-4-yl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)N1CCOCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,81,KRAS-Activation by SOS no GTP,1.12e-06
80,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3'-(morpholin-4-yl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)N1CCOCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,81,EGFR kinase inhibition IC50,
81,"N-{(1R)-1-[2'-(benzyloxy)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)OC1=C(C=CC=C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,82,KRAS-SOS1 Interaction,0.42
81,"N-{(1R)-1-[2'-(benzyloxy)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)OC1=C(C=CC=C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,82,KRAS-Activation by SOS high GTP,0.33
81,"N-{(1R)-1-[2'-(benzyloxy)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)OC1=C(C=CC=C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,82,KRAS-Activation by SOS no GTP,0.24
81,"N-{(1R)-1-[2'-(benzyloxy)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)OC1=C(C=CC=C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,82,EGFR kinase inhibition IC50,
82,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4'-(methylsulfonyl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,83,KRAS-SOS1 Interaction,5.98e-07
82,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4'-(methylsulfonyl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,83,KRAS-Activation by SOS high GTP,8.57e-07
82,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4'-(methylsulfonyl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,83,KRAS-Activation by SOS no GTP,1e-06
82,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4'-(methylsulfonyl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,83,EGFR kinase inhibition IC50,
83,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[2'-(trifluoromethoxy)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)OC(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,84,KRAS-SOS1 Interaction,8.5e-06
83,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[2'-(trifluoromethoxy)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)OC(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,84,KRAS-Activation by SOS high GTP,7.85e-06
83,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[2'-(trifluoromethoxy)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)OC(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,84,KRAS-Activation by SOS no GTP,1.74e-05
83,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[2'-(trifluoromethoxy)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)OC(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,84,EGFR kinase inhibition IC50,
84,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3'-(trifluoromethoxy)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)OC(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,85,KRAS-SOS1 Interaction,5.33e-06
84,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3'-(trifluoromethoxy)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)OC(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,85,KRAS-Activation by SOS high GTP,7.29e-06
84,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3'-(trifluoromethoxy)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)OC(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,85,KRAS-Activation by SOS no GTP,1.1e-05
84,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3'-(trifluoromethoxy)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)OC(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,85,EGFR kinase inhibition IC50,
85,"N-{(1R)-1-[3-(1H-indol-5-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=CC(=CC=C12)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,86,KRAS-SOS1 Interaction,8.87e-07
85,"N-{(1R)-1-[3-(1H-indol-5-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=CC(=CC=C12)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,86,KRAS-Activation by SOS high GTP,7.58e-07
85,"N-{(1R)-1-[3-(1H-indol-5-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=CC(=CC=C12)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,86,KRAS-Activation by SOS no GTP,1.26e-06
85,"N-{(1R)-1-[3-(1H-indol-5-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=CC(=CC=C12)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,86,EGFR kinase inhibition IC50,
86,"N-{(1R)-1-[3-(furan-3-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1C=C(C=C1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,87,KRAS-SOS1 Interaction,5.81e-07
86,"N-{(1R)-1-[3-(furan-3-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1C=C(C=C1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,87,KRAS-Activation by SOS high GTP,9.35e-07
86,"N-{(1R)-1-[3-(furan-3-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1C=C(C=C1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,87,KRAS-Activation by SOS no GTP,8.93e-07
86,"N-{(1R)-1-[3-(furan-3-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1C=C(C=C1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,87,EGFR kinase inhibition IC50,
87,"N-{(1R)-1-[3-(1-benzothiophen-3-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=C(C2=C1C=CC=C2)C=2C=C(C=CC2)[C@@H](C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,88,KRAS-SOS1 Interaction,4.42e-06
87,"N-{(1R)-1-[3-(1-benzothiophen-3-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=C(C2=C1C=CC=C2)C=2C=C(C=CC2)[C@@H](C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,88,KRAS-Activation by SOS high GTP,3.48e-06
87,"N-{(1R)-1-[3-(1-benzothiophen-3-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=C(C2=C1C=CC=C2)C=2C=C(C=CC2)[C@@H](C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,88,KRAS-Activation by SOS no GTP,7.42e-06
87,"N-{(1R)-1-[3-(1-benzothiophen-3-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=C(C2=C1C=CC=C2)C=2C=C(C=CC2)[C@@H](C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,88,EGFR kinase inhibition IC50,
88,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1-methyl-1H-indol-2-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1N(C2=CC=CC=C2C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,89,KRAS-SOS1 Interaction,3.58e-06
88,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1-methyl-1H-indol-2-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1N(C2=CC=CC=C2C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,89,KRAS-Activation by SOS high GTP,2.58e-06
88,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1-methyl-1H-indol-2-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1N(C2=CC=CC=C2C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,89,KRAS-Activation by SOS no GTP,8.18e-06
88,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1-methyl-1H-indol-2-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1N(C2=CC=CC=C2C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,89,EGFR kinase inhibition IC50,
89,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{3-[(1E)-pent-1-en-1-yl]phenyl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)\C=C\CCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,90,KRAS-SOS1 Interaction,1.88e-06
89,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{3-[(1E)-pent-1-en-1-yl]phenyl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)\C=C\CCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,90,KRAS-Activation by SOS high GTP,2.88e-06
89,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{3-[(1E)-pent-1-en-1-yl]phenyl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)\C=C\CCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,90,KRAS-Activation by SOS no GTP,4.28e-06
89,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{3-[(1E)-pent-1-en-1-yl]phenyl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)\C=C\CCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,90,EGFR kinase inhibition IC50,
90,"N-[(1R)-1-{3-[(E)-2-cyclohexylethenyl]phenyl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CCCCC1)/C=C/C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,91,KRAS-SOS1 Interaction,1.1e-05
90,"N-[(1R)-1-{3-[(E)-2-cyclohexylethenyl]phenyl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CCCCC1)/C=C/C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,91,KRAS-Activation by SOS high GTP,0.48
90,"N-[(1R)-1-{3-[(E)-2-cyclohexylethenyl]phenyl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CCCCC1)/C=C/C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,91,KRAS-Activation by SOS no GTP,0.33
90,"N-[(1R)-1-{3-[(E)-2-cyclohexylethenyl]phenyl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CCCCC1)/C=C/C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,91,EGFR kinase inhibition IC50,
91,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(2'-phenoxybiphenyl-3-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)OC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,92,KRAS-SOS1 Interaction,1.5e-05
91,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(2'-phenoxybiphenyl-3-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)OC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,92,KRAS-Activation by SOS high GTP,0.38
91,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(2'-phenoxybiphenyl-3-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)OC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,92,KRAS-Activation by SOS no GTP,0.38
91,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(2'-phenoxybiphenyl-3-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)OC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,92,EGFR kinase inhibition IC50,
92,"tert-butyl(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-4-yl)carbamate",C(C)(C)(C)OC(NC1=CC=C(C=C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,93,KRAS-SOS1 Interaction,4.7e-06
92,"tert-butyl(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-4-yl)carbamate",C(C)(C)(C)OC(NC1=CC=C(C=C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,93,KRAS-Activation by SOS high GTP,3.87e-06
92,"tert-butyl(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-4-yl)carbamate",C(C)(C)(C)OC(NC1=CC=C(C=C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,93,KRAS-Activation by SOS no GTP,9.26e-06
92,"tert-butyl(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-4-yl)carbamate",C(C)(C)(C)OC(NC1=CC=C(C=C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,93,EGFR kinase inhibition IC50,
93,"(2E)-3-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-3-yl)prop-2-enenitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)/C=C/C#N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,94,KRAS-SOS1 Interaction,1.85e-06
93,"(2E)-3-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-3-yl)prop-2-enenitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)/C=C/C#N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,94,KRAS-Activation by SOS high GTP,1.58e-06
93,"(2E)-3-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-3-yl)prop-2-enenitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)/C=C/C#N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,94,KRAS-Activation by SOS no GTP,2.89e-06
93,"(2E)-3-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-3-yl)prop-2-enenitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)/C=C/C#N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,94,EGFR kinase inhibition IC50,
94,"N-[(1R)-1-(2',4'-dimethylbiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1=C(C=CC(=C1)C)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,95,KRAS-SOS1 Interaction,2.42e-06
94,"N-[(1R)-1-(2',4'-dimethylbiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1=C(C=CC(=C1)C)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,95,KRAS-Activation by SOS high GTP,3.14e-06
94,"N-[(1R)-1-(2',4'-dimethylbiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1=C(C=CC(=C1)C)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,95,KRAS-Activation by SOS no GTP,4.28e-06
94,"N-[(1R)-1-(2',4'-dimethylbiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1=C(C=CC(=C1)C)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,95,EGFR kinase inhibition IC50,
95,"1-[5-(3-((1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)thiophen-2-yl]ethanone",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(S1)C(C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,96,KRAS-SOS1 Interaction,8.91e-07
95,"1-[5-(3-((1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)thiophen-2-yl]ethanone",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(S1)C(C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,96,KRAS-Activation by SOS high GTP,4.73e-07
95,"1-[5-(3-((1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)thiophen-2-yl]ethanone",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(S1)C(C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,96,KRAS-Activation by SOS no GTP,1.98e-06
95,"1-[5-(3-((1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)thiophen-2-yl]ethanone",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(S1)C(C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,96,EGFR kinase inhibition IC50,
96,"N-{(1R)-1-[3-(1,3-benzodioxol-5-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1COC2=C1C=CC(=C2)C=2C=C(C=CC2)[C@@H](C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,97,KRAS-SOS1 Interaction,1.84e-06
96,"N-{(1R)-1-[3-(1,3-benzodioxol-5-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1COC2=C1C=CC(=C2)C=2C=C(C=CC2)[C@@H](C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,97,KRAS-Activation by SOS high GTP,1.09e-06
96,"N-{(1R)-1-[3-(1,3-benzodioxol-5-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1COC2=C1C=CC(=C2)C=2C=C(C=CC2)[C@@H](C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,97,KRAS-Activation by SOS no GTP,1.39e-06
96,"N-{(1R)-1-[3-(1,3-benzodioxol-5-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1COC2=C1C=CC(=C2)C=2C=C(C=CC2)[C@@H](C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,97,EGFR kinase inhibition IC50,
97,"N-{(1R)-1-[4'-(benzyloxy)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)OC1=CC=C(C=C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,98,KRAS-SOS1 Interaction,0.39
97,"N-{(1R)-1-[4'-(benzyloxy)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)OC1=CC=C(C=C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,98,KRAS-Activation by SOS high GTP,0.28
97,"N-{(1R)-1-[4'-(benzyloxy)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)OC1=CC=C(C=C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,98,KRAS-Activation by SOS no GTP,0.38
97,"N-{(1R)-1-[4'-(benzyloxy)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)OC1=CC=C(C=C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,98,EGFR kinase inhibition IC50,
98,"N-{1-[5-(2,3-dihydro-1,4-benzodioxin-6-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCOC2=C1C=CC(=C2)C2=CC=C(S2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,99,KRAS-SOS1 Interaction,1.81e-05
98,"N-{1-[5-(2,3-dihydro-1,4-benzodioxin-6-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCOC2=C1C=CC(=C2)C2=CC=C(S2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,99,KRAS-Activation by SOS high GTP,0.43
98,"N-{1-[5-(2,3-dihydro-1,4-benzodioxin-6-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCOC2=C1C=CC(=C2)C2=CC=C(S2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,99,KRAS-Activation by SOS no GTP,0.24
98,"N-{1-[5-(2,3-dihydro-1,4-benzodioxin-6-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCOC2=C1C=CC(=C2)C2=CC=C(S2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,99,EGFR kinase inhibition IC50,
99,"6,7-dimethoxy-N-[(1R)-1-(3'-methoxybiphenyl-3-yl)ethyl]-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,100,KRAS-SOS1 Interaction,2.18e-06
99,"6,7-dimethoxy-N-[(1R)-1-(3'-methoxybiphenyl-3-yl)ethyl]-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,100,KRAS-Activation by SOS high GTP,1.42e-06
99,"6,7-dimethoxy-N-[(1R)-1-(3'-methoxybiphenyl-3-yl)ethyl]-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,100,KRAS-Activation by SOS no GTP,2.63e-06
99,"6,7-dimethoxy-N-[(1R)-1-(3'-methoxybiphenyl-3-yl)ethyl]-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,100,EGFR kinase inhibition IC50,
100,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3'-(trifluoromethyl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)C(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,101,KRAS-SOS1 Interaction,2.18e-08
100,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3'-(trifluoromethyl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)C(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,101,KRAS-Activation by SOS high GTP,1.42e-08
100,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3'-(trifluoromethyl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)C(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,101,KRAS-Activation by SOS no GTP,2.63e-06
100,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3'-(trifluoromethyl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)C(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,101,EGFR kinase inhibition IC50,
101,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N,N-dimethylbiphenyl-2-sulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C=1C(=CC=CC1)S(=O)(=O)N(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,102,KRAS-SOS1 Interaction,7.15e-07
101,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N,N-dimethylbiphenyl-2-sulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C=1C(=CC=CC1)S(=O)(=O)N(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,102,KRAS-Activation by SOS high GTP,8.97e-07
101,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N,N-dimethylbiphenyl-2-sulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C=1C(=CC=CC1)S(=O)(=O)N(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,102,KRAS-Activation by SOS no GTP,1.8e-06
101,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N,N-dimethylbiphenyl-2-sulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C=1C(=CC=CC1)S(=O)(=O)N(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,102,EGFR kinase inhibition IC50,
102,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(2'-propoxybiphenyl-3-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)OCCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,103,KRAS-SOS1 Interaction,8.38e-06
102,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(2'-propoxybiphenyl-3-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)OCCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,103,KRAS-Activation by SOS high GTP,3.58e-06
102,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(2'-propoxybiphenyl-3-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)OCCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,103,KRAS-Activation by SOS no GTP,1.15e-05
102,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(2'-propoxybiphenyl-3-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)OCCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,103,EGFR kinase inhibition IC50,
103,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N,N-dimethylbiphenyl-2-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C=1C(=CC=CC1)C(=O)N(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,104,KRAS-SOS1 Interaction,1.44e-06
103,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N,N-dimethylbiphenyl-2-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C=1C(=CC=CC1)C(=O)N(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,104,KRAS-Activation by SOS high GTP,2.48e-06
103,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N,N-dimethylbiphenyl-2-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C=1C(=CC=CC1)C(=O)N(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,104,KRAS-Activation by SOS no GTP,2.74e-06
103,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N,N-dimethylbiphenyl-2-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C=1C(=CC=CC1)C(=O)N(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,104,EGFR kinase inhibition IC50,
104,"6,7-dimethoxy-N-{(1R)-1-[2'-(methoxymethyl)biphenyl-3-yl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)COC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,105,KRAS-SOS1 Interaction,1.82e-06
104,"6,7-dimethoxy-N-{(1R)-1-[2'-(methoxymethyl)biphenyl-3-yl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)COC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,105,KRAS-Activation by SOS high GTP,1.99e-06
104,"6,7-dimethoxy-N-{(1R)-1-[2'-(methoxymethyl)biphenyl-3-yl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)COC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,105,KRAS-Activation by SOS no GTP,2.52e-06
104,"6,7-dimethoxy-N-{(1R)-1-[2'-(methoxymethyl)biphenyl-3-yl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)COC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,105,EGFR kinase inhibition IC50,
105,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1-methyl-1H-indol-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=C2C=CN(C2=CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,106,KRAS-SOS1 Interaction,2.4e-06
105,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1-methyl-1H-indol-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=C2C=CN(C2=CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,106,KRAS-Activation by SOS high GTP,1.39e-06
105,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1-methyl-1H-indol-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=C2C=CN(C2=CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,106,KRAS-Activation by SOS no GTP,2.77e-06
105,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1-methyl-1H-indol-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=C2C=CN(C2=CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,106,EGFR kinase inhibition IC50,
106,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N,N-dimethylbiphenyl-3-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)C(=O)N(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,107,KRAS-SOS1 Interaction,1.41e-06
106,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N,N-dimethylbiphenyl-3-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)C(=O)N(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,107,KRAS-Activation by SOS high GTP,1.53e-06
106,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N,N-dimethylbiphenyl-3-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)C(=O)N(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,107,KRAS-Activation by SOS no GTP,2.95e-06
106,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N,N-dimethylbiphenyl-3-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)C(=O)N(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,107,EGFR kinase inhibition IC50,
107,"[5-(3-((1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)thiophen-2-yl]methanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(S1)CO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,108,KRAS-SOS1 Interaction,3.19e-07
107,"[5-(3-((1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)thiophen-2-yl]methanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(S1)CO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,108,KRAS-Activation by SOS high GTP,4.87e-07
107,"[5-(3-((1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)thiophen-2-yl]methanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(S1)CO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,108,KRAS-Activation by SOS no GTP,4.38e-07
107,"[5-(3-((1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)thiophen-2-yl]methanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(S1)CO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,108,EGFR kinase inhibition IC50,
108,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(3-methylpyridin-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C1=C(C=NC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,109,KRAS-SOS1 Interaction,8.21e-07
108,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(3-methylpyridin-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C1=C(C=NC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,109,KRAS-Activation by SOS high GTP,9.01e-07
108,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(3-methylpyridin-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C1=C(C=NC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,109,KRAS-Activation by SOS no GTP,1.41e-06
108,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(3-methylpyridin-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C1=C(C=NC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,109,EGFR kinase inhibition IC50,
109,"N-{(1R)-1-[3-(1H-indol-6-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=CC=C(C=C12)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,110,KRAS-SOS1 Interaction,1.99e-06
109,"N-{(1R)-1-[3-(1H-indol-6-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=CC=C(C=C12)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,110,KRAS-Activation by SOS high GTP,3.92e-07
109,"N-{(1R)-1-[3-(1H-indol-6-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=CC=C(C=C12)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,110,KRAS-Activation by SOS no GTP,1.41e-06
109,"N-{(1R)-1-[3-(1H-indol-6-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=CC=C(C=C12)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,110,EGFR kinase inhibition IC50,
110,"N-{(1R)-1-[3-(1H-indol-4-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=C(C=CC=C12)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,111,KRAS-SOS1 Interaction,1.94e-06
110,"N-{(1R)-1-[3-(1H-indol-4-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=C(C=CC=C12)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,111,KRAS-Activation by SOS high GTP,9.08e-07
110,"N-{(1R)-1-[3-(1H-indol-4-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=C(C=CC=C12)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,111,KRAS-Activation by SOS no GTP,1.19e-06
110,"N-{(1R)-1-[3-(1H-indol-4-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=C(C=CC=C12)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,111,EGFR kinase inhibition IC50,
111,"6,7-dimethoxy-N-{(1R)-1-[3-(2-methoxypyrimidin-5-yl)phenyl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NC(=NC1)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,112,KRAS-SOS1 Interaction,2.18e-06
111,"6,7-dimethoxy-N-{(1R)-1-[3-(2-methoxypyrimidin-5-yl)phenyl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NC(=NC1)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,112,KRAS-Activation by SOS high GTP,1.67e-06
111,"6,7-dimethoxy-N-{(1R)-1-[3-(2-methoxypyrimidin-5-yl)phenyl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NC(=NC1)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,112,KRAS-Activation by SOS no GTP,3.34e-06
111,"6,7-dimethoxy-N-{(1R)-1-[3-(2-methoxypyrimidin-5-yl)phenyl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NC(=NC1)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,112,EGFR kinase inhibition IC50,
112,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3'-(methylsulfonyl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,113,KRAS-SOS1 Interaction,6.98e-07
112,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3'-(methylsulfonyl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,113,KRAS-Activation by SOS high GTP,9.48e-07
112,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3'-(methylsulfonyl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,113,KRAS-Activation by SOS no GTP,1.12e-06
112,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3'-(methylsulfonyl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,113,EGFR kinase inhibition IC50,
113,"N-{(1R)-1-[3-(2,3-dihydro-1-benzofuran-5-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCC2=C1C=CC(=C2)C=2C=C(C=CC2)[C@@H](C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,114,KRAS-SOS1 Interaction,1.35e-06
113,"N-{(1R)-1-[3-(2,3-dihydro-1-benzofuran-5-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCC2=C1C=CC(=C2)C=2C=C(C=CC2)[C@@H](C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,114,KRAS-Activation by SOS high GTP,8.39e-07
113,"N-{(1R)-1-[3-(2,3-dihydro-1-benzofuran-5-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCC2=C1C=CC(=C2)C=2C=C(C=CC2)[C@@H](C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,114,KRAS-Activation by SOS no GTP,2.19e-06
113,"N-{(1R)-1-[3-(2,3-dihydro-1-benzofuran-5-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCC2=C1C=CC(=C2)C=2C=C(C=CC2)[C@@H](C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,114,EGFR kinase inhibition IC50,
114,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{3-[(E)-2-phenylethenyl]phenyl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)\C=C\C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,115,KRAS-SOS1 Interaction,5.28e-06
114,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{3-[(E)-2-phenylethenyl]phenyl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)\C=C\C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,115,KRAS-Activation by SOS high GTP,2.39e-06
114,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{3-[(E)-2-phenylethenyl]phenyl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)\C=C\C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,115,KRAS-Activation by SOS no GTP,9.21e-06
114,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{3-[(E)-2-phenylethenyl]phenyl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)\C=C\C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,115,EGFR kinase inhibition IC50,
115,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N,N-dimethylbiphenyl-4-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)C(=O)N(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,116,KRAS-SOS1 Interaction,8.85e-07
115,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N,N-dimethylbiphenyl-4-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)C(=O)N(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,116,KRAS-Activation by SOS high GTP,8.92e-07
115,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N,N-dimethylbiphenyl-4-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)C(=O)N(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,116,KRAS-Activation by SOS no GTP,1.57e-06
115,"3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-N,N-dimethylbiphenyl-4-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC=C(C=C1)C(=O)N(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,116,EGFR kinase inhibition IC50,
116,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{3-[(1E)-prop-1-en-1-yl]phenyl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)\C=C\C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,117,KRAS-SOS1 Interaction,1.08e-06
116,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{3-[(1E)-prop-1-en-1-yl]phenyl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)\C=C\C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,117,KRAS-Activation by SOS high GTP,1.15e-06
116,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{3-[(1E)-prop-1-en-1-yl]phenyl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)\C=C\C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,117,KRAS-Activation by SOS no GTP,1.72e-06
116,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{3-[(1E)-prop-1-en-1-yl]phenyl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)\C=C\C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,117,EGFR kinase inhibition IC50,
117,"N-{(1R)-1-[3-(cyclopent-1-en-1-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(=CCCC1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,118,KRAS-SOS1 Interaction,1.85e-06
117,"N-{(1R)-1-[3-(cyclopent-1-en-1-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(=CCCC1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,118,KRAS-Activation by SOS high GTP,1.35e-06
117,"N-{(1R)-1-[3-(cyclopent-1-en-1-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(=CCCC1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,118,KRAS-Activation by SOS no GTP,3.98e-06
117,"N-{(1R)-1-[3-(cyclopent-1-en-1-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(=CCCC1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,118,EGFR kinase inhibition IC50,
118,"N-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-3-yl)methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)NS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,119,KRAS-SOS1 Interaction,5.29e-07
118,"N-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-3-yl)methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)NS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,119,KRAS-Activation by SOS high GTP,4.81e-07
118,"N-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-3-yl)methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)NS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,119,KRAS-Activation by SOS no GTP,7.74e-07
118,"N-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-3-yl)methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=CC=C1)NS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,119,EGFR kinase inhibition IC50,
119,"N-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-2-yl)acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)NC(C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,120,KRAS-SOS1 Interaction,8.58e-07
119,"N-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-2-yl)acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)NC(C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,120,KRAS-Activation by SOS high GTP,1.28e-06
119,"N-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-2-yl)acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)NC(C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,120,KRAS-Activation by SOS no GTP,1.48e-06
119,"N-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-2-yl)acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)NC(C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,120,EGFR kinase inhibition IC50,
120,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[2'-(methylsulfonyl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,121,KRAS-SOS1 Interaction,1.59e-06
120,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[2'-(methylsulfonyl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,121,KRAS-Activation by SOS high GTP,2.02e-06
120,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[2'-(methylsulfonyl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,121,KRAS-Activation by SOS no GTP,3.53e-06
120,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[2'-(methylsulfonyl)biphenyl-3-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,121,EGFR kinase inhibition IC50,
121,"N-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-2-yl)methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)NS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,122,KRAS-SOS1 Interaction,4.52e-07
121,"N-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-2-yl)methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)NS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,122,KRAS-Activation by SOS high GTP,6.79e-07
121,"N-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-2-yl)methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)NS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,122,KRAS-Activation by SOS no GTP,7.91e-07
121,"N-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-2-yl)methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)NS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,122,EGFR kinase inhibition IC50,
122,"N-{1-[5-(3,5-dichlorophenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=C(C=C(C1)Cl)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,123,KRAS-SOS1 Interaction,0.48
122,"N-{1-[5-(3,5-dichlorophenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=C(C=C(C1)Cl)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,123,KRAS-Activation by SOS high GTP,0.17
122,"N-{1-[5-(3,5-dichlorophenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=C(C=C(C1)Cl)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,123,KRAS-Activation by SOS no GTP,0.21
122,"N-{1-[5-(3,5-dichlorophenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=C(C=C(C1)Cl)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,123,EGFR kinase inhibition IC50,
123,"N-{(1R)-1-[3'-(benzyloxy)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)OC=1C=C(C=CC1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,124,KRAS-SOS1 Interaction,0.52
123,"N-{(1R)-1-[3'-(benzyloxy)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)OC=1C=C(C=CC1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,124,KRAS-Activation by SOS high GTP,1.31e-05
123,"N-{(1R)-1-[3'-(benzyloxy)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)OC=1C=C(C=CC1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,124,KRAS-Activation by SOS no GTP,0.42
123,"N-{(1R)-1-[3'-(benzyloxy)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)OC=1C=C(C=CC1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,124,EGFR kinase inhibition IC50,
124,"N-[(1R)-1-(3',5'-dichlorobiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=C(C=C(C1)Cl)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,125,KRAS-SOS1 Interaction,1.83e-05
124,"N-[(1R)-1-(3',5'-dichlorobiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=C(C=C(C1)Cl)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,125,KRAS-Activation by SOS high GTP,9.39e-06
124,"N-[(1R)-1-(3',5'-dichlorobiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=C(C=C(C1)Cl)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,125,KRAS-Activation by SOS no GTP,0.37
124,"N-[(1R)-1-(3',5'-dichlorobiphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=C(C=C(C1)Cl)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,125,EGFR kinase inhibition IC50,
125,"N-{(1R)-1-[3-(2,3-dihydro-1,4-benzodioxin-6-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCOC2=C1C=CC(=C2)C=2C=C(C=CC2)[C@@H](C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,126,KRAS-SOS1 Interaction,2.03e-06
125,"N-{(1R)-1-[3-(2,3-dihydro-1,4-benzodioxin-6-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCOC2=C1C=CC(=C2)C=2C=C(C=CC2)[C@@H](C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,126,KRAS-Activation by SOS high GTP,1.99e-06
125,"N-{(1R)-1-[3-(2,3-dihydro-1,4-benzodioxin-6-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCOC2=C1C=CC(=C2)C=2C=C(C=CC2)[C@@H](C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,126,KRAS-Activation by SOS no GTP,2.94e-06
125,"N-{(1R)-1-[3-(2,3-dihydro-1,4-benzodioxin-6-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCOC2=C1C=CC(=C2)C=2C=C(C=CC2)[C@@H](C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,126,EGFR kinase inhibition IC50,
126,"6,7-dimethoxy-2-methyl-N-[1-{5-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)C=1OC(=NN1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,127,KRAS-SOS1 Interaction,0.52
126,"6,7-dimethoxy-2-methyl-N-[1-{5-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)C=1OC(=NN1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,127,KRAS-Activation by SOS high GTP,0.31
126,"6,7-dimethoxy-2-methyl-N-[1-{5-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)C=1OC(=NN1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,127,KRAS-Activation by SOS no GTP,0.11
126,"6,7-dimethoxy-2-methyl-N-[1-{5-[3-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)C=1OC(=NN1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,127,EGFR kinase inhibition IC50,
127,"6,7-dimethoxy-2-methyl-N-[1-{5-[5-(methylsulfonyl)pyridin-3-yl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=NC=C(C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,128,KRAS-SOS1 Interaction,1.78e-05
127,"6,7-dimethoxy-2-methyl-N-[1-{5-[5-(methylsulfonyl)pyridin-3-yl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=NC=C(C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,128,KRAS-Activation by SOS high GTP,0.44
127,"6,7-dimethoxy-2-methyl-N-[1-{5-[5-(methylsulfonyl)pyridin-3-yl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=NC=C(C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,128,KRAS-Activation by SOS no GTP,0.42
127,"6,7-dimethoxy-2-methyl-N-[1-{5-[5-(methylsulfonyl)pyridin-3-yl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=NC=C(C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,128,EGFR kinase inhibition IC50,
128,"6,7-dimethoxy-2-methyl-N-[1-{5-[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC=C(C=C1)C=1OC(=NN1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,129,KRAS-SOS1 Interaction,1.39e-05
128,"6,7-dimethoxy-2-methyl-N-[1-{5-[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC=C(C=C1)C=1OC(=NN1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,129,KRAS-Activation by SOS high GTP,1.89e-05
128,"6,7-dimethoxy-2-methyl-N-[1-{5-[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC=C(C=C1)C=1OC(=NN1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,129,KRAS-Activation by SOS no GTP,0.16
128,"6,7-dimethoxy-2-methyl-N-[1-{5-[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC=C(C=C1)C=1OC(=NN1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,129,EGFR kinase inhibition IC50,
129,"6,7-dimethoxy-2-methyl-N-{1-[5-(1H-pyrrolo[2,3-b]pyridin-5-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=C2C(=NC1)NC=C2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,130,KRAS-SOS1 Interaction,1.48e-06
129,"6,7-dimethoxy-2-methyl-N-{1-[5-(1H-pyrrolo[2,3-b]pyridin-5-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=C2C(=NC1)NC=C2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,130,KRAS-Activation by SOS high GTP,2.38e-06
129,"6,7-dimethoxy-2-methyl-N-{1-[5-(1H-pyrrolo[2,3-b]pyridin-5-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=C2C(=NC1)NC=C2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,130,KRAS-Activation by SOS no GTP,3.45e-06
129,"6,7-dimethoxy-2-methyl-N-{1-[5-(1H-pyrrolo[2,3-b]pyridin-5-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=C2C(=NC1)NC=C2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,130,EGFR kinase inhibition IC50,
130,"3-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzenesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C=CC1)S(=O)(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,131,KRAS-SOS1 Interaction,3.43e-06
130,"3-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzenesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C=CC1)S(=O)(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,131,KRAS-Activation by SOS high GTP,4.31e-06
130,"3-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzenesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C=CC1)S(=O)(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,131,KRAS-Activation by SOS no GTP,1.17e-05
130,"3-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzenesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C=CC1)S(=O)(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,131,EGFR kinase inhibition IC50,
131,"N-{1-[5-(2-aminopyrimidin-5-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NC1=NC=C(C=N1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,132,KRAS-SOS1 Interaction,2.23e-06
131,"N-{1-[5-(2-aminopyrimidin-5-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NC1=NC=C(C=N1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,132,KRAS-Activation by SOS high GTP,3.37e-06
131,"N-{1-[5-(2-aminopyrimidin-5-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NC1=NC=C(C=N1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,132,KRAS-Activation by SOS no GTP,5.94e-06
131,"N-{1-[5-(2-aminopyrimidin-5-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NC1=NC=C(C=N1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,132,EGFR kinase inhibition IC50,
132,"N-[1-{5-[(E)-2-cyclopropylethenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)/C=C/C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,133,KRAS-SOS1 Interaction,8.58e-06
132,"N-[1-{5-[(E)-2-cyclopropylethenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)/C=C/C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,133,KRAS-Activation by SOS high GTP,8.05e-06
132,"N-[1-{5-[(E)-2-cyclopropylethenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)/C=C/C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,133,KRAS-Activation by SOS no GTP,0.46
132,"N-[1-{5-[(E)-2-cyclopropylethenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)/C=C/C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,133,EGFR kinase inhibition IC50,
133,"N-[1-{5-[2-(ethoxymethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C)OCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,134,KRAS-SOS1 Interaction,4.3e-06
133,"N-[1-{5-[2-(ethoxymethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C)OCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,134,KRAS-Activation by SOS high GTP,4.03e-06
133,"N-[1-{5-[2-(ethoxymethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C)OCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,134,KRAS-Activation by SOS no GTP,5.67e-06
133,"N-[1-{5-[2-(ethoxymethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C)OCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,134,EGFR kinase inhibition IC50,
134,"N-{1-[5-(3-fluoro-5-methoxyphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",FC=1C=C(C=C(C1)OC)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,135,KRAS-SOS1 Interaction,0.43
134,"N-{1-[5-(3-fluoro-5-methoxyphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",FC=1C=C(C=C(C1)OC)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,135,KRAS-Activation by SOS high GTP,0.23
134,"N-{1-[5-(3-fluoro-5-methoxyphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",FC=1C=C(C=C(C1)OC)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,135,KRAS-Activation by SOS no GTP,0.27
134,"N-{1-[5-(3-fluoro-5-methoxyphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",FC=1C=C(C=C(C1)OC)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,135,EGFR kinase inhibition IC50,
135,"N-[1-{5-[3-(benzyloxy)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)OC=1C=C(C=CC1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,136,KRAS-SOS1 Interaction,0.28
135,"N-[1-{5-[3-(benzyloxy)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)OC=1C=C(C=CC1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,136,KRAS-Activation by SOS high GTP,0.05
135,"N-[1-{5-[3-(benzyloxy)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)OC=1C=C(C=CC1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,136,KRAS-Activation by SOS no GTP,0.13
135,"N-[1-{5-[3-(benzyloxy)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)OC=1C=C(C=CC1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,136,EGFR kinase inhibition IC50,
136,"N-{1-[5-(2-butoxy-6-fluorophenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(CCC)OC1=C(C(=CC=C1)F)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,137,KRAS-SOS1 Interaction,0.37
136,"N-{1-[5-(2-butoxy-6-fluorophenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(CCC)OC1=C(C(=CC=C1)F)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,137,KRAS-Activation by SOS high GTP,0.29
136,"N-{1-[5-(2-butoxy-6-fluorophenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(CCC)OC1=C(C(=CC=C1)F)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,137,KRAS-Activation by SOS no GTP,0.18
136,"N-{1-[5-(2-butoxy-6-fluorophenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(CCC)OC1=C(C(=CC=C1)F)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,137,EGFR kinase inhibition IC50,
137,"2-[4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]-2-methylpropanenitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(C=C1)C(C#N)(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,138,KRAS-SOS1 Interaction,0.48
137,"2-[4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]-2-methylpropanenitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(C=C1)C(C#N)(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,138,KRAS-Activation by SOS high GTP,0.38
137,"2-[4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]-2-methylpropanenitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(C=C1)C(C#N)(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,138,KRAS-Activation by SOS no GTP,0.32
137,"2-[4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]-2-methylpropanenitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(C=C1)C(C#N)(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,138,EGFR kinase inhibition IC50,
138,"N-[4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(CNC(C)=O)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,139,KRAS-SOS1 Interaction,5.57e-06
138,"N-[4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(CNC(C)=O)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,139,KRAS-Activation by SOS high GTP,7.43e-06
138,"N-[4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(CNC(C)=O)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,139,KRAS-Activation by SOS no GTP,0.4
138,"N-[4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(CNC(C)=O)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,139,EGFR kinase inhibition IC50,
139,"N-[3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(CNS(=O)(=O)C)C=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,140,KRAS-SOS1 Interaction,4.7e-06
139,"N-[3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(CNS(=O)(=O)C)C=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,140,KRAS-Activation by SOS high GTP,6.13e-06
139,"N-[3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(CNS(=O)(=O)C)C=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,140,KRAS-Activation by SOS no GTP,0.41
139,"N-[3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(CNS(=O)(=O)C)C=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,140,EGFR kinase inhibition IC50,
140,"N-[4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(CNS(=O)(=O)C)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,141,KRAS-SOS1 Interaction,5.33e-06
140,"N-[4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(CNS(=O)(=O)C)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,141,KRAS-Activation by SOS high GTP,5.26e-06
140,"N-[4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(CNS(=O)(=O)C)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,141,KRAS-Activation by SOS no GTP,0.33
140,"N-[4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(CNS(=O)(=O)C)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,141,EGFR kinase inhibition IC50,
141,"4-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N-propylbenzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(C(=O)NCCC)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,142,KRAS-SOS1 Interaction,5.83e-06
141,"4-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N-propylbenzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(C(=O)NCCC)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,142,KRAS-Activation by SOS high GTP,0.25
141,"4-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N-propylbenzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(C(=O)NCCC)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,142,KRAS-Activation by SOS no GTP,1.11e-05
141,"4-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N-propylbenzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(C(=O)NCCC)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,142,EGFR kinase inhibition IC50,
142,"4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N-[2-(dimethylamino)ethyl]benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(C(=O)NCCN(C)C)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,143,KRAS-SOS1 Interaction,1.01e-06
142,"4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N-[2-(dimethylamino)ethyl]benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(C(=O)NCCN(C)C)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,143,KRAS-Activation by SOS high GTP,1.81e-06
142,"4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N-[2-(dimethylamino)ethyl]benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(C(=O)NCCN(C)C)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,143,KRAS-Activation by SOS no GTP,1.92e-06
142,"4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N-[2-(dimethylamino)ethyl]benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(C(=O)NCCN(C)C)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,143,EGFR kinase inhibition IC50,
143,"N-[1-{5-[(2E)-but-2-en-2-yl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C/C(=C\C)/C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,144,KRAS-SOS1 Interaction,7.84e-06
143,"N-[1-{5-[(2E)-but-2-en-2-yl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C/C(=C\C)/C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,144,KRAS-Activation by SOS high GTP,8.78e-06
143,"N-[1-{5-[(2E)-but-2-en-2-yl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C/C(=C\C)/C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,144,KRAS-Activation by SOS no GTP,1.78e-05
143,"N-[1-{5-[(2E)-but-2-en-2-yl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C/C(=C\C)/C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,144,EGFR kinase inhibition IC50,
144,"N-{1-[5-(5-chloro-2-propoxyphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=CC(=C(C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)OCCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,145,KRAS-SOS1 Interaction,0.3
144,"N-{1-[5-(5-chloro-2-propoxyphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=CC(=C(C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)OCCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,145,KRAS-Activation by SOS high GTP,0.12
144,"N-{1-[5-(5-chloro-2-propoxyphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=CC(=C(C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)OCCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,145,KRAS-Activation by SOS no GTP,0.19
144,"N-{1-[5-(5-chloro-2-propoxyphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=CC(=C(C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)OCCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,145,EGFR kinase inhibition IC50,
145,"6,7-dimethoxy-2-methyl-N-[1-{5-[(1E)-3-phenylprop-1-en-1-yl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)\C=C\CC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,146,KRAS-SOS1 Interaction,0.4
145,"6,7-dimethoxy-2-methyl-N-[1-{5-[(1E)-3-phenylprop-1-en-1-yl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)\C=C\CC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,146,KRAS-Activation by SOS high GTP,0.18
145,"6,7-dimethoxy-2-methyl-N-[1-{5-[(1E)-3-phenylprop-1-en-1-yl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)\C=C\CC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,146,KRAS-Activation by SOS no GTP,0.11
145,"6,7-dimethoxy-2-methyl-N-[1-{5-[(1E)-3-phenylprop-1-en-1-yl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)\C=C\CC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,146,EGFR kinase inhibition IC50,
146,"N-{1-[5-(5-amino-2-methylphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NC=1C=CC(=C(C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,147,KRAS-SOS1 Interaction,9.11e-07
146,"N-{1-[5-(5-amino-2-methylphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NC=1C=CC(=C(C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,147,KRAS-Activation by SOS high GTP,1.5e-06
146,"N-{1-[5-(5-amino-2-methylphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NC=1C=CC(=C(C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,147,KRAS-Activation by SOS no GTP,1.48e-06
146,"N-{1-[5-(5-amino-2-methylphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NC=1C=CC(=C(C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,147,EGFR kinase inhibition IC50,
147,"N-{1-[5-(3,5-dimethyl-1,2-oxazol-4-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1=NOC(=C1C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,148,KRAS-SOS1 Interaction,3.97e-07
147,"N-{1-[5-(3,5-dimethyl-1,2-oxazol-4-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1=NOC(=C1C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,148,KRAS-Activation by SOS high GTP,7.87e-07
147,"N-{1-[5-(3,5-dimethyl-1,2-oxazol-4-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1=NOC(=C1C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,148,KRAS-Activation by SOS no GTP,8.58e-07
147,"N-{1-[5-(3,5-dimethyl-1,2-oxazol-4-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1=NOC(=C1C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,148,EGFR kinase inhibition IC50,
148,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(methylsulfonyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,149,KRAS-SOS1 Interaction,1.41e-06
148,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(methylsulfonyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,149,KRAS-Activation by SOS high GTP,3.48e-06
148,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(methylsulfonyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,149,KRAS-Activation by SOS no GTP,3.96e-06
148,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(methylsulfonyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,149,EGFR kinase inhibition IC50,
149,"6,7-dimethoxy-2-methyl-N-[1-{5-[4-(methylsulfonyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC=C(C=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,150,KRAS-SOS1 Interaction,2.38e-06
149,"6,7-dimethoxy-2-methyl-N-[1-{5-[4-(methylsulfonyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC=C(C=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,150,KRAS-Activation by SOS high GTP,4.39e-06
149,"6,7-dimethoxy-2-methyl-N-[1-{5-[4-(methylsulfonyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC=C(C=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,150,KRAS-Activation by SOS no GTP,0.17
149,"6,7-dimethoxy-2-methyl-N-[1-{5-[4-(methylsulfonyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC=C(C=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,150,EGFR kinase inhibition IC50,
150,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(trifluoromethoxy)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)OC(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,151,KRAS-SOS1 Interaction,7.38e-06
150,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(trifluoromethoxy)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)OC(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,151,KRAS-Activation by SOS high GTP,1.32e-05
150,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(trifluoromethoxy)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)OC(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,151,KRAS-Activation by SOS no GTP,1.32e-05
150,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(trifluoromethoxy)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)OC(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,151,EGFR kinase inhibition IC50,
151,"6,7-dimethoxy-2-methyl-N-[1-{5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)OC(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,152,KRAS-SOS1 Interaction,1.84e-05
151,"6,7-dimethoxy-2-methyl-N-[1-{5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)OC(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,152,KRAS-Activation by SOS high GTP,0.51
151,"6,7-dimethoxy-2-methyl-N-[1-{5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)OC(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,152,KRAS-Activation by SOS no GTP,1.33e-05
151,"6,7-dimethoxy-2-methyl-N-[1-{5-[3-(trifluoromethoxy)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)OC(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,152,EGFR kinase inhibition IC50,
152,"N-{1-[5-(1H-indol-5-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=CC(=CC=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,153,KRAS-SOS1 Interaction,5.48e-06
152,"N-{1-[5-(1H-indol-5-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=CC(=CC=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,153,KRAS-Activation by SOS high GTP,7.33e-06
152,"N-{1-[5-(1H-indol-5-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=CC(=CC=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,153,KRAS-Activation by SOS no GTP,1.11e-05
152,"N-{1-[5-(1H-indol-5-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=CC(=CC=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,153,EGFR kinase inhibition IC50,
153,"N-{1-[5-(furan-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1C=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,154,KRAS-SOS1 Interaction,2.35e-06
153,"N-{1-[5-(furan-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1C=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,154,KRAS-Activation by SOS high GTP,2.73e-06
153,"N-{1-[5-(furan-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1C=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,154,KRAS-Activation by SOS no GTP,4.1e-06
153,"N-{1-[5-(furan-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1C=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,154,EGFR kinase inhibition IC50,
154,"N-{1-[5-(1-benzothiophen-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=C(C2=C1C=CC=C2)C2=CC=C(S2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,155,KRAS-SOS1 Interaction,7.82e-06
154,"N-{1-[5-(1-benzothiophen-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=C(C2=C1C=CC=C2)C2=CC=C(S2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,155,KRAS-Activation by SOS high GTP,8.78e-06
154,"N-{1-[5-(1-benzothiophen-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=C(C2=C1C=CC=C2)C2=CC=C(S2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,155,KRAS-Activation by SOS no GTP,1.29e-05
154,"N-{1-[5-(1-benzothiophen-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=C(C2=C1C=CC=C2)C2=CC=C(S2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,155,EGFR kinase inhibition IC50,
155,"6,7-dimethoxy-2-methyl-N-{1-[5-(1-methyl-1H-indol-2-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1N(C2=CC=CC=C2C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,156,KRAS-SOS1 Interaction,9.92e-07
155,"6,7-dimethoxy-2-methyl-N-{1-[5-(1-methyl-1H-indol-2-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1N(C2=CC=CC=C2C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,156,KRAS-Activation by SOS high GTP,1.47e-06
155,"6,7-dimethoxy-2-methyl-N-{1-[5-(1-methyl-1H-indol-2-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1N(C2=CC=CC=C2C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,156,KRAS-Activation by SOS no GTP,1.64e-06
155,"6,7-dimethoxy-2-methyl-N-{1-[5-(1-methyl-1H-indol-2-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1N(C2=CC=CC=C2C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,156,EGFR kinase inhibition IC50,
156,"6,7-dimethoxy-2-methyl-N-[1-{5-[(1E)-pent-1-en-1-yl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)\C=C\CCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,157,KRAS-SOS1 Interaction,4.12e-06
156,"6,7-dimethoxy-2-methyl-N-[1-{5-[(1E)-pent-1-en-1-yl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)\C=C\CCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,157,KRAS-Activation by SOS high GTP,5.78e-06
156,"6,7-dimethoxy-2-methyl-N-[1-{5-[(1E)-pent-1-en-1-yl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)\C=C\CCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,157,KRAS-Activation by SOS no GTP,1.08e-05
156,"6,7-dimethoxy-2-methyl-N-[1-{5-[(1E)-pent-1-en-1-yl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)\C=C\CCC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,157,EGFR kinase inhibition IC50,
157,"N-[1-{5-[(E)-2-cyclohexylethenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CCCCC1)/C=C/C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,158,KRAS-SOS1 Interaction,0.44
157,"N-[1-{5-[(E)-2-cyclohexylethenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CCCCC1)/C=C/C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,158,KRAS-Activation by SOS high GTP,0.19
157,"N-[1-{5-[(E)-2-cyclohexylethenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CCCCC1)/C=C/C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,158,KRAS-Activation by SOS no GTP,0.12
157,"N-[1-{5-[(E)-2-cyclohexylethenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CCCCC1)/C=C/C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,158,EGFR kinase inhibition IC50,
158,"6,7-dimethoxy-2-methyl-N-{1-[5-(2-phenoxyphenyl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)OC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,159,KRAS-SOS1 Interaction,0.29
158,"6,7-dimethoxy-2-methyl-N-{1-[5-(2-phenoxyphenyl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)OC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,159,KRAS-Activation by SOS high GTP,0.04
158,"6,7-dimethoxy-2-methyl-N-{1-[5-(2-phenoxyphenyl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)OC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,159,KRAS-Activation by SOS no GTP,0.1
158,"6,7-dimethoxy-2-methyl-N-{1-[5-(2-phenoxyphenyl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)OC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,159,EGFR kinase inhibition IC50,
159,"tert-butyl[4-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]carbamate",C(C)(C)(C)OC(NC1=CC=C(C=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,160,KRAS-SOS1 Interaction,0.43
159,"tert-butyl[4-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]carbamate",C(C)(C)(C)OC(NC1=CC=C(C=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,160,KRAS-Activation by SOS high GTP,0.27
159,"tert-butyl[4-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]carbamate",C(C)(C)(C)OC(NC1=CC=C(C=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,160,KRAS-Activation by SOS no GTP,0.35
159,"tert-butyl[4-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]carbamate",C(C)(C)(C)OC(NC1=CC=C(C=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,160,EGFR kinase inhibition IC50,
160,"(2E)-3-[3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]prop-2-enenitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C=CC1)/C=C/C#N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,161,KRAS-SOS1 Interaction,1.81e-05
160,"(2E)-3-[3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]prop-2-enenitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C=CC1)/C=C/C#N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,161,KRAS-Activation by SOS high GTP,0.33
160,"(2E)-3-[3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]prop-2-enenitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C=CC1)/C=C/C#N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,161,KRAS-Activation by SOS no GTP,0.13
160,"(2E)-3-[3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]prop-2-enenitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C=CC1)/C=C/C#N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,161,EGFR kinase inhibition IC50,
161,"N-{1-[5-(2,4-dimethylphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1=C(C=CC(=C1)C)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,162,KRAS-SOS1 Interaction,4.17e-06
161,"N-{1-[5-(2,4-dimethylphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1=C(C=CC(=C1)C)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,162,KRAS-Activation by SOS high GTP,3.97e-06
161,"N-{1-[5-(2,4-dimethylphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1=C(C=CC(=C1)C)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,162,KRAS-Activation by SOS no GTP,7e-06
161,"N-{1-[5-(2,4-dimethylphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1=C(C=CC(=C1)C)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,162,EGFR kinase inhibition IC50,
162,"1-(5'-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2,2'-bithiophen-5-yl)ethanone",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1SC(=CC1)C(C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,163,KRAS-SOS1 Interaction,8.78e-06
162,"1-(5'-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2,2'-bithiophen-5-yl)ethanone",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1SC(=CC1)C(C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,163,KRAS-Activation by SOS high GTP,1.18e-05
162,"1-(5'-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2,2'-bithiophen-5-yl)ethanone",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1SC(=CC1)C(C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,163,KRAS-Activation by SOS no GTP,1.89e-05
162,"1-(5'-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2,2'-bithiophen-5-yl)ethanone",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1SC(=CC1)C(C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,163,EGFR kinase inhibition IC50,
163,"N-{1-[5-(1,3-benzodioxol-5-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1COC2=C1C=CC(=C2)C2=CC=C(S2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,164,KRAS-SOS1 Interaction,1.38e-05
163,"N-{1-[5-(1,3-benzodioxol-5-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1COC2=C1C=CC(=C2)C2=CC=C(S2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,164,KRAS-Activation by SOS high GTP,0.42
163,"N-{1-[5-(1,3-benzodioxol-5-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1COC2=C1C=CC(=C2)C2=CC=C(S2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,164,KRAS-Activation by SOS no GTP,0.35
163,"N-{1-[5-(1,3-benzodioxol-5-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1COC2=C1C=CC(=C2)C2=CC=C(S2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,164,EGFR kinase inhibition IC50,
164,"6,7-dimethoxy-2-methyl-N-{1-[5-(4-methyl-3,4-dihydro-2H-1,4-benzoxazin-7-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC2=C(N(CCO2)C)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,165,KRAS-SOS1 Interaction,0.41
164,"6,7-dimethoxy-2-methyl-N-{1-[5-(4-methyl-3,4-dihydro-2H-1,4-benzoxazin-7-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC2=C(N(CCO2)C)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,165,KRAS-Activation by SOS high GTP,0.19
164,"6,7-dimethoxy-2-methyl-N-{1-[5-(4-methyl-3,4-dihydro-2H-1,4-benzoxazin-7-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC2=C(N(CCO2)C)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,165,KRAS-Activation by SOS no GTP,0.22
164,"6,7-dimethoxy-2-methyl-N-{1-[5-(4-methyl-3,4-dihydro-2H-1,4-benzoxazin-7-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC2=C(N(CCO2)C)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,165,EGFR kinase inhibition IC50,
165,"N-[3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C=CC1)NS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,166,KRAS-SOS1 Interaction,1.06e-06
165,"N-[3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C=CC1)NS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,166,KRAS-Activation by SOS high GTP,1.84e-05
165,"N-[3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C=CC1)NS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,166,KRAS-Activation by SOS no GTP,0.32
165,"N-[3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]methanesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C=CC1)NS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,166,EGFR kinase inhibition IC50,
166,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)NC(C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,167,KRAS-SOS1 Interaction,1.8e-06
166,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)NC(C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,167,KRAS-Activation by SOS high GTP,3.88e-06
166,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)NC(C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,167,KRAS-Activation by SOS no GTP,4.99e-06
166,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)NC(C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,167,EGFR kinase inhibition IC50,
167,"6,7-dimethoxy-N-{1-[5-(3-methoxyphenyl)thiophen-2-yl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,168,KRAS-SOS1 Interaction,1.89e-05
167,"6,7-dimethoxy-N-{1-[5-(3-methoxyphenyl)thiophen-2-yl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,168,KRAS-Activation by SOS high GTP,0.4
167,"6,7-dimethoxy-N-{1-[5-(3-methoxyphenyl)thiophen-2-yl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,168,KRAS-Activation by SOS no GTP,0.37
167,"6,7-dimethoxy-N-{1-[5-(3-methoxyphenyl)thiophen-2-yl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,168,EGFR kinase inhibition IC50,
168,"6,7-dimethoxy-2-methyl-N-[1-{5-[3-(trifluoromethyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)C(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,169,KRAS-SOS1 Interaction,1.22e-05
168,"6,7-dimethoxy-2-methyl-N-[1-{5-[3-(trifluoromethyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)C(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,169,KRAS-Activation by SOS high GTP,0.38
168,"6,7-dimethoxy-2-methyl-N-[1-{5-[3-(trifluoromethyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)C(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,169,KRAS-Activation by SOS no GTP,0.32
168,"6,7-dimethoxy-2-methyl-N-[1-{5-[3-(trifluoromethyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)C(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,169,EGFR kinase inhibition IC50,
169,"2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N,N-dimethylbenzenesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)S(=O)(=O)N(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,170,KRAS-SOS1 Interaction,2.18e-06
169,"2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N,N-dimethylbenzenesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)S(=O)(=O)N(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,170,KRAS-Activation by SOS high GTP,3.78e-06
169,"2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N,N-dimethylbenzenesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)S(=O)(=O)N(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,170,KRAS-Activation by SOS no GTP,4.53e-06
169,"2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N,N-dimethylbenzenesulfonamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)S(=O)(=O)N(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,170,EGFR kinase inhibition IC50,
170,"N-[1-{5-[3-(cyclopropylmethoxy)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)COC=1C=C(C=CC1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,171,KRAS-SOS1 Interaction,0.45
170,"N-[1-{5-[3-(cyclopropylmethoxy)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)COC=1C=C(C=CC1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,171,KRAS-Activation by SOS high GTP,0.07
170,"N-[1-{5-[3-(cyclopropylmethoxy)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)COC=1C=C(C=CC1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,171,KRAS-Activation by SOS no GTP,0.15
170,"N-[1-{5-[3-(cyclopropylmethoxy)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)COC=1C=C(C=CC1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,171,EGFR kinase inhibition IC50,
171,"N-{1-[5-(1H-indol-4-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=C(C=CC=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,172,KRAS-SOS1 Interaction,5.59e-06
171,"N-{1-[5-(1H-indol-4-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=C(C=CC=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,172,KRAS-Activation by SOS high GTP,3.37e-06
171,"N-{1-[5-(1H-indol-4-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=C(C=CC=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,172,KRAS-Activation by SOS no GTP,7.18e-06
171,"N-{1-[5-(1H-indol-4-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=CC2=C(C=CC=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,172,EGFR kinase inhibition IC50,
172,"6,7-dimethoxy-N-{1-[5-(2-methoxypyrimidin-5-yl)thiophen-2-yl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=NC(=NC1)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,173,KRAS-SOS1 Interaction,4.07e-06
172,"6,7-dimethoxy-N-{1-[5-(2-methoxypyrimidin-5-yl)thiophen-2-yl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=NC(=NC1)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,173,KRAS-Activation by SOS high GTP,7.33e-06
172,"6,7-dimethoxy-N-{1-[5-(2-methoxypyrimidin-5-yl)thiophen-2-yl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=NC(=NC1)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,173,KRAS-Activation by SOS no GTP,9.19e-06
172,"6,7-dimethoxy-N-{1-[5-(2-methoxypyrimidin-5-yl)thiophen-2-yl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=NC(=NC1)OC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,173,EGFR kinase inhibition IC50,
173,"6,7-dimethoxy-2-methyl-N-[1-{5-[3-(methylsulfonyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,174,KRAS-SOS1 Interaction,6.88e-06
173,"6,7-dimethoxy-2-methyl-N-[1-{5-[3-(methylsulfonyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,174,KRAS-Activation by SOS high GTP,8.85e-06
173,"6,7-dimethoxy-2-methyl-N-[1-{5-[3-(methylsulfonyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,174,KRAS-Activation by SOS no GTP,0.48
173,"6,7-dimethoxy-2-methyl-N-[1-{5-[3-(methylsulfonyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=CC(=CC=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,174,EGFR kinase inhibition IC50,
174,"N-{1-[5-(2,3-dihydro-1-benzofuran-5-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCC2=C1C=CC(=C2)C2=CC=C(S2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,175,KRAS-SOS1 Interaction,6.92e-06
174,"N-{1-[5-(2,3-dihydro-1-benzofuran-5-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCC2=C1C=CC(=C2)C2=CC=C(S2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,175,KRAS-Activation by SOS high GTP,9.28e-06
174,"N-{1-[5-(2,3-dihydro-1-benzofuran-5-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCC2=C1C=CC(=C2)C2=CC=C(S2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,175,KRAS-Activation by SOS no GTP,1.83e-05
174,"N-{1-[5-(2,3-dihydro-1-benzofuran-5-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCC2=C1C=CC(=C2)C2=CC=C(S2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,175,EGFR kinase inhibition IC50,
175,"6,7-dimethoxy-2-methyl-N-[1-{5-[(E)-2-phenylethenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)\C=C\C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,176,KRAS-SOS1 Interaction,1.78e-05
175,"6,7-dimethoxy-2-methyl-N-[1-{5-[(E)-2-phenylethenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)\C=C\C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,176,KRAS-Activation by SOS high GTP,0.59
175,"6,7-dimethoxy-2-methyl-N-[1-{5-[(E)-2-phenylethenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)\C=C\C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,176,KRAS-Activation by SOS no GTP,0.44
175,"6,7-dimethoxy-2-methyl-N-[1-{5-[(E)-2-phenylethenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)\C=C\C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,176,EGFR kinase inhibition IC50,
176,"4-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N,N-dimethylbenzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(C(=O)N(C)C)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,177,KRAS-SOS1 Interaction,3.49e-06
176,"4-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N,N-dimethylbenzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(C(=O)N(C)C)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,177,KRAS-Activation by SOS high GTP,5.82e-06
176,"4-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N,N-dimethylbenzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(C(=O)N(C)C)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,177,KRAS-Activation by SOS no GTP,0.42
176,"4-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-N,N-dimethylbenzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(C(=O)N(C)C)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,177,EGFR kinase inhibition IC50,
177,"6,7-dimethoxy-2-methyl-N-[1-{5-[(1E)-prop-1-en-1-yl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)\C=C\C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,178,KRAS-SOS1 Interaction,5.77e-06
177,"6,7-dimethoxy-2-methyl-N-[1-{5-[(1E)-prop-1-en-1-yl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)\C=C\C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,178,KRAS-Activation by SOS high GTP,6.78e-06
177,"6,7-dimethoxy-2-methyl-N-[1-{5-[(1E)-prop-1-en-1-yl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)\C=C\C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,178,KRAS-Activation by SOS no GTP,0.49
177,"6,7-dimethoxy-2-methyl-N-[1-{5-[(1E)-prop-1-en-1-yl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)\C=C\C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,178,EGFR kinase inhibition IC50,
178,"methyl2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzoate",COC(C1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,179,KRAS-SOS1 Interaction,1.43e-06
178,"methyl2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzoate",COC(C1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,179,KRAS-Activation by SOS high GTP,5.11e-06
178,"methyl2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzoate",COC(C1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,179,KRAS-Activation by SOS no GTP,7.12e-06
178,"methyl2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzoate",COC(C1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,179,EGFR kinase inhibition IC50,>2.00E-5
179,"1-[2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]piperidine-4-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN2CCC(CC2)C(=O)N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,180,KRAS-SOS1 Interaction,9.04e-08
179,"1-[2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]piperidine-4-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN2CCC(CC2)C(=O)N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,180,KRAS-Activation by SOS high GTP,2.45e-07
179,"1-[2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]piperidine-4-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN2CCC(CC2)C(=O)N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,180,KRAS-Activation by SOS no GTP,2.14e-07
179,"1-[2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]piperidine-4-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN2CCC(CC2)C(=O)N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,180,EGFR kinase inhibition IC50,>2.00E-5
180,"2-(2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,181,KRAS-SOS1 Interaction,2.41e-07
180,"2-(2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,181,KRAS-Activation by SOS high GTP,9.21e-07
180,"2-(2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,181,KRAS-Activation by SOS no GTP,8.2e-07
180,"2-(2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,181,EGFR kinase inhibition IC50,>2.00E-5
181,"2-(3-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C=CC1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,182,KRAS-SOS1 Interaction,3.5e-06
181,"2-(3-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C=CC1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,182,KRAS-Activation by SOS high GTP,6.51e-06
181,"2-(3-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C=CC1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,182,KRAS-Activation by SOS no GTP,0.45
181,"2-(3-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C=CC1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,182,EGFR kinase inhibition IC50,>2.00E-5
182,"6,7-dimethoxy-2-methyl-N-[1-(5-[2-(2-oxa-6-azaspiro[33]hept-6-ylmethyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN1CC2(COC2)C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,183,KRAS-SOS1 Interaction,5.1e-08
182,"6,7-dimethoxy-2-methyl-N-[1-(5-[2-(2-oxa-6-azaspiro[33]hept-6-ylmethyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN1CC2(COC2)C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,183,KRAS-Activation by SOS high GTP,1.23e-07
182,"6,7-dimethoxy-2-methyl-N-[1-(5-[2-(2-oxa-6-azaspiro[33]hept-6-ylmethyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN1CC2(COC2)C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,183,KRAS-Activation by SOS no GTP,1.21e-07
182,"6,7-dimethoxy-2-methyl-N-[1-(5-[2-(2-oxa-6-azaspiro[33]hept-6-ylmethyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN1CC2(COC2)C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,183,EGFR kinase inhibition IC50,>2.00E-5
183,"N-[1-(5-bromo-4-methylthiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=C(C=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,184,KRAS-SOS1 Interaction,2.11e-06
183,"N-[1-(5-bromo-4-methylthiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=C(C=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,184,KRAS-Activation by SOS high GTP,4.2e-06
183,"N-[1-(5-bromo-4-methylthiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=C(C=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,184,KRAS-Activation by SOS no GTP,9.14e-06
183,"N-[1-(5-bromo-4-methylthiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=C(C=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,184,EGFR kinase inhibition IC50,>2.00E-5
184,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(pyrrolidin-1-ylmethyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,185,KRAS-SOS1 Interaction,4.16e-08
184,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(pyrrolidin-1-ylmethyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,185,KRAS-Activation by SOS high GTP,1.06e-07
184,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(pyrrolidin-1-ylmethyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,185,KRAS-Activation by SOS no GTP,1.22e-07
184,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(pyrrolidin-1-ylmethyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,185,EGFR kinase inhibition IC50,>2.00E-5
185,"N-[1-{5-[2-({2-[(dimethylamino)methyl]pyrrolidin-1-yl}methyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1N(CCC1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,186,KRAS-SOS1 Interaction,7.88e-08
185,"N-[1-{5-[2-({2-[(dimethylamino)methyl]pyrrolidin-1-yl}methyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1N(CCC1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,186,KRAS-Activation by SOS high GTP,3.44e-07
185,"N-[1-{5-[2-({2-[(dimethylamino)methyl]pyrrolidin-1-yl}methyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1N(CCC1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,186,KRAS-Activation by SOS no GTP,3.23e-07
185,"N-[1-{5-[2-({2-[(dimethylamino)methyl]pyrrolidin-1-yl}methyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1N(CCC1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,186,EGFR kinase inhibition IC50,>2.00E-5
186,2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]quinazolin-4-amine,CC1=NC2=CC=CC=C2C(=N1)N[C@H](C)C1=CC=CC2=CC=CC=C12,data/bronze/artifacts/2018_raw.xlsx,Sheet1,187,KRAS-SOS1 Interaction,9.84e-06
186,2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]quinazolin-4-amine,CC1=NC2=CC=CC=C2C(=N1)N[C@H](C)C1=CC=CC2=CC=CC=C12,data/bronze/artifacts/2018_raw.xlsx,Sheet1,187,KRAS-Activation by SOS high GTP,3.31e-06
186,2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]quinazolin-4-amine,CC1=NC2=CC=CC=C2C(=N1)N[C@H](C)C1=CC=CC2=CC=CC=C12,data/bronze/artifacts/2018_raw.xlsx,Sheet1,187,KRAS-Activation by SOS no GTP,0.22
186,2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]quinazolin-4-amine,CC1=NC2=CC=CC=C2C(=N1)N[C@H](C)C1=CC=CC2=CC=CC=C12,data/bronze/artifacts/2018_raw.xlsx,Sheet1,187,EGFR kinase inhibition IC50,>2.00E-5
187,"N-[(1R)-1-(4-bromophenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC=C(C=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,188,KRAS-SOS1 Interaction,4.78e-07
187,"N-[(1R)-1-(4-bromophenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC=C(C=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,188,KRAS-Activation by SOS high GTP,5.82e-07
187,"N-[(1R)-1-(4-bromophenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC=C(C=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,188,KRAS-Activation by SOS no GTP,1.26e-06
187,"N-[(1R)-1-(4-bromophenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC=C(C=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,188,EGFR kinase inhibition IC50,>2.00E-5
188,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4-(methylsulfonyl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,189,KRAS-SOS1 Interaction,1.57e-05
188,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4-(methylsulfonyl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,189,KRAS-Activation by SOS high GTP,1.87e-05
188,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4-(methylsulfonyl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,189,KRAS-Activation by SOS no GTP,0.38
188,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4-(methylsulfonyl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,189,EGFR kinase inhibition IC50,>2.00E-5
189,"4-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}benzonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C#N)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,190,KRAS-SOS1 Interaction,9.98e-06
189,"4-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}benzonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C#N)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,190,KRAS-Activation by SOS high GTP,1.17e-06
189,"4-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}benzonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C#N)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,190,KRAS-Activation by SOS no GTP,2.76e-06
189,"4-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}benzonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C#N)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,190,EGFR kinase inhibition IC50,>2.00E-5
190,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(3-methylphenyl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,191,KRAS-SOS1 Interaction,1.75e-07
190,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(3-methylphenyl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,191,KRAS-Activation by SOS high GTP,1.53e-07
190,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(3-methylphenyl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,191,KRAS-Activation by SOS no GTP,5.53e-07
190,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(3-methylphenyl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,191,EGFR kinase inhibition IC50,>2.00E-5
191,"N-[(1R)-1-(3-bromophenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,192,KRAS-SOS1 Interaction,1.74e-07
191,"N-[(1R)-1-(3-bromophenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,192,KRAS-Activation by SOS high GTP,2.45e-07
191,"N-[(1R)-1-(3-bromophenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,192,KRAS-Activation by SOS no GTP,3.82e-07
191,"N-[(1R)-1-(3-bromophenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,192,EGFR kinase inhibition IC50,>2.00E-5
192,"4-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C(=O)N)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,193,KRAS-SOS1 Interaction,4.59e-06
192,"4-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C(=O)N)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,193,KRAS-Activation by SOS high GTP,4.99e-06
192,"4-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C(=O)N)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,193,KRAS-Activation by SOS no GTP,1.42e-05
192,"4-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C(=O)N)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,193,EGFR kinase inhibition IC50,>2.00E-5
193,"N-[(1R)-1-(biphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,194,KRAS-SOS1 Interaction,4.18e-07
193,"N-[(1R)-1-(biphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,194,KRAS-Activation by SOS high GTP,4.05e-07
193,"N-[(1R)-1-(biphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,194,KRAS-Activation by SOS no GTP,8.2e-07
193,"N-[(1R)-1-(biphenyl-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,194,EGFR kinase inhibition IC50,>2.00E-5
194,"3-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}benzonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C#N)C=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,195,KRAS-SOS1 Interaction,4.93e-07
194,"3-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}benzonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C#N)C=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,195,KRAS-Activation by SOS high GTP,5.94e-07
194,"3-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}benzonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C#N)C=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,195,KRAS-Activation by SOS no GTP,2.43e-06
194,"3-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}benzonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C#N)C=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,195,EGFR kinase inhibition IC50,>2.00E-5
195,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(4-methylphenyl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,196,KRAS-SOS1 Interaction,3.8e-07
195,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(4-methylphenyl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,196,KRAS-Activation by SOS high GTP,6.35e-07
195,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(4-methylphenyl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,196,KRAS-Activation by SOS no GTP,7.4e-07
195,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(4-methylphenyl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,196,EGFR kinase inhibition IC50,>2.00E-5
196,"N-[(1R)-1-(biphenyl-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(=CC=C(C=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,197,KRAS-SOS1 Interaction,2.42e-06
196,"N-[(1R)-1-(biphenyl-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(=CC=C(C=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,197,KRAS-Activation by SOS high GTP,1.99e-06
196,"N-[(1R)-1-(biphenyl-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(=CC=C(C=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,197,KRAS-Activation by SOS no GTP,8.1e-06
196,"N-[(1R)-1-(biphenyl-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(=CC=C(C=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,197,EGFR kinase inhibition IC50,>2.00E-5
197,"N-[(1R)-1-(4-cyclopropylphenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)C1=CC=C(C=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,198,KRAS-SOS1 Interaction,2.88e-07
197,"N-[(1R)-1-(4-cyclopropylphenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)C1=CC=C(C=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,198,KRAS-Activation by SOS high GTP,3.03e-07
197,"N-[(1R)-1-(4-cyclopropylphenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)C1=CC=C(C=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,198,KRAS-Activation by SOS no GTP,8.38e-07
197,"N-[(1R)-1-(4-cyclopropylphenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)C1=CC=C(C=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,198,EGFR kinase inhibition IC50,>2.00E-5
198,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(methylsulfonyl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,199,KRAS-SOS1 Interaction,2.91e-07
198,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(methylsulfonyl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,199,KRAS-Activation by SOS high GTP,5.18e-07
198,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(methylsulfonyl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,199,KRAS-Activation by SOS no GTP,1.09e-06
198,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(methylsulfonyl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)S(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,199,EGFR kinase inhibition IC50,>2.00E-5
199,"3-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C(=O)N)C=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,200,KRAS-SOS1 Interaction,1.73e-06
199,"3-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C(=O)N)C=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,200,KRAS-Activation by SOS high GTP,1.42e-06
199,"3-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C(=O)N)C=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,200,KRAS-Activation by SOS no GTP,8.7e-06
199,"3-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C(=O)N)C=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,200,EGFR kinase inhibition IC50,>2.00E-5
200,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,201,KRAS-SOS1 Interaction,1.39e-07
200,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,201,KRAS-Activation by SOS high GTP,2.38e-07
200,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,201,KRAS-Activation by SOS no GTP,4.04e-07
200,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,201,EGFR kinase inhibition IC50,>2.00E-5
201,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C=C1)C=1CCN(CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,202,KRAS-SOS1 Interaction,1.97e-05
201,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C=C1)C=1CCN(CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,202,KRAS-Activation by SOS high GTP,0.29
201,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C=C1)C=1CCN(CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,202,KRAS-Activation by SOS no GTP,0.5
201,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C=C1)C=1CCN(CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,202,EGFR kinase inhibition IC50,>2.00E-5
202,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1CCN(CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,203,KRAS-SOS1 Interaction,1.42e-06
202,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1CCN(CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,203,KRAS-Activation by SOS high GTP,9.79e-07
202,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1CCN(CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,203,KRAS-Activation by SOS no GTP,5.32e-06
202,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1CCN(CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,203,EGFR kinase inhibition IC50,>2.00E-5
203,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4-(prop-1-en-2-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C=C1)C(=C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,204,KRAS-SOS1 Interaction,1.37e-06
203,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4-(prop-1-en-2-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C=C1)C(=C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,204,KRAS-Activation by SOS high GTP,1.38e-06
203,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4-(prop-1-en-2-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C=C1)C(=C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,204,KRAS-Activation by SOS no GTP,3.3e-06
203,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[4-(prop-1-en-2-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=C(C=C1)C(=C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,204,EGFR kinase inhibition IC50,>2.00E-5
204,"N-[(1R)-1-(3-cyclopropylphenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,205,KRAS-SOS1 Interaction,2.29e-07
204,"N-[(1R)-1-(3-cyclopropylphenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,205,KRAS-Activation by SOS high GTP,2.85e-07
204,"N-[(1R)-1-(3-cyclopropylphenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,205,KRAS-Activation by SOS no GTP,8.4e-07
204,"N-[(1R)-1-(3-cyclopropylphenyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,205,EGFR kinase inhibition IC50,>2.00E-5
205,"N-[1-(1-benzothiophen-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=CC2=C1C=CC=C2C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,206,KRAS-SOS1 Interaction,7.38e-08
205,"N-[1-(1-benzothiophen-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=CC2=C1C=CC=C2C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,206,KRAS-Activation by SOS high GTP,8.72e-08
205,"N-[1-(1-benzothiophen-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=CC2=C1C=CC=C2C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,206,KRAS-Activation by SOS no GTP,1.28e-07
205,"N-[1-(1-benzothiophen-4-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",S1C=CC2=C1C=CC=C2C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,206,EGFR kinase inhibition IC50,>2.00E-5
206,"6,7-dimethoxy-2-methyl-N-[(1R)-1-phenylethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,207,KRAS-SOS1 Interaction,4.81e-07
206,"6,7-dimethoxy-2-methyl-N-[(1R)-1-phenylethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,207,KRAS-Activation by SOS high GTP,1.09e-06
206,"6,7-dimethoxy-2-methyl-N-[(1R)-1-phenylethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,207,KRAS-Activation by SOS no GTP,1.75e-06
206,"6,7-dimethoxy-2-methyl-N-[(1R)-1-phenylethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,207,EGFR kinase inhibition IC50,>2.00E-5
207,"6,7-dimethoxy-2-methyl-N-[1-(thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,208,KRAS-SOS1 Interaction,2.73e-06
207,"6,7-dimethoxy-2-methyl-N-[1-(thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,208,KRAS-Activation by SOS high GTP,2.27e-06
207,"6,7-dimethoxy-2-methyl-N-[1-(thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,208,KRAS-Activation by SOS no GTP,1.23e-05
207,"6,7-dimethoxy-2-methyl-N-[1-(thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,208,EGFR kinase inhibition IC50,>2.00E-5
208,"N-[1-(5-bromofuran-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC=C(O1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,209,KRAS-SOS1 Interaction,5.97e-06
208,"N-[1-(5-bromofuran-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC=C(O1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,209,KRAS-Activation by SOS high GTP,
208,"N-[1-(5-bromofuran-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC=C(O1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,209,KRAS-Activation by SOS no GTP,0.47
208,"N-[1-(5-bromofuran-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC=C(O1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,209,EGFR kinase inhibition IC50,>2.00E-5
209,"N-[1-(5-bromothiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,210,KRAS-SOS1 Interaction,1.98e-06
209,"N-[1-(5-bromothiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,210,KRAS-Activation by SOS high GTP,
209,"N-[1-(5-bromothiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,210,KRAS-Activation by SOS no GTP,4.95e-06
209,"N-[1-(5-bromothiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,210,EGFR kinase inhibition IC50,>2.00E-5
210,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]pyrrolidin-3-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN2CC(CC2)O)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,211,KRAS-SOS1 Interaction,3.85e-08
210,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]pyrrolidin-3-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN2CC(CC2)O)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,211,KRAS-Activation by SOS high GTP,1.89e-07
210,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]pyrrolidin-3-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN2CC(CC2)O)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,211,KRAS-Activation by SOS no GTP,1.9e-07
210,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]pyrrolidin-3-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN2CC(CC2)O)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,211,EGFR kinase inhibition IC50,>2.00E-5
211,"N-{1-[5-(2-{[(3S)-3-fluoropyrrolidin-1-yl]methyl}phenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",F[C@@H]1CN(CC1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,212,KRAS-SOS1 Interaction,1.33e-07
211,"N-{1-[5-(2-{[(3S)-3-fluoropyrrolidin-1-yl]methyl}phenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",F[C@@H]1CN(CC1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,212,KRAS-Activation by SOS high GTP,2.92e-07
211,"N-{1-[5-(2-{[(3S)-3-fluoropyrrolidin-1-yl]methyl}phenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",F[C@@H]1CN(CC1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,212,KRAS-Activation by SOS no GTP,2.33e-07
211,"N-{1-[5-(2-{[(3S)-3-fluoropyrrolidin-1-yl]methyl}phenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",F[C@@H]1CN(CC1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,212,EGFR kinase inhibition IC50,>2.00E-5
212,"6,7-dimethoxy-2-methyl-N-[1-(quinolin-5-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C=CC=NC2=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,213,KRAS-SOS1 Interaction,6.48e-07
212,"6,7-dimethoxy-2-methyl-N-[1-(quinolin-5-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C=CC=NC2=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,213,KRAS-Activation by SOS high GTP,
212,"6,7-dimethoxy-2-methyl-N-[1-(quinolin-5-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C=CC=NC2=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,213,KRAS-Activation by SOS no GTP,2.64e-06
212,"6,7-dimethoxy-2-methyl-N-[1-(quinolin-5-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C=CC=NC2=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,213,EGFR kinase inhibition IC50,>2.00E-5
213,"6,7-dimethoxy-2-methyl-N-[1-(5-phenylfuran-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1OC(=CC1)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,214,KRAS-SOS1 Interaction,6.78e-06
213,"6,7-dimethoxy-2-methyl-N-[1-(5-phenylfuran-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1OC(=CC1)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,214,KRAS-Activation by SOS high GTP,6.31e-06
213,"6,7-dimethoxy-2-methyl-N-[1-(5-phenylfuran-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1OC(=CC1)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,214,KRAS-Activation by SOS no GTP,0.42
213,"6,7-dimethoxy-2-methyl-N-[1-(5-phenylfuran-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1OC(=CC1)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,214,EGFR kinase inhibition IC50,>2.00E-5
214,"N-[1-(5-bromo-2,3-dihydro-1-benzofuran-7-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC=1C=C(C2=C(CCO2)C1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,215,KRAS-SOS1 Interaction,3.33e-06
214,"N-[1-(5-bromo-2,3-dihydro-1-benzofuran-7-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC=1C=C(C2=C(CCO2)C1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,215,KRAS-Activation by SOS high GTP,3.96e-06
214,"N-[1-(5-bromo-2,3-dihydro-1-benzofuran-7-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC=1C=C(C2=C(CCO2)C1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,215,KRAS-Activation by SOS no GTP,1.36e-05
214,"N-[1-(5-bromo-2,3-dihydro-1-benzofuran-7-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC=1C=C(C2=C(CCO2)C1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,215,EGFR kinase inhibition IC50,>2.00E-5
215,"6,7-dimethoxy-2-methyl-N-[1-(3-phenoxyphenyl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC(=CC=C1)OC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,216,KRAS-SOS1 Interaction,9.98e-07
215,"6,7-dimethoxy-2-methyl-N-[1-(3-phenoxyphenyl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC(=CC=C1)OC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,216,KRAS-Activation by SOS high GTP,1.18e-06
215,"6,7-dimethoxy-2-methyl-N-[1-(3-phenoxyphenyl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC(=CC=C1)OC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,216,KRAS-Activation by SOS no GTP,2.95e-06
215,"6,7-dimethoxy-2-methyl-N-[1-(3-phenoxyphenyl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC(=CC=C1)OC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,216,EGFR kinase inhibition IC50,2.57e-06
216,"6,7-dimethoxy-2-methyl-N-{1-[3-(2H-tetrazol-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC(=CC=C1)C=1N=NNN1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,217,KRAS-SOS1 Interaction,6.58e-06
216,"6,7-dimethoxy-2-methyl-N-{1-[3-(2H-tetrazol-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC(=CC=C1)C=1N=NNN1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,217,KRAS-Activation by SOS high GTP,1.79e-05
216,"6,7-dimethoxy-2-methyl-N-{1-[3-(2H-tetrazol-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC(=CC=C1)C=1N=NNN1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,217,KRAS-Activation by SOS no GTP,1.61e-05
216,"6,7-dimethoxy-2-methyl-N-{1-[3-(2H-tetrazol-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC(=CC=C1)C=1N=NNN1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,217,EGFR kinase inhibition IC50,>2.00E-5
217,"6,7-dimethoxy-2-methyl-N-[1-(quinolin-8-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C=CC=C2C=CC=NC12,data/bronze/artifacts/2018_raw.xlsx,Sheet1,218,KRAS-SOS1 Interaction,8.8e-06
217,"6,7-dimethoxy-2-methyl-N-[1-(quinolin-8-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C=CC=C2C=CC=NC12,data/bronze/artifacts/2018_raw.xlsx,Sheet1,218,KRAS-Activation by SOS high GTP,0.59
217,"6,7-dimethoxy-2-methyl-N-[1-(quinolin-8-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C=CC=C2C=CC=NC12,data/bronze/artifacts/2018_raw.xlsx,Sheet1,218,KRAS-Activation by SOS no GTP,0.45
217,"6,7-dimethoxy-2-methyl-N-[1-(quinolin-8-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C=CC=C2C=CC=NC12,data/bronze/artifacts/2018_raw.xlsx,Sheet1,218,EGFR kinase inhibition IC50,>2.00E-5
218,"2-[4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1H-pyrazol-1-yl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=NN(C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,219,KRAS-SOS1 Interaction,1.98e-06
218,"2-[4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1H-pyrazol-1-yl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=NN(C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,219,KRAS-Activation by SOS high GTP,1.37e-06
218,"2-[4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1H-pyrazol-1-yl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=NN(C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,219,KRAS-Activation by SOS no GTP,3.78e-06
218,"2-[4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1H-pyrazol-1-yl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=NN(C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,219,EGFR kinase inhibition IC50,>2.00E-5
219,"N-{1-[5-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1=C2N(C(=C1)C1=CC=C(S1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,220,KRAS-SOS1 Interaction,4.13e-07
219,"N-{1-[5-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1=C2N(C(=C1)C1=CC=C(S1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,220,KRAS-Activation by SOS high GTP,5.7e-07
219,"N-{1-[5-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1=C2N(C(=C1)C1=CC=C(S1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,220,KRAS-Activation by SOS no GTP,9.08e-07
219,"N-{1-[5-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1=C2N(C(=C1)C1=CC=C(S1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,220,EGFR kinase inhibition IC50,>2.00E-5
220,"6,7-dimethoxy-2-methyl-N-[1-(5-{1-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrazol-4-yl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=NN(C1)CCN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,221,KRAS-SOS1 Interaction,3.79e-07
220,"6,7-dimethoxy-2-methyl-N-[1-(5-{1-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrazol-4-yl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=NN(C1)CCN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,221,KRAS-Activation by SOS high GTP,3.81e-07
220,"6,7-dimethoxy-2-methyl-N-[1-(5-{1-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrazol-4-yl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=NN(C1)CCN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,221,KRAS-Activation by SOS no GTP,1.91e-06
220,"6,7-dimethoxy-2-methyl-N-[1-(5-{1-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrazol-4-yl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C=1C=NN(C1)CCN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,221,EGFR kinase inhibition IC50,>2.00E-5
221,"N-{1-[5-(1-cyclopentyl-1H-pyrazol-4-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CCCC1)N1N=CC(=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,222,KRAS-SOS1 Interaction,3.06e-06
221,"N-{1-[5-(1-cyclopentyl-1H-pyrazol-4-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CCCC1)N1N=CC(=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,222,KRAS-Activation by SOS high GTP,4.65e-06
221,"N-{1-[5-(1-cyclopentyl-1H-pyrazol-4-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CCCC1)N1N=CC(=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,222,KRAS-Activation by SOS no GTP,4.81e-06
221,"N-{1-[5-(1-cyclopentyl-1H-pyrazol-4-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CCCC1)N1N=CC(=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,222,EGFR kinase inhibition IC50,>2.00E-5
222,"6,7-dimethoxy-2-methyl-N-{1-[5-(1H-pyrazol-3-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=NNC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,223,KRAS-SOS1 Interaction,3.88e-06
222,"6,7-dimethoxy-2-methyl-N-{1-[5-(1H-pyrazol-3-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=NNC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,223,KRAS-Activation by SOS high GTP,4.44e-06
222,"6,7-dimethoxy-2-methyl-N-{1-[5-(1H-pyrazol-3-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=NNC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,223,KRAS-Activation by SOS no GTP,1.35e-05
222,"6,7-dimethoxy-2-methyl-N-{1-[5-(1H-pyrazol-3-yl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=NNC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,223,EGFR kinase inhibition IC50,>2.00E-5
223,"N-[1-(5-{2-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1(CN(CC1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,224,KRAS-SOS1 Interaction,2.11e-06
223,"N-[1-(5-{2-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1(CN(CC1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,224,KRAS-Activation by SOS high GTP,5.6e-06
223,"N-[1-(5-{2-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1(CN(CC1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,224,KRAS-Activation by SOS no GTP,7.18e-06
223,"N-[1-(5-{2-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1(CN(CC1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,224,EGFR kinase inhibition IC50,>2.00E-5
224,"6,7-dimethoxy-2-methyl-N-[1-(5-phenylfuran-2-yl)ethyl]quinazolin-4-amine,enantiomer1",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1OC(=CC1)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,225,KRAS-SOS1 Interaction,3.6e-06
224,"6,7-dimethoxy-2-methyl-N-[1-(5-phenylfuran-2-yl)ethyl]quinazolin-4-amine,enantiomer1",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1OC(=CC1)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,225,KRAS-Activation by SOS high GTP,2.55e-06
224,"6,7-dimethoxy-2-methyl-N-[1-(5-phenylfuran-2-yl)ethyl]quinazolin-4-amine,enantiomer1",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1OC(=CC1)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,225,KRAS-Activation by SOS no GTP,9.37e-06
224,"6,7-dimethoxy-2-methyl-N-[1-(5-phenylfuran-2-yl)ethyl]quinazolin-4-amine,enantiomer1",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1OC(=CC1)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,225,EGFR kinase inhibition IC50,>2.00E-5
225,"N-[1-(5-bromo-2,3-dihydro-1-benzofuran-7-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC=1C=C(C2=C(CCO2)C1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,226,KRAS-SOS1 Interaction,1.54e-06
225,"N-[1-(5-bromo-2,3-dihydro-1-benzofuran-7-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC=1C=C(C2=C(CCO2)C1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,226,KRAS-Activation by SOS high GTP,2.27e-06
225,"N-[1-(5-bromo-2,3-dihydro-1-benzofuran-7-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC=1C=C(C2=C(CCO2)C1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,226,KRAS-Activation by SOS no GTP,4.68e-06
225,"N-[1-(5-bromo-2,3-dihydro-1-benzofuran-7-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC=1C=C(C2=C(CCO2)C1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,226,EGFR kinase inhibition IC50,>2.00E-5
226,"2-[1-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}furan-2-yl)-1H-pyrazol-3-yl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(O1)N1N=C(C=C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,227,KRAS-SOS1 Interaction,0.43
226,"2-[1-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}furan-2-yl)-1H-pyrazol-3-yl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(O1)N1N=C(C=C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,227,KRAS-Activation by SOS high GTP,0.37
226,"2-[1-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}furan-2-yl)-1H-pyrazol-3-yl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(O1)N1N=C(C=C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,227,KRAS-Activation by SOS no GTP,0.24
226,"2-[1-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}furan-2-yl)-1H-pyrazol-3-yl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(O1)N1N=C(C=C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,227,EGFR kinase inhibition IC50,>2.00E-5
227,"5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}pyridin-2(1H)-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C=CC(NC1)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,228,KRAS-SOS1 Interaction,0.43
227,"5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}pyridin-2(1H)-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C=CC(NC1)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,228,KRAS-Activation by SOS high GTP,0.24
227,"5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}pyridin-2(1H)-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C=CC(NC1)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,228,KRAS-Activation by SOS no GTP,0.34
227,"5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}pyridin-2(1H)-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C=CC(NC1)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,228,EGFR kinase inhibition IC50,>2.00E-5
228,"6,7-dimethoxy-2-methyl-N-[1-(3-phenoxyphenyl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC(=CC=C1)OC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,229,KRAS-SOS1 Interaction,5.89e-07
228,"6,7-dimethoxy-2-methyl-N-[1-(3-phenoxyphenyl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC(=CC=C1)OC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,229,KRAS-Activation by SOS high GTP,6.47e-07
228,"6,7-dimethoxy-2-methyl-N-[1-(3-phenoxyphenyl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC(=CC=C1)OC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,229,KRAS-Activation by SOS no GTP,1.43e-06
228,"6,7-dimethoxy-2-methyl-N-[1-(3-phenoxyphenyl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC(=CC=C1)OC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,229,EGFR kinase inhibition IC50,3.41e-07
229,"N-[1-(2,1,3-benzothiadiazol-5-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",N=1SN=C2C1C=CC(=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,230,KRAS-SOS1 Interaction,8.95e-06
229,"N-[1-(2,1,3-benzothiadiazol-5-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",N=1SN=C2C1C=CC(=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,230,KRAS-Activation by SOS high GTP,7.82e-06
229,"N-[1-(2,1,3-benzothiadiazol-5-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",N=1SN=C2C1C=CC(=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,230,KRAS-Activation by SOS no GTP,0.29
229,"N-[1-(2,1,3-benzothiadiazol-5-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",N=1SN=C2C1C=CC(=C2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,230,EGFR kinase inhibition IC50,>2.00E-5
230,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(quinolin-8-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=CC=C2C=CC=NC12,data/bronze/artifacts/2018_raw.xlsx,Sheet1,231,KRAS-SOS1 Interaction,4.9e-06
230,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(quinolin-8-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=CC=C2C=CC=NC12,data/bronze/artifacts/2018_raw.xlsx,Sheet1,231,KRAS-Activation by SOS high GTP,6.89e-06
230,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(quinolin-8-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=CC=C2C=CC=NC12,data/bronze/artifacts/2018_raw.xlsx,Sheet1,231,KRAS-Activation by SOS no GTP,1.33e-05
230,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(quinolin-8-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=CC=C2C=CC=NC12,data/bronze/artifacts/2018_raw.xlsx,Sheet1,231,EGFR kinase inhibition IC50,>2.00E-5
231,"N-{1-[5-(cyclopent-1-en-1-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(=CCCC1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,232,KRAS-SOS1 Interaction,0.56
231,"N-{1-[5-(cyclopent-1-en-1-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(=CCCC1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,232,KRAS-Activation by SOS high GTP,0.53
231,"N-{1-[5-(cyclopent-1-en-1-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(=CCCC1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,232,KRAS-Activation by SOS no GTP,0.24
231,"N-{1-[5-(cyclopent-1-en-1-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(=CCCC1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,232,EGFR kinase inhibition IC50,>2.00E-5
232,"N-{1-[5-(2-ethoxyphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C)OC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,233,KRAS-SOS1 Interaction,9.01e-06
232,"N-{1-[5-(2-ethoxyphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C)OC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,233,KRAS-Activation by SOS high GTP,9.29e-06
232,"N-{1-[5-(2-ethoxyphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C)OC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,233,KRAS-Activation by SOS no GTP,4.04e-06
232,"N-{1-[5-(2-ethoxyphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C)OC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,233,EGFR kinase inhibition IC50,>2.00E-5
233,"N-{1-[5-(4-fluoronaphthalen-1-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1=CC=C(C2=CC=CC=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,234,KRAS-SOS1 Interaction,1.04e-05
233,"N-{1-[5-(4-fluoronaphthalen-1-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1=CC=C(C2=CC=CC=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,234,KRAS-Activation by SOS high GTP,2.08e-06
233,"N-{1-[5-(4-fluoronaphthalen-1-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1=CC=C(C2=CC=CC=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,234,KRAS-Activation by SOS no GTP,1.61e-05
233,"N-{1-[5-(4-fluoronaphthalen-1-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1=CC=C(C2=CC=CC=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,234,EGFR kinase inhibition IC50,>2.00E-5
234,"N-[1-{5-[2-(aminomethyl)-4-fluorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)F)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,235,KRAS-SOS1 Interaction,7.58e-08
234,"N-[1-{5-[2-(aminomethyl)-4-fluorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)F)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,235,KRAS-Activation by SOS high GTP,6.54e-08
234,"N-[1-{5-[2-(aminomethyl)-4-fluorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)F)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,235,KRAS-Activation by SOS no GTP,9.21e-08
234,"N-[1-{5-[2-(aminomethyl)-4-fluorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)F)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,235,EGFR kinase inhibition IC50,>2.00E-5
235,"N-{1-[5-(3,6-dihydro-2H-pyran-4-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCC(=CC1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,236,KRAS-SOS1 Interaction,5.47e-06
235,"N-{1-[5-(3,6-dihydro-2H-pyran-4-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCC(=CC1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,236,KRAS-Activation by SOS high GTP,4.72e-06
235,"N-{1-[5-(3,6-dihydro-2H-pyran-4-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCC(=CC1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,236,KRAS-Activation by SOS no GTP,5.27e-06
235,"N-{1-[5-(3,6-dihydro-2H-pyran-4-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",O1CCC(=CC1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,236,EGFR kinase inhibition IC50,>2.00E-5
236,"tert-butyl{[5-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)furan-2-yl]methyl}carbamate",C(C)(C)(C)OC(NCC=1OC(=CC1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,237,KRAS-SOS1 Interaction,0.37
236,"tert-butyl{[5-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)furan-2-yl]methyl}carbamate",C(C)(C)(C)OC(NCC=1OC(=CC1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,237,KRAS-Activation by SOS high GTP,3.82e-06
236,"tert-butyl{[5-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)furan-2-yl]methyl}carbamate",C(C)(C)(C)OC(NCC=1OC(=CC1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,237,KRAS-Activation by SOS no GTP,0.17
236,"tert-butyl{[5-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)furan-2-yl]methyl}carbamate",C(C)(C)(C)OC(NCC=1OC(=CC1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,237,EGFR kinase inhibition IC50,>2.00E-5
237,"methyl3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1-methyl-1H-pyrazole-5-carboxylate",COC(=O)C1=CC(=NN1C)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,238,KRAS-SOS1 Interaction,0.31
237,"methyl3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1-methyl-1H-pyrazole-5-carboxylate",COC(=O)C1=CC(=NN1C)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,238,KRAS-Activation by SOS high GTP,0.32
237,"methyl3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1-methyl-1H-pyrazole-5-carboxylate",COC(=O)C1=CC(=NN1C)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,238,KRAS-Activation by SOS no GTP,0.1
237,"methyl3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1-methyl-1H-pyrazole-5-carboxylate",COC(=O)C1=CC(=NN1C)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,238,EGFR kinase inhibition IC50,>2.00E-5
238,"N-{1-[5-(2-{[3-(dimethylamino)pyrrolidin-1-yl]methyl}phenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C1CN(CC1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,239,KRAS-SOS1 Interaction,8.18e-08
238,"N-{1-[5-(2-{[3-(dimethylamino)pyrrolidin-1-yl]methyl}phenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C1CN(CC1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,239,KRAS-Activation by SOS high GTP,2.17e-07
238,"N-{1-[5-(2-{[3-(dimethylamino)pyrrolidin-1-yl]methyl}phenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C1CN(CC1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,239,KRAS-Activation by SOS no GTP,2.16e-07
238,"N-{1-[5-(2-{[3-(dimethylamino)pyrrolidin-1-yl]methyl}phenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C1CN(CC1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,239,EGFR kinase inhibition IC50,>2.00E-5
239,"N-[1-(5-bromothiophen-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC(=CS1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,240,KRAS-SOS1 Interaction,7.07e-06
239,"N-[1-(5-bromothiophen-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC(=CS1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,240,KRAS-Activation by SOS high GTP,3.83e-06
239,"N-[1-(5-bromothiophen-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC(=CS1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,240,KRAS-Activation by SOS no GTP,1.43e-05
239,"N-[1-(5-bromothiophen-3-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC(=CS1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,240,EGFR kinase inhibition IC50,>2.00E-5
240,"2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C(=O)N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,241,KRAS-SOS1 Interaction,3.21e-06
240,"2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C(=O)N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,241,KRAS-Activation by SOS high GTP,3.19e-06
240,"2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C(=O)N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,241,KRAS-Activation by SOS no GTP,7.57e-06
240,"2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C(=O)N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,241,EGFR kinase inhibition IC50,>2.00E-5
241,"3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C(=O)N)C=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,242,KRAS-SOS1 Interaction,1.12e-06
241,"3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C(=O)N)C=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,242,KRAS-Activation by SOS high GTP,1.44e-06
241,"3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C(=O)N)C=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,242,KRAS-Activation by SOS no GTP,1.31e-06
241,"3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=C(C(=O)N)C=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,242,EGFR kinase inhibition IC50,>2.00E-5
242,"4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(C(=O)N)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,243,KRAS-SOS1 Interaction,1.83e-06
242,"4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(C(=O)N)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,243,KRAS-Activation by SOS high GTP,1.59e-06
242,"4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(C(=O)N)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,243,KRAS-Activation by SOS no GTP,3.01e-06
242,"4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC=C(C(=O)N)C=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,243,EGFR kinase inhibition IC50,>2.00E-5
243,"N-{1-[5-(2-aminophenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,244,KRAS-SOS1 Interaction,2.52e-07
243,"N-{1-[5-(2-aminophenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,244,KRAS-Activation by SOS high GTP,3.25e-07
243,"N-{1-[5-(2-aminophenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,244,KRAS-Activation by SOS no GTP,4.18e-07
243,"N-{1-[5-(2-aminophenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,244,EGFR kinase inhibition IC50,>2.00E-5
244,"[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]methanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)CO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,245,KRAS-SOS1 Interaction,2.82e-07
244,"[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]methanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)CO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,245,KRAS-Activation by SOS high GTP,4.01e-07
244,"[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]methanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)CO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,245,KRAS-Activation by SOS no GTP,4.44e-07
244,"[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]methanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)CO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,245,EGFR kinase inhibition IC50,>2.00E-5
245,"2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C#N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,246,KRAS-SOS1 Interaction,5.92e-07
245,"2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C#N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,246,KRAS-Activation by SOS high GTP,9e-07
245,"2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C#N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,246,KRAS-Activation by SOS no GTP,9.18e-07
245,"2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C#N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,246,EGFR kinase inhibition IC50,>2.00E-5
246,"N-{1-[5-(1H-indazol-7-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1N=CC2=CC=CC(=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,247,KRAS-SOS1 Interaction,7.59e-06
246,"N-{1-[5-(1H-indazol-7-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1N=CC2=CC=CC(=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,247,KRAS-Activation by SOS high GTP,4.21e-06
246,"N-{1-[5-(1H-indazol-7-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1N=CC2=CC=CC(=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,247,KRAS-Activation by SOS no GTP,0.44
246,"N-{1-[5-(1H-indazol-7-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1N=CC2=CC=CC(=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,247,EGFR kinase inhibition IC50,>2.00E-5
247,"N-{1-[5-(1H-indazol-4-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1N=CC2=C(C=CC=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,248,KRAS-SOS1 Interaction,5.91e-07
247,"N-{1-[5-(1H-indazol-4-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1N=CC2=C(C=CC=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,248,KRAS-Activation by SOS high GTP,8.8E-07
247,"N-{1-[5-(1H-indazol-4-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1N=CC2=C(C=CC=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,248,KRAS-Activation by SOS no GTP,2.7e-06
247,"N-{1-[5-(1H-indazol-4-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1N=CC2=C(C=CC=C12)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,248,EGFR kinase inhibition IC50,>2.00E-5
248,"N-{1-[5-(2-ethenylphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(=C)C1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,249,KRAS-SOS1 Interaction,1.49e-06
248,"N-{1-[5-(2-ethenylphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(=C)C1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,249,KRAS-Activation by SOS high GTP,8.98e-06
248,"N-{1-[5-(2-ethenylphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(=C)C1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,249,KRAS-Activation by SOS no GTP,8.43e-06
248,"N-{1-[5-(2-ethenylphenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(=C)C1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,249,EGFR kinase inhibition IC50,>2.00E-5
249,"2-(4-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1H-pyrazol-1-yl]acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=NN(C1)CC(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,250,KRAS-SOS1 Interaction,6.1e-06
249,"2-(4-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1H-pyrazol-1-yl]acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=NN(C1)CC(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,250,KRAS-Activation by SOS high GTP,5.31e-06
249,"2-(4-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1H-pyrazol-1-yl]acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=NN(C1)CC(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,250,KRAS-Activation by SOS no GTP,8.79e-06
249,"2-(4-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1H-pyrazol-1-yl]acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=NN(C1)CC(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,250,EGFR kinase inhibition IC50,>2.00E-5
250,"6,7-dimethoxy-2-methyl-N-[1-(5-(2-[(methylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,251,KRAS-SOS1 Interaction,5.8e-08
250,"6,7-dimethoxy-2-methyl-N-[1-(5-(2-[(methylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,251,KRAS-Activation by SOS high GTP,5.81e-08
250,"6,7-dimethoxy-2-methyl-N-[1-(5-(2-[(methylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,251,KRAS-Activation by SOS no GTP,7.04e-08
250,"6,7-dimethoxy-2-methyl-N-[1-(5-(2-[(methylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,251,EGFR kinase inhibition IC50,>2.00E-5
251,"2-(4-(4-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1H-pyrazol-1-yl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C=C(SC1)C=1C=NN(C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,252,KRAS-SOS1 Interaction,4.57e-06
251,"2-(4-(4-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1H-pyrazol-1-yl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C=C(SC1)C=1C=NN(C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,252,KRAS-Activation by SOS high GTP,5.84e-06
251,"2-(4-(4-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1H-pyrazol-1-yl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C=C(SC1)C=1C=NN(C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,252,KRAS-Activation by SOS no GTP,0.52
251,"2-(4-(4-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1H-pyrazol-1-yl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1C=C(SC1)C=1C=NN(C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,252,EGFR kinase inhibition IC50,>2.00E-5
252,"N-[1-{5-[2-(aminomethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,253,KRAS-SOS1 Interaction,8.92e-08
252,"N-[1-{5-[2-(aminomethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,253,KRAS-Activation by SOS high GTP,7.41e-08
252,"N-[1-{5-[2-(aminomethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,253,KRAS-Activation by SOS no GTP,1.03e-07
252,"N-[1-{5-[2-(aminomethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,253,EGFR kinase inhibition IC50,>2.00E-5
253,"N-{1-[5-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)thiophen-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1=C2N(C(=C1)C1=CC(=CS1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,254,KRAS-SOS1 Interaction,1.31e-06
253,"N-{1-[5-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)thiophen-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1=C2N(C(=C1)C1=CC(=CS1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,254,KRAS-Activation by SOS high GTP,2.33e-06
253,"N-{1-[5-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)thiophen-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1=C2N(C(=C1)C1=CC(=CS1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,254,KRAS-Activation by SOS no GTP,5.8e-06
253,"N-{1-[5-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)thiophen-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1=C2N(C(=C1)C1=CC(=CS1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,254,EGFR kinase inhibition IC50,>2.00E-5
254,"6,7-dimethoxy-2-methyl-N-[1-(5-{1-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrazol-4-yl}thiophen-3-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CSC(=C1)C=1C=NN(C1)CCN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,255,KRAS-SOS1 Interaction,8.14e-07
254,"6,7-dimethoxy-2-methyl-N-[1-(5-{1-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrazol-4-yl}thiophen-3-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CSC(=C1)C=1C=NN(C1)CCN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,255,KRAS-Activation by SOS high GTP,1.59e-06
254,"6,7-dimethoxy-2-methyl-N-[1-(5-{1-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrazol-4-yl}thiophen-3-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CSC(=C1)C=1C=NN(C1)CCN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,255,KRAS-Activation by SOS no GTP,3.45e-06
254,"6,7-dimethoxy-2-methyl-N-[1-(5-{1-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrazol-4-yl}thiophen-3-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CSC(=C1)C=1C=NN(C1)CCN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,255,EGFR kinase inhibition IC50,>2.00E-5
255,"N-[1-{5-[2-(aminomethyl)-4-fluorophenyl]thiophen-3-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)F)C1=CC(=CS1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,256,KRAS-SOS1 Interaction,2.48e-07
255,"N-[1-{5-[2-(aminomethyl)-4-fluorophenyl]thiophen-3-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)F)C1=CC(=CS1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,256,KRAS-Activation by SOS high GTP,3.17e-07
255,"N-[1-{5-[2-(aminomethyl)-4-fluorophenyl]thiophen-3-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)F)C1=CC(=CS1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,256,KRAS-Activation by SOS no GTP,3.9e-07
255,"N-[1-{5-[2-(aminomethyl)-4-fluorophenyl]thiophen-3-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)F)C1=CC(=CS1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,256,EGFR kinase inhibition IC50,>2.00E-5
256,"2-[4-(3-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)-1H-pyrazol-1-yl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C=1C=NN(C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,257,KRAS-SOS1 Interaction,4.73e-07
256,"2-[4-(3-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)-1H-pyrazol-1-yl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C=1C=NN(C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,257,KRAS-Activation by SOS high GTP,8.28e-07
256,"2-[4-(3-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)-1H-pyrazol-1-yl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C=1C=NN(C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,257,KRAS-Activation by SOS no GTP,1.35e-06
256,"2-[4-(3-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)-1H-pyrazol-1-yl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C=1C=NN(C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,257,EGFR kinase inhibition IC50,>2.00E-5
257,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(3-{1-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrazol-4-yl}phenyl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NN(C1)CCN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,258,KRAS-SOS1 Interaction,3.83e-07
257,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(3-{1-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrazol-4-yl}phenyl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NN(C1)CCN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,258,KRAS-Activation by SOS high GTP,7.54e-07
257,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(3-{1-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrazol-4-yl}phenyl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NN(C1)CCN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,258,KRAS-Activation by SOS no GTP,8.52e-07
257,"6,7-dimethoxy-2-methyl-N-[(1R)-1-(3-{1-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrazol-4-yl}phenyl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NN(C1)CCN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,258,EGFR kinase inhibition IC50,>2.00E-5
258,"N-{(1R)-1-[2'-(aminomethyl)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,259,KRAS-SOS1 Interaction,2.84e-07
258,"N-{(1R)-1-[2'-(aminomethyl)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,259,KRAS-Activation by SOS high GTP,1.9e-07
258,"N-{(1R)-1-[2'-(aminomethyl)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,259,KRAS-Activation by SOS no GTP,2.45e-07
258,"N-{(1R)-1-[2'-(aminomethyl)biphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,259,EGFR kinase inhibition IC50,>2.00E-5
259,"N-[1-{5-[2-(aminomethyl)phenyl]thiophen-3-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C1=CC(=CS1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,260,KRAS-SOS1 Interaction,4.82e-07
259,"N-[1-{5-[2-(aminomethyl)phenyl]thiophen-3-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C1=CC(=CS1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,260,KRAS-Activation by SOS high GTP,4.35e-07
259,"N-[1-{5-[2-(aminomethyl)phenyl]thiophen-3-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C1=CC(=CS1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,260,KRAS-Activation by SOS no GTP,8.5e-07
259,"N-[1-{5-[2-(aminomethyl)phenyl]thiophen-3-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C1=CC(=CS1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,260,EGFR kinase inhibition IC50,>2.00E-5
260,"N-{(1R)-1-[3-(aminomethyl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,261,KRAS-SOS1 Interaction,4.88e-06
260,"N-{(1R)-1-[3-(aminomethyl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,261,KRAS-Activation by SOS high GTP,2.04e-06
260,"N-{(1R)-1-[3-(aminomethyl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,261,KRAS-Activation by SOS no GTP,5.68e-06
260,"N-{(1R)-1-[3-(aminomethyl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,261,EGFR kinase inhibition IC50,>2.00E-5
261,"N-{(1R)-1-[3-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1=C2N(C(=C1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,262,KRAS-SOS1 Interaction,8.39e-07
261,"N-{(1R)-1-[3-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1=C2N(C(=C1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,262,KRAS-Activation by SOS high GTP,8.73e-07
261,"N-{(1R)-1-[3-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1=C2N(C(=C1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,262,KRAS-Activation by SOS no GTP,1.1e-06
261,"N-{(1R)-1-[3-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1=C2N(C(=C1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,262,EGFR kinase inhibition IC50,>2.00E-5
262,"N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,263,KRAS-SOS1 Interaction,4.83e-08
262,"N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,263,KRAS-Activation by SOS high GTP,4.49e-08
262,"N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,263,KRAS-Activation by SOS no GTP,5.11e-08
262,"N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,263,EGFR kinase inhibition IC50,>2.00E-5
263,"6,7-dimethoxy-2-methyl-N-[1-(5-(2-[(methylamino)methyl]phenyl}thiophen-3-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CSC(=C1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,264,KRAS-SOS1 Interaction,2.37e-07
263,"6,7-dimethoxy-2-methyl-N-[1-(5-(2-[(methylamino)methyl]phenyl}thiophen-3-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CSC(=C1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,264,KRAS-Activation by SOS high GTP,2.32e-07
263,"6,7-dimethoxy-2-methyl-N-[1-(5-(2-[(methylamino)methyl]phenyl}thiophen-3-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CSC(=C1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,264,KRAS-Activation by SOS no GTP,3.24e-07
263,"6,7-dimethoxy-2-methyl-N-[1-(5-(2-[(methylamino)methyl]phenyl}thiophen-3-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CSC(=C1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,264,EGFR kinase inhibition IC50,>2.00E-5
264,"N-[1-(4-bromothiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC=1C=C(SC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,265,KRAS-SOS1 Interaction,5.94e-06
264,"N-[1-(4-bromothiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC=1C=C(SC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,265,KRAS-Activation by SOS high GTP,1.67e-06
264,"N-[1-(4-bromothiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC=1C=C(SC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,265,KRAS-Activation by SOS no GTP,4.61e-06
264,"N-[1-(4-bromothiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC=1C=C(SC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,265,EGFR kinase inhibition IC50,>2.00E-5
265,"N-[1-{5-[3-(aminomethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC=1C=C(C=CC1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,266,KRAS-SOS1 Interaction,2.77e-06
265,"N-[1-{5-[3-(aminomethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC=1C=C(C=CC1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,266,KRAS-Activation by SOS high GTP,1.47e-06
265,"N-[1-{5-[3-(aminomethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC=1C=C(C=CC1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,266,KRAS-Activation by SOS no GTP,1.11e-06
265,"N-[1-{5-[3-(aminomethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC=1C=C(C=CC1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,266,EGFR kinase inhibition IC50,>2.00E-5
266,"N-[1-{5-[4-(aminomethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=CC=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,267,KRAS-SOS1 Interaction,3.61e-06
266,"N-[1-{5-[4-(aminomethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=CC=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,267,KRAS-Activation by SOS high GTP,1.78e-06
266,"N-[1-{5-[4-(aminomethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=CC=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,267,KRAS-Activation by SOS no GTP,3.74e-06
266,"N-[1-{5-[4-(aminomethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=CC=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,267,EGFR kinase inhibition IC50,>2.00E-5
267,"6,7-dimethoxy-2-methyl-N-[1-(4-{1-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrazol-3-yl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=C(C1)C1=NN(C=C1)CCN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,268,KRAS-SOS1 Interaction,3.39e-06
267,"6,7-dimethoxy-2-methyl-N-[1-(4-{1-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrazol-3-yl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=C(C1)C1=NN(C=C1)CCN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,268,KRAS-Activation by SOS high GTP,1.52e-06
267,"6,7-dimethoxy-2-methyl-N-[1-(4-{1-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrazol-3-yl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=C(C1)C1=NN(C=C1)CCN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,268,KRAS-Activation by SOS no GTP,1.78e-06
267,"6,7-dimethoxy-2-methyl-N-[1-(4-{1-[2-(pyrrolidin-1-yl)ethyl]-1H-pyrazol-3-yl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=C(C1)C1=NN(C=C1)CCN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,268,EGFR kinase inhibition IC50,>2.00E-5
268,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{2'-[(methylamino)methyl]biphenyl-3-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,269,KRAS-SOS1 Interaction,1.88e-07
268,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{2'-[(methylamino)methyl]biphenyl-3-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,269,KRAS-Activation by SOS high GTP,1.51e-07
268,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{2'-[(methylamino)methyl]biphenyl-3-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,269,KRAS-Activation by SOS no GTP,1.89e-07
268,"6,7-dimethoxy-2-methyl-N-[(1R)-1-{2'-[(methylamino)methyl]biphenyl-3-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,269,EGFR kinase inhibition IC50,>2.00E-5
269,"N-[1-{4-[2-(aminomethyl)-4-fluorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)F)C=1C=C(SC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,270,KRAS-SOS1 Interaction,1.62e-07
269,"N-[1-{4-[2-(aminomethyl)-4-fluorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)F)C=1C=C(SC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,270,KRAS-Activation by SOS high GTP,1.15e-07
269,"N-[1-{4-[2-(aminomethyl)-4-fluorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)F)C=1C=C(SC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,270,KRAS-Activation by SOS no GTP,1.35e-07
269,"N-[1-{4-[2-(aminomethyl)-4-fluorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)F)C=1C=C(SC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,270,EGFR kinase inhibition IC50,>2.00E-5
270,"N-[1-{4-[2-(aminomethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C=1C=C(SC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,271,KRAS-SOS1 Interaction,9.14e-08
270,"N-[1-{4-[2-(aminomethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C=1C=C(SC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,271,KRAS-Activation by SOS high GTP,8.22e-08
270,"N-[1-{4-[2-(aminomethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C=1C=C(SC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,271,KRAS-Activation by SOS no GTP,9.8e-08
270,"N-[1-{4-[2-(aminomethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C=1C=C(SC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,271,EGFR kinase inhibition IC50,>2.00E-5
271,"6,7-dimethoxy-2-methyl-N-[1-(4-{2-[(methylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=C(C1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,272,KRAS-SOS1 Interaction,6.05e-08
271,"6,7-dimethoxy-2-methyl-N-[1-(4-{2-[(methylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=C(C1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,272,KRAS-Activation by SOS high GTP,7.28e-08
271,"6,7-dimethoxy-2-methyl-N-[1-(4-{2-[(methylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=C(C1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,272,KRAS-Activation by SOS no GTP,7.59e-08
271,"6,7-dimethoxy-2-methyl-N-[1-(4-{2-[(methylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=C(C1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,272,EGFR kinase inhibition IC50,>2.00E-5
272,"N-{1-[4-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1=C2N(C(=C1)C=1C=C(SC1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,273,KRAS-SOS1 Interaction,1.82e-06
272,"N-{1-[4-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1=C2N(C(=C1)C=1C=C(SC1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,273,KRAS-Activation by SOS high GTP,1.58e-06
272,"N-{1-[4-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1=C2N(C(=C1)C=1C=C(SC1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,273,KRAS-Activation by SOS no GTP,2.5e-06
272,"N-{1-[4-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1=C2N(C(=C1)C=1C=C(SC1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,273,EGFR kinase inhibition IC50,>2.00E-5
273,"2-[3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-3-yl)-1H-pyrazol-1-yl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC(=CS1)C1=NN(C=C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,274,KRAS-SOS1 Interaction,2.32e-06
273,"2-[3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-3-yl)-1H-pyrazol-1-yl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC(=CS1)C1=NN(C=C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,274,KRAS-Activation by SOS high GTP,2.38e-06
273,"2-[3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-3-yl)-1H-pyrazol-1-yl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC(=CS1)C1=NN(C=C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,274,KRAS-Activation by SOS no GTP,3.83e-06
273,"2-[3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-3-yl)-1H-pyrazol-1-yl]ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC(=CS1)C1=NN(C=C1)CCO,data/bronze/artifacts/2018_raw.xlsx,Sheet1,274,EGFR kinase inhibition IC50,>2.00E-5
274,"N-{(1R)-1-[2'-(aminomethyl)-4'-fluorobiphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,275,KRAS-SOS1 Interaction,1.3e-07
274,"N-{(1R)-1-[2'-(aminomethyl)-4'-fluorobiphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,275,KRAS-Activation by SOS high GTP,1.41e-07
274,"N-{(1R)-1-[2'-(aminomethyl)-4'-fluorobiphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,275,KRAS-Activation by SOS no GTP,2.14e-07
274,"N-{(1R)-1-[2'-(aminomethyl)-4'-fluorobiphenyl-3-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)F)C1=CC(=CC=C1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,275,EGFR kinase inhibition IC50,>2.00E-5
275,"N-[1-{5-[5-(aminomethyl)furan-2-yl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=CC=C(O1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,276,KRAS-SOS1 Interaction,2.8e-06
275,"N-[1-{5-[5-(aminomethyl)furan-2-yl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=CC=C(O1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,276,KRAS-Activation by SOS high GTP,2.97e-06
275,"N-[1-{5-[5-(aminomethyl)furan-2-yl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=CC=C(O1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,276,KRAS-Activation by SOS no GTP,8.37e-06
275,"N-[1-{5-[5-(aminomethyl)furan-2-yl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=CC=C(O1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,276,EGFR kinase inhibition IC50,>2.00E-5
276,"N-{1-[5'-(aminomethyl)-2,2'-bithiophen-5-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=CC=C(S1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,277,KRAS-SOS1 Interaction,1.41e-06
276,"N-{1-[5'-(aminomethyl)-2,2'-bithiophen-5-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=CC=C(S1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,277,KRAS-Activation by SOS high GTP,1.88e-06
276,"N-{1-[5'-(aminomethyl)-2,2'-bithiophen-5-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=CC=C(S1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,277,KRAS-Activation by SOS no GTP,2.16e-06
276,"N-{1-[5'-(aminomethyl)-2,2'-bithiophen-5-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=CC=C(S1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,277,EGFR kinase inhibition IC50,>2.00E-5
277,"2-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]amino}-1-(1H-indol-3-yl)ethanone",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNCC(=O)C2=CNC3=CC=CC=C23)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,278,KRAS-SOS1 Interaction,2.14e-07
277,"2-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]amino}-1-(1H-indol-3-yl)ethanone",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNCC(=O)C2=CNC3=CC=CC=C23)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,278,KRAS-Activation by SOS high GTP,2.37e-07
277,"2-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]amino}-1-(1H-indol-3-yl)ethanone",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNCC(=O)C2=CNC3=CC=CC=C23)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,278,KRAS-Activation by SOS no GTP,2.63e-07
277,"2-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]amino}-1-(1H-indol-3-yl)ethanone",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNCC(=O)C2=CNC3=CC=CC=C23)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,278,EGFR kinase inhibition IC50,>2.00E-5
278,"3-amino-4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1-benzothiophene-2-carboxamide",NC1=C(SC2=C1C(=CC=C2)C=2SC(=CC2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C)C(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,279,KRAS-SOS1 Interaction,1.25e-05
278,"3-amino-4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1-benzothiophene-2-carboxamide",NC1=C(SC2=C1C(=CC=C2)C=2SC(=CC2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C)C(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,279,KRAS-Activation by SOS high GTP,3.71e-06
278,"3-amino-4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1-benzothiophene-2-carboxamide",NC1=C(SC2=C1C(=CC=C2)C=2SC(=CC2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C)C(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,279,KRAS-Activation by SOS no GTP,0.43
278,"3-amino-4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1-benzothiophene-2-carboxamide",NC1=C(SC2=C1C(=CC=C2)C=2SC(=CC2)C(C)NC2=NC(=NC1=CC(=C(C=C21)OC)OC)C)C(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,279,EGFR kinase inhibition IC50,>2.00E-5
279,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]glycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CC(N)C(=O)N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,280,KRAS-SOS1 Interaction,1.76e-07
279,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]glycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CC(N)C(=O)N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,280,KRAS-Activation by SOS high GTP,1.88e-07
279,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]glycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CC(N)C(=O)N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,280,KRAS-Activation by SOS no GTP,1.8e-07
279,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]glycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CC(N)C(=O)N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,280,EGFR kinase inhibition IC50,>2.00E-5
280,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]-N,N-dimethylglycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CC(N)C(=O)N(C)C)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,281,KRAS-SOS1 Interaction,1.48e-07
280,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]-N,N-dimethylglycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CC(N)C(=O)N(C)C)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,281,KRAS-Activation by SOS high GTP,1.29e-07
280,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]-N,N-dimethylglycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CC(N)C(=O)N(C)C)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,281,KRAS-Activation by SOS no GTP,1.35e-07
280,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]-N,N-dimethylglycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CC(N)C(=O)N(C)C)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,281,EGFR kinase inhibition IC50,>2.00E-5
281,"methylN-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]glycinate",COC(CNCC1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,282,KRAS-SOS1 Interaction,5.59e-07
281,"methylN-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]glycinate",COC(CNCC1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,282,KRAS-Activation by SOS high GTP,4.47e-07
281,"methylN-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]glycinate",COC(CNCC1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,282,KRAS-Activation by SOS no GTP,3.87e-07
281,"methylN-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]glycinate",COC(CNCC1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,282,EGFR kinase inhibition IC50,>2.00E-5
282,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]-N-methylglycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CC(N)C(=O)NC)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,283,KRAS-SOS1 Interaction,2.57e-07
282,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]-N-methylglycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CC(N)C(=O)NC)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,283,KRAS-Activation by SOS high GTP,2.65e-07
282,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]-N-methylglycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CC(N)C(=O)NC)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,283,KRAS-Activation by SOS no GTP,2.12e-07
282,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]-N-methylglycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CC(N)C(=O)NC)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,283,EGFR kinase inhibition IC50,>2.00E-5
283,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]-N-(2-methoxyethyl)glycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CC(N)C(=O)NCCOC)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,284,KRAS-SOS1 Interaction,4.18e-07
283,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]-N-(2-methoxyethyl)glycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CC(N)C(=O)NCCOC)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,284,KRAS-Activation by SOS high GTP,3.71e-07
283,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]-N-(2-methoxyethyl)glycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CC(N)C(=O)NCCOC)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,284,KRAS-Activation by SOS no GTP,3.44e-07
283,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]-N-(2-methoxyethyl)glycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CC(N)C(=O)NCCOC)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,284,EGFR kinase inhibition IC50,>2.00E-5
284,"N-benzyl-2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]glycinamide",C(C1=CC=CC=C1)NC(C(N)CC1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,285,KRAS-SOS1 Interaction,1.06e-06
284,"N-benzyl-2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]glycinamide",C(C1=CC=CC=C1)NC(C(N)CC1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,285,KRAS-Activation by SOS high GTP,8.79e-07
284,"N-benzyl-2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]glycinamide",C(C1=CC=CC=C1)NC(C(N)CC1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,285,KRAS-Activation by SOS no GTP,8.89e-07
284,"N-benzyl-2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]glycinamide",C(C1=CC=CC=C1)NC(C(N)CC1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,285,EGFR kinase inhibition IC50,>2.00E-5
285,"2-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]amino}-1-(morpholin-4-yl)ethanone",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNCC(=O)N2CCOCC2)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,286,KRAS-SOS1 Interaction,2.03e-07
285,"2-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]amino}-1-(morpholin-4-yl)ethanone",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNCC(=O)N2CCOCC2)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,286,KRAS-Activation by SOS high GTP,1.58e-07
285,"2-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]amino}-1-(morpholin-4-yl)ethanone",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNCC(=O)N2CCOCC2)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,286,KRAS-Activation by SOS no GTP,1.81e-07
285,"2-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]amino}-1-(morpholin-4-yl)ethanone",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNCC(=O)N2CCOCC2)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,286,EGFR kinase inhibition IC50,>2.00E-5
286,"3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1,5-dimethyl-1H-pyrrole-2-carbonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(N(C(=C1)C)C)C#N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,287,KRAS-SOS1 Interaction,1.87e-05
286,"3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1,5-dimethyl-1H-pyrrole-2-carbonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(N(C(=C1)C)C)C#N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,287,KRAS-Activation by SOS high GTP,1.74e-05
286,"3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1,5-dimethyl-1H-pyrrole-2-carbonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(N(C(=C1)C)C)C#N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,287,KRAS-Activation by SOS no GTP,0.36
286,"3-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1,5-dimethyl-1H-pyrrole-2-carbonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(N(C(=C1)C)C)C#N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,287,EGFR kinase inhibition IC50,>2.00E-5
287,"5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2,3'-bithiophene-4'-carbonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CSC=C1C#N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,288,KRAS-SOS1 Interaction,5.88e-06
287,"5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2,3'-bithiophene-4'-carbonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CSC=C1C#N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,288,KRAS-Activation by SOS high GTP,1.88e-06
287,"5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2,3'-bithiophene-4'-carbonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CSC=C1C#N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,288,KRAS-Activation by SOS no GTP,5.76e-06
287,"5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2,3'-bithiophene-4'-carbonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CSC=C1C#N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,288,EGFR kinase inhibition IC50,>2.00E-5
288,"N-[1-(5-{2-[(diethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C)N(CC)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,289,KRAS-SOS1 Interaction,1.7e-07
288,"N-[1-(5-{2-[(diethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C)N(CC)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,289,KRAS-Activation by SOS high GTP,1.4e-07
288,"N-[1-(5-{2-[(diethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C)N(CC)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,289,KRAS-Activation by SOS no GTP,2.47e-07
288,"N-[1-(5-{2-[(diethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C)N(CC)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,289,EGFR kinase inhibition IC50,>2.00E-5
289,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]-N-phenylglycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CC(N)C(=O)NC2=CC=CC=C2)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,290,KRAS-SOS1 Interaction,2.11e-06
289,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]-N-phenylglycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CC(N)C(=O)NC2=CC=CC=C2)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,290,KRAS-Activation by SOS high GTP,1.18e-06
289,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]-N-phenylglycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CC(N)C(=O)NC2=CC=CC=C2)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,290,KRAS-Activation by SOS no GTP,2.73e-06
289,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]-N-phenylglycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CC(N)C(=O)NC2=CC=CC=C2)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,290,EGFR kinase inhibition IC50,>2.00E-5
290,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]piperidine-3-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN2CC(CCC2)C(=O)N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,291,KRAS-SOS1 Interaction,1.76e-07
290,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]piperidine-3-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN2CC(CCC2)C(=O)N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,291,KRAS-Activation by SOS high GTP,1.16e-07
290,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]piperidine-3-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN2CC(CCC2)C(=O)N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,291,KRAS-Activation by SOS no GTP,1.59e-07
290,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]piperidine-3-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN2CC(CCC2)C(=O)N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,291,EGFR kinase inhibition IC50,>2.00E-5
291,"N-{1-[5-(2-{[(2,2-difluoroethyl)(methyl)amino]methyl}phenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",FC(CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,292,KRAS-SOS1 Interaction,1.12e-06
291,"N-{1-[5-(2-{[(2,2-difluoroethyl)(methyl)amino]methyl}phenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",FC(CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,292,KRAS-Activation by SOS high GTP,1.32e-06
291,"N-{1-[5-(2-{[(2,2-difluoroethyl)(methyl)amino]methyl}phenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",FC(CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,292,KRAS-Activation by SOS no GTP,2.23e-06
291,"N-{1-[5-(2-{[(2,2-difluoroethyl)(methyl)amino]methyl}phenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",FC(CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,292,EGFR kinase inhibition IC50,>2.00E-5
292,"N-[1-{5-[2-(aminomethyl)-5-chlorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=C(C=C1)Cl)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,293,KRAS-SOS1 Interaction,3.15e-08
292,"N-[1-{5-[2-(aminomethyl)-5-chlorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=C(C=C1)Cl)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,293,KRAS-Activation by SOS high GTP,3.87e-08
292,"N-[1-{5-[2-(aminomethyl)-5-chlorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=C(C=C1)Cl)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,293,KRAS-Activation by SOS no GTP,4.13e-08
292,"N-[1-{5-[2-(aminomethyl)-5-chlorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=C(C=C1)Cl)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,293,EGFR kinase inhibition IC50,>2.00E-5
293,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-1H-imidazole-2-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(=O)C=2NC=CN2)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,294,KRAS-SOS1 Interaction,2.75e-06
293,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-1H-imidazole-2-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(=O)C=2NC=CN2)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,294,KRAS-Activation by SOS high GTP,3.92e-06
293,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-1H-imidazole-2-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(=O)C=2NC=CN2)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,294,KRAS-Activation by SOS no GTP,8.26e-06
293,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-1H-imidazole-2-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(=O)C=2NC=CN2)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,294,EGFR kinase inhibition IC50,>2.00E-5
294,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-1H-imidazole-5-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(=O)C2=CN=CN2)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,295,KRAS-SOS1 Interaction,3.1e-06
294,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-1H-imidazole-5-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(=O)C2=CN=CN2)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,295,KRAS-Activation by SOS high GTP,3.93e-06
294,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-1H-imidazole-5-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(=O)C2=CN=CN2)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,295,KRAS-Activation by SOS no GTP,8.58e-06
294,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-1H-imidazole-5-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(=O)C2=CN=CN2)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,295,EGFR kinase inhibition IC50,>2.00E-5
295,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-N&lt;sup&gt;2&lt;/sup&gt;-(2,2,2-trifluoroethyl)glycinamide",nan,data/bronze/artifacts/2018_raw.xlsx,Sheet1,296,KRAS-SOS1 Interaction,9.8e-07
295,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-N&lt;sup&gt;2&lt;/sup&gt;-(2,2,2-trifluoroethyl)glycinamide",nan,data/bronze/artifacts/2018_raw.xlsx,Sheet1,296,KRAS-Activation by SOS high GTP,1.47e-06
295,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-N&lt;sup&gt;2&lt;/sup&gt;-(2,2,2-trifluoroethyl)glycinamide",nan,data/bronze/artifacts/2018_raw.xlsx,Sheet1,296,KRAS-Activation by SOS no GTP,2.78e-06
295,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-N&lt;sup&gt;2&lt;/sup&gt;-(2,2,2-trifluoroethyl)glycinamide",nan,data/bronze/artifacts/2018_raw.xlsx,Sheet1,296,EGFR kinase inhibition IC50,>2.00E-5
296,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-1H-indole-2-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(=O)C=2NC3=CC=CC=C3C2)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,297,KRAS-SOS1 Interaction,0.34
296,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-1H-indole-2-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(=O)C=2NC3=CC=CC=C3C2)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,297,KRAS-Activation by SOS high GTP,0.48
296,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-1H-indole-2-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(=O)C=2NC3=CC=CC=C3C2)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,297,KRAS-Activation by SOS no GTP,1.18e-05
296,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-1H-indole-2-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(=O)C=2NC3=CC=CC=C3C2)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,297,EGFR kinase inhibition IC50,>2.00E-5
297,"2-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]amino}ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNCCO)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,298,KRAS-SOS1 Interaction,4.88e-08
297,"2-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]amino}ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNCCO)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,298,KRAS-Activation by SOS high GTP,5.78e-08
297,"2-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]amino}ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNCCO)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,298,KRAS-Activation by SOS no GTP,8.08e-08
297,"2-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]amino}ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNCCO)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,298,EGFR kinase inhibition IC50,>2.00E-5
298,"2-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl](methyl)amino}ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN(CCO)C)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,299,KRAS-SOS1 Interaction,4.72e-08
298,"2-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl](methyl)amino}ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN(CCO)C)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,299,KRAS-Activation by SOS high GTP,4.93e-08
298,"2-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl](methyl)amino}ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN(CCO)C)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,299,KRAS-Activation by SOS no GTP,5.88e-08
298,"2-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl](methyl)amino}ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN(CCO)C)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,299,EGFR kinase inhibition IC50,>2.00E-5
299,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-N2-phenylglycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(CNC2=CC=CC=C2)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,300,KRAS-SOS1 Interaction,9.48e-07
299,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-N2-phenylglycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(CNC2=CC=CC=C2)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,300,KRAS-Activation by SOS high GTP,1.23e-06
299,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-N2-phenylglycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(CNC2=CC=CC=C2)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,300,KRAS-Activation by SOS no GTP,1.88e-06
299,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-N2-phenylglycinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(CNC2=CC=CC=C2)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,300,EGFR kinase inhibition IC50,>2.00E-5
300,"6,7-dimethoxy-2-methyl-N-{1-[5-(2-{[(2,2,2-trifluoroethyl)amino]methyl}phenyl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNCC(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,301,KRAS-SOS1 Interaction,3.15e-06
300,"6,7-dimethoxy-2-methyl-N-{1-[5-(2-{[(2,2,2-trifluoroethyl)amino]methyl}phenyl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNCC(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,301,KRAS-Activation by SOS high GTP,3.07e-06
300,"6,7-dimethoxy-2-methyl-N-{1-[5-(2-{[(2,2,2-trifluoroethyl)amino]methyl}phenyl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNCC(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,301,KRAS-Activation by SOS no GTP,5.08e-06
300,"6,7-dimethoxy-2-methyl-N-{1-[5-(2-{[(2,2,2-trifluoroethyl)amino]methyl}phenyl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNCC(F)(F)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,301,EGFR kinase inhibition IC50,>2.00E-5
301,"6,7-dimethoxy-2-methyl-N-[1-(5-{2-[(pyridin-2-ylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNC1=NC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,302,KRAS-SOS1 Interaction,7.99e-07
301,"6,7-dimethoxy-2-methyl-N-[1-(5-{2-[(pyridin-2-ylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNC1=NC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,302,KRAS-Activation by SOS high GTP,9.31e-07
301,"6,7-dimethoxy-2-methyl-N-[1-(5-{2-[(pyridin-2-ylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNC1=NC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,302,KRAS-Activation by SOS no GTP,1.93e-06
301,"6,7-dimethoxy-2-methyl-N-[1-(5-{2-[(pyridin-2-ylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNC1=NC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,302,EGFR kinase inhibition IC50,>2.00E-5
302,"6,7-dimethoxy-2-methyl-N-[1-(5-{2-[(1H-pyrazol-3-ylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNC1=NNC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,303,KRAS-SOS1 Interaction,7.87e-07
302,"6,7-dimethoxy-2-methyl-N-[1-(5-{2-[(1H-pyrazol-3-ylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNC1=NNC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,303,KRAS-Activation by SOS high GTP,1.26e-06
302,"6,7-dimethoxy-2-methyl-N-[1-(5-{2-[(1H-pyrazol-3-ylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNC1=NNC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,303,KRAS-Activation by SOS no GTP,1.54e-06
302,"6,7-dimethoxy-2-methyl-N-[1-(5-{2-[(1H-pyrazol-3-ylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNC1=NNC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,303,EGFR kinase inhibition IC50,>2.00E-5
303,"1-(3,4-dihydroisoquinolin-2(1H)-yl)-2-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]amino}ethanone",C1N(CCC2=CC=CC=C12)C(CNCC1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,304,KRAS-SOS1 Interaction,7.24e-07
303,"1-(3,4-dihydroisoquinolin-2(1H)-yl)-2-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]amino}ethanone",C1N(CCC2=CC=CC=C12)C(CNCC1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,304,KRAS-Activation by SOS high GTP,8.49e-07
303,"1-(3,4-dihydroisoquinolin-2(1H)-yl)-2-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]amino}ethanone",C1N(CCC2=CC=CC=C12)C(CNCC1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,304,KRAS-Activation by SOS no GTP,8.89e-07
303,"1-(3,4-dihydroisoquinolin-2(1H)-yl)-2-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]amino}ethanone",C1N(CCC2=CC=CC=C12)C(CNCC1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,304,EGFR kinase inhibition IC50,>2.00E-5
304,"N-[1-{5-[4-fluoro-2-({[(1-methyl-1H-imidazol-2-yl)methyl]amino}methyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1=CC(=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)CNCC=1N(C=CN1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,305,KRAS-SOS1 Interaction,4.17e-07
304,"N-[1-{5-[4-fluoro-2-({[(1-methyl-1H-imidazol-2-yl)methyl]amino}methyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1=CC(=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)CNCC=1N(C=CN1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,305,KRAS-Activation by SOS high GTP,4.69e-07
304,"N-[1-{5-[4-fluoro-2-({[(1-methyl-1H-imidazol-2-yl)methyl]amino}methyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1=CC(=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)CNCC=1N(C=CN1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,305,KRAS-Activation by SOS no GTP,3.99e-07
304,"N-[1-{5-[4-fluoro-2-({[(1-methyl-1H-imidazol-2-yl)methyl]amino}methyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1=CC(=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)CNCC=1N(C=CN1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,305,EGFR kinase inhibition IC50,>2.00E-5
305,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(piperazin-1-ylmethyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine hydrochloride",Cl.COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN1CCNCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,306,KRAS-SOS1 Interaction,6.18e-08
305,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(piperazin-1-ylmethyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine hydrochloride",Cl.COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN1CCNCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,306,KRAS-Activation by SOS high GTP,5.52e-08
305,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(piperazin-1-ylmethyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine hydrochloride",Cl.COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN1CCNCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,306,KRAS-Activation by SOS no GTP,5.84e-08
305,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(piperazin-1-ylmethyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine hydrochloride",Cl.COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN1CCNCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,306,EGFR kinase inhibition IC50,>2.00E-5
306,"tert-butyl4-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]piperazine-1-carboxylate",C(C)(C)(C)OC(=O)N1CCN(CC1)CC1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,307,KRAS-SOS1 Interaction,0.45
306,"tert-butyl4-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]piperazine-1-carboxylate",C(C)(C)(C)OC(=O)N1CCN(CC1)CC1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,307,KRAS-Activation by SOS high GTP,4.29e-06
306,"tert-butyl4-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]piperazine-1-carboxylate",C(C)(C)(C)OC(=O)N1CCN(CC1)CC1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,307,KRAS-Activation by SOS no GTP,7.94e-06
306,"tert-butyl4-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]piperazine-1-carboxylate",C(C)(C)(C)OC(=O)N1CCN(CC1)CC1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,307,EGFR kinase inhibition IC50,>2.00E-5
307,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(C)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,308,KRAS-SOS1 Interaction,5.89e-07
307,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(C)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,308,KRAS-Activation by SOS high GTP,5.93e-07
307,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(C)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,308,KRAS-Activation by SOS no GTP,7.8e-07
307,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(C)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,308,EGFR kinase inhibition IC50,>2.00E-5
308,"6,7-dimethoxy-2-methyl-N-[1-(5-{2-[(4-methylpiperazin-1-yl)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN1CCN(CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,309,KRAS-SOS1 Interaction,2.8e-07
308,"6,7-dimethoxy-2-methyl-N-[1-(5-{2-[(4-methylpiperazin-1-yl)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN1CCN(CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,309,KRAS-Activation by SOS high GTP,2.29e-07
308,"6,7-dimethoxy-2-methyl-N-[1-(5-{2-[(4-methylpiperazin-1-yl)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN1CCN(CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,309,KRAS-Activation by SOS no GTP,2.2e-07
308,"6,7-dimethoxy-2-methyl-N-[1-(5-{2-[(4-methylpiperazin-1-yl)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN1CCN(CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,309,EGFR kinase inhibition IC50,>2.00E-5
309,"(3S)-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]amino}-1-methylpyrrolidin-2-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN[C@@H]2C(N(CC2)C)=O)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,310,KRAS-SOS1 Interaction,1.32e-06
309,"(3S)-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]amino}-1-methylpyrrolidin-2-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN[C@@H]2C(N(CC2)C)=O)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,310,KRAS-Activation by SOS high GTP,6.99e-07
309,"(3S)-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]amino}-1-methylpyrrolidin-2-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN[C@@H]2C(N(CC2)C)=O)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,310,KRAS-Activation by SOS no GTP,8.8e-07
309,"(3S)-{[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]amino}-1-methylpyrrolidin-2-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN[C@@H]2C(N(CC2)C)=O)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,310,EGFR kinase inhibition IC50,>2.00E-5
310,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-1H-pyrazole-3-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(=O)C2=NNC=C2)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,311,KRAS-SOS1 Interaction,5.82e-06
310,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-1H-pyrazole-3-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(=O)C2=NNC=C2)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,311,KRAS-Activation by SOS high GTP,1.34e-06
310,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-1H-pyrazole-3-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(=O)C2=NNC=C2)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,311,KRAS-Activation by SOS no GTP,5.76e-06
310,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-1H-pyrazole-3-carboxamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(=O)C2=NNC=C2)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,311,EGFR kinase inhibition IC50,>2.00E-5
311,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(morpholin-4-ylmethyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN1CCOCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,312,KRAS-SOS1 Interaction,7.83e-07
311,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(morpholin-4-ylmethyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN1CCOCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,312,KRAS-Activation by SOS high GTP,5.13e-07
311,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(morpholin-4-ylmethyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN1CCOCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,312,KRAS-Activation by SOS no GTP,8.29e-07
311,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(morpholin-4-ylmethyl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN1CCOCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,312,EGFR kinase inhibition IC50,>2.00E-5
312,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]azetidin-3-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN2CC(C2)O)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,313,KRAS-SOS1 Interaction,6.82e-08
312,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]azetidin-3-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN2CC(C2)O)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,313,KRAS-Activation by SOS high GTP,6.65e-08
312,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]azetidin-3-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN2CC(C2)O)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,313,KRAS-Activation by SOS no GTP,7.32e-08
312,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]azetidin-3-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN2CC(C2)O)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,313,EGFR kinase inhibition IC50,>2.00E-5
313,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]-2,5,7-triazaspiro[34]octan-6-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN2CC3(C2)NC(NC3)=O)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,314,KRAS-SOS1 Interaction,1.87e-07
313,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]-2,5,7-triazaspiro[34]octan-6-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN2CC3(C2)NC(NC3)=O)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,314,KRAS-Activation by SOS high GTP,1.62e-07
313,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]-2,5,7-triazaspiro[34]octan-6-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN2CC3(C2)NC(NC3)=O)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,314,KRAS-Activation by SOS no GTP,1.5e-07
313,"2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]-2,5,7-triazaspiro[34]octan-6-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN2CC3(C2)NC(NC3)=O)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,314,EGFR kinase inhibition IC50,>2.00E-5
314,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-L-prolinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC([C@H]2NCCC2)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,315,KRAS-SOS1 Interaction,1.84e-07
314,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-L-prolinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC([C@H]2NCCC2)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,315,KRAS-Activation by SOS high GTP,8.73e-08
314,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-L-prolinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC([C@H]2NCCC2)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,315,KRAS-Activation by SOS no GTP,9.01e-08
314,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-L-prolinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC([C@H]2NCCC2)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,315,EGFR kinase inhibition IC50,>2.00E-5
315,"N-{1-[5-(2-{[(2,2-difluoroethyl)amino]methyl}phenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",FC(CNCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,316,KRAS-SOS1 Interaction,7.77e-07
315,"N-{1-[5-(2-{[(2,2-difluoroethyl)amino]methyl}phenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",FC(CNCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,316,KRAS-Activation by SOS high GTP,9.67e-07
315,"N-{1-[5-(2-{[(2,2-difluoroethyl)amino]methyl}phenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",FC(CNCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,316,KRAS-Activation by SOS no GTP,1.28e-06
315,"N-{1-[5-(2-{[(2,2-difluoroethyl)amino]methyl}phenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",FC(CNCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,316,EGFR kinase inhibition IC50,>2.00E-5
316,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-prolinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC([C@H]2NCCC2)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,317,KRAS-SOS1 Interaction,2.71e-07
316,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-prolinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC([C@H]2NCCC2)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,317,KRAS-Activation by SOS high GTP,2.84e-07
316,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-prolinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC([C@H]2NCCC2)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,317,KRAS-Activation by SOS no GTP,3.98e-07
316,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-prolinamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC([C@H]2NCCC2)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,317,EGFR kinase inhibition IC50,>2.00E-5
317,"N-[1-{5-[2-(azetidin-1-ylmethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",N1(CCC1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,318,KRAS-SOS1 Interaction,7.8e-08
317,"N-[1-{5-[2-(azetidin-1-ylmethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",N1(CCC1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,318,KRAS-Activation by SOS high GTP,8.27e-08
317,"N-[1-{5-[2-(azetidin-1-ylmethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",N1(CCC1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,318,KRAS-Activation by SOS no GTP,8.84e-08
317,"N-[1-{5-[2-(azetidin-1-ylmethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",N1(CCC1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,318,EGFR kinase inhibition IC50,>2.00E-5
318,"{1-[(2S)-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]azetidin-2-yl}methanol",nan,data/bronze/artifacts/2018_raw.xlsx,Sheet1,319,KRAS-SOS1 Interaction,1.71e-07
318,"{1-[(2S)-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]azetidin-2-yl}methanol",nan,data/bronze/artifacts/2018_raw.xlsx,Sheet1,319,KRAS-Activation by SOS high GTP,1.67e-07
318,"{1-[(2S)-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]azetidin-2-yl}methanol",nan,data/bronze/artifacts/2018_raw.xlsx,Sheet1,319,KRAS-Activation by SOS no GTP,2.21e-07
318,"{1-[(2S)-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]azetidin-2-yl}methanol",nan,data/bronze/artifacts/2018_raw.xlsx,Sheet1,319,EGFR kinase inhibition IC50,>2.00E-5
319,"N-{1-[5-(2-{[3-(dimethylamino)azetidin-1-yl]methyl}phenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C1CN(C1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,320,KRAS-SOS1 Interaction,1.84e-07
319,"N-{1-[5-(2-{[3-(dimethylamino)azetidin-1-yl]methyl}phenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C1CN(C1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,320,KRAS-Activation by SOS high GTP,1.19e-07
319,"N-{1-[5-(2-{[3-(dimethylamino)azetidin-1-yl]methyl}phenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C1CN(C1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,320,KRAS-Activation by SOS no GTP,1.27e-07
319,"N-{1-[5-(2-{[3-(dimethylamino)azetidin-1-yl]methyl}phenyl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C1CN(C1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,320,EGFR kinase inhibition IC50,>2.00E-5
320,"N-[1-(5-{2-[(3,3-difluoroazetidin-1-yl)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1(CN(C1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,321,KRAS-SOS1 Interaction,2.28e-06
320,"N-[1-(5-{2-[(3,3-difluoroazetidin-1-yl)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1(CN(C1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,321,KRAS-Activation by SOS high GTP,1.39e-06
320,"N-[1-(5-{2-[(3,3-difluoroazetidin-1-yl)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1(CN(C1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,321,KRAS-Activation by SOS no GTP,3.49e-06
320,"N-[1-(5-{2-[(3,3-difluoroazetidin-1-yl)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1(CN(C1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,321,EGFR kinase inhibition IC50,>2.00E-5
321,"6,7-dimethoxy-2-methyl-N-{1-[5-(2-{[methyl(2,2,2-trifluoroethyl)amino]methyl}phenyl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN(CC(F)(F)F)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,322,KRAS-SOS1 Interaction,1.48e-05
321,"6,7-dimethoxy-2-methyl-N-{1-[5-(2-{[methyl(2,2,2-trifluoroethyl)amino]methyl}phenyl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN(CC(F)(F)F)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,322,KRAS-Activation by SOS high GTP,6.24e-06
321,"6,7-dimethoxy-2-methyl-N-{1-[5-(2-{[methyl(2,2,2-trifluoroethyl)amino]methyl}phenyl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN(CC(F)(F)F)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,322,KRAS-Activation by SOS no GTP,1.28e-05
321,"6,7-dimethoxy-2-methyl-N-{1-[5-(2-{[methyl(2,2,2-trifluoroethyl)amino]methyl}phenyl)thiophen-2-yl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN(CC(F)(F)F)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,322,EGFR kinase inhibition IC50,>2.00E-5
322,"N-[1-(5-{2-[(3-fluoroazetidin-1-yl)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1CN(C1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,323,KRAS-SOS1 Interaction,4.88e-07
322,"N-[1-(5-{2-[(3-fluoroazetidin-1-yl)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1CN(C1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,323,KRAS-Activation by SOS high GTP,2.47e-07
322,"N-[1-(5-{2-[(3-fluoroazetidin-1-yl)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1CN(C1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,323,KRAS-Activation by SOS no GTP,2.68e-07
322,"N-[1-(5-{2-[(3-fluoroazetidin-1-yl)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",FC1CN(C1)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,323,EGFR kinase inhibition IC50,>2.00E-5
323,"N-[1-(5-{4-chloro-2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC1=CC(=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)CN(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,324,KRAS-SOS1 Interaction,3.95e-08
323,"N-[1-(5-{4-chloro-2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC1=CC(=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)CN(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,324,KRAS-Activation by SOS high GTP,7.29e-08
323,"N-[1-(5-{4-chloro-2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC1=CC(=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)CN(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,324,KRAS-Activation by SOS no GTP,6.84e-08
323,"N-[1-(5-{4-chloro-2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC1=CC(=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)CN(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,324,EGFR kinase inhibition IC50,>2.00E-5
324,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethanone",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,325,KRAS-SOS1 Interaction,1.29e-06
324,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethanone",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,325,KRAS-Activation by SOS high GTP,3.38e-06
324,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethanone",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,325,KRAS-Activation by SOS no GTP,8.84e-06
324,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethanone",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,325,EGFR kinase inhibition IC50,>2.00E-5
325,"6,7-dimethoxy-2-methyl-N-[1-(5-{2-[2-(pyrrolidin-1-yl)ethoxy]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)OCCN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,326,KRAS-SOS1 Interaction,2.28e-07
325,"6,7-dimethoxy-2-methyl-N-[1-(5-{2-[2-(pyrrolidin-1-yl)ethoxy]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)OCCN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,326,KRAS-Activation by SOS high GTP,4.43e-07
325,"6,7-dimethoxy-2-methyl-N-[1-(5-{2-[2-(pyrrolidin-1-yl)ethoxy]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)OCCN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,326,KRAS-Activation by SOS no GTP,4.38e-07
325,"6,7-dimethoxy-2-methyl-N-[1-(5-{2-[2-(pyrrolidin-1-yl)ethoxy]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)OCCN1CCCC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,326,EGFR kinase inhibition IC50,>2.00E-5
326,"6,7-dimethoxy-2-methyl-N-[1-(4-{2-[(methylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine,enantiomer1",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=C(C1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,327,KRAS-SOS1 Interaction,1.29e-08
326,"6,7-dimethoxy-2-methyl-N-[1-(4-{2-[(methylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine,enantiomer1",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=C(C1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,327,KRAS-Activation by SOS high GTP,2.91e-08
326,"6,7-dimethoxy-2-methyl-N-[1-(4-{2-[(methylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine,enantiomer1",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=C(C1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,327,KRAS-Activation by SOS no GTP,2.77e-08
326,"6,7-dimethoxy-2-methyl-N-[1-(4-{2-[(methylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine,enantiomer1",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=C(C1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,327,EGFR kinase inhibition IC50,>2.00E-5
327,"6,7-dimethoxy-2-methyl-N-[1-(4-{2-[(methylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine,enantiomer2",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=C(C1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,328,KRAS-SOS1 Interaction,1.38e-06
327,"6,7-dimethoxy-2-methyl-N-[1-(4-{2-[(methylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine,enantiomer2",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=C(C1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,328,KRAS-Activation by SOS high GTP,1.94e-06
327,"6,7-dimethoxy-2-methyl-N-[1-(4-{2-[(methylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine,enantiomer2",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=C(C1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,328,KRAS-Activation by SOS no GTP,2.56e-06
327,"6,7-dimethoxy-2-methyl-N-[1-(4-{2-[(methylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine,enantiomer2",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=C(C1)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,328,EGFR kinase inhibition IC50,>2.00E-5
328,"N-{1-[5-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine,enantiomer1",N1=C2N(C(=C1)C1=CC=C(S1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,329,KRAS-SOS1 Interaction,1.42e-07
328,"N-{1-[5-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine,enantiomer1",N1=C2N(C(=C1)C1=CC=C(S1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,329,KRAS-Activation by SOS high GTP,5.28e-07
328,"N-{1-[5-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine,enantiomer1",N1=C2N(C(=C1)C1=CC=C(S1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,329,KRAS-Activation by SOS no GTP,8.89e-07
328,"N-{1-[5-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine,enantiomer1",N1=C2N(C(=C1)C1=CC=C(S1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,329,EGFR kinase inhibition IC50,>2.00E-5
329,"N-{1-[5-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine,enantiomer2",N1=C2N(C(=C1)C1=CC=C(S1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,330,KRAS-SOS1 Interaction,2.41e-06
329,"N-{1-[5-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine,enantiomer2",N1=C2N(C(=C1)C1=CC=C(S1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,330,KRAS-Activation by SOS high GTP,6.47e-06
329,"N-{1-[5-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine,enantiomer2",N1=C2N(C(=C1)C1=CC=C(S1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,330,KRAS-Activation by SOS no GTP,1.06e-05
329,"N-{1-[5-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)thiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine,enantiomer2",N1=C2N(C(=C1)C1=CC=C(S1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,330,EGFR kinase inhibition IC50,>2.00E-5
330,"6,7-dimethoxy-2-methyl-N-[1-(2-methyl-1-benzothiophen-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=CC2=C1C=C(S2)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,331,KRAS-SOS1 Interaction,2.27e-07
330,"6,7-dimethoxy-2-methyl-N-[1-(2-methyl-1-benzothiophen-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=CC2=C1C=C(S2)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,331,KRAS-Activation by SOS high GTP,3.65e-07
330,"6,7-dimethoxy-2-methyl-N-[1-(2-methyl-1-benzothiophen-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=CC2=C1C=C(S2)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,331,KRAS-Activation by SOS no GTP,5.47e-07
330,"6,7-dimethoxy-2-methyl-N-[1-(2-methyl-1-benzothiophen-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=CC2=C1C=C(S2)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,331,EGFR kinase inhibition IC50,>2.00E-5
331,"6,7-dimethoxy-2-methyl-N-[1-(thieno[2,3-b]pyridin-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C(=NC=C1)SC=C2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,332,KRAS-SOS1 Interaction,9.19e-07
331,"6,7-dimethoxy-2-methyl-N-[1-(thieno[2,3-b]pyridin-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C(=NC=C1)SC=C2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,332,KRAS-Activation by SOS high GTP,9.92e-07
331,"6,7-dimethoxy-2-methyl-N-[1-(thieno[2,3-b]pyridin-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C(=NC=C1)SC=C2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,332,KRAS-Activation by SOS no GTP,3.17e-06
331,"6,7-dimethoxy-2-methyl-N-[1-(thieno[2,3-b]pyridin-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C(=NC=C1)SC=C2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,332,EGFR kinase inhibition IC50,>2.00E-5
332,"6,7-dimethoxy-2-methyl-N-[1-(thieno[2,3-c]pyridin-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C(=CN=C1)SC=C2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,333,KRAS-SOS1 Interaction,2.25e-06
332,"6,7-dimethoxy-2-methyl-N-[1-(thieno[2,3-c]pyridin-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C(=CN=C1)SC=C2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,333,KRAS-Activation by SOS high GTP,2.62e-06
332,"6,7-dimethoxy-2-methyl-N-[1-(thieno[2,3-c]pyridin-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C(=CN=C1)SC=C2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,333,KRAS-Activation by SOS no GTP,1.14e-05
332,"6,7-dimethoxy-2-methyl-N-[1-(thieno[2,3-c]pyridin-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=C2C(=CN=C1)SC=C2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,333,EGFR kinase inhibition IC50,>2.00E-5
333,"6,7-dimethoxy-2-methyl-N-[1-(thieno[3,2-c]pyridin-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=NC=CC2=C1C=CS2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,334,KRAS-SOS1 Interaction,1.3e-05
333,"6,7-dimethoxy-2-methyl-N-[1-(thieno[3,2-c]pyridin-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=NC=CC2=C1C=CS2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,334,KRAS-Activation by SOS high GTP,6.28e-06
333,"6,7-dimethoxy-2-methyl-N-[1-(thieno[3,2-c]pyridin-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=NC=CC2=C1C=CS2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,334,KRAS-Activation by SOS no GTP,1.48e-05
333,"6,7-dimethoxy-2-methyl-N-[1-(thieno[3,2-c]pyridin-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=NC=CC2=C1C=CS2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,334,EGFR kinase inhibition IC50,1.64e-05
334,"N-{(1R)-1-[3-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1=NNC(=C1C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,335,KRAS-SOS1 Interaction,3.82e-07
334,"N-{(1R)-1-[3-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1=NNC(=C1C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,335,KRAS-Activation by SOS high GTP,7.73e-07
334,"N-{(1R)-1-[3-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1=NNC(=C1C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,335,KRAS-Activation by SOS no GTP,1.41e-06
334,"N-{(1R)-1-[3-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1=NNC(=C1C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,335,EGFR kinase inhibition IC50,>2.00E-5
335,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(5-methyl-1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,336,KRAS-SOS1 Interaction,1.45e-07
335,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(5-methyl-1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,336,KRAS-Activation by SOS high GTP,3.71e-07
335,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(5-methyl-1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,336,KRAS-Activation by SOS no GTP,5.64e-07
335,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(5-methyl-1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,336,EGFR kinase inhibition IC50,>2.00E-5
336,"N-{(1R)-1-[3-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1=NOC(=C1C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,337,KRAS-SOS1 Interaction,6.87e-07
336,"N-{(1R)-1-[3-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1=NOC(=C1C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,337,KRAS-Activation by SOS high GTP,1.28e-06
336,"N-{(1R)-1-[3-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1=NOC(=C1C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,337,KRAS-Activation by SOS no GTP,1.99e-06
336,"N-{(1R)-1-[3-(3,5-dimethyl-1,2-oxazol-4-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",CC1=NOC(=C1C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,337,EGFR kinase inhibition IC50,>2.00E-5
337,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C1=CC=NN1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,338,KRAS-SOS1 Interaction,3.44e-07
337,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C1=CC=NN1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,338,KRAS-Activation by SOS high GTP,8.08e-07
337,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C1=CC=NN1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,338,KRAS-Activation by SOS no GTP,1.35e-06
337,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C1=CC=NN1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,338,EGFR kinase inhibition IC50,>2.00E-5
338,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1-methyl-1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NN(C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,339,KRAS-SOS1 Interaction,3.25e-07
338,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1-methyl-1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NN(C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,339,KRAS-Activation by SOS high GTP,8.38e-07
338,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1-methyl-1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NN(C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,339,KRAS-Activation by SOS no GTP,1.39e-06
338,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1-methyl-1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NN(C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,339,EGFR kinase inhibition IC50,>2.00E-5
339,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1-methyl-1H-pyrazol-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C1=CC=NN1C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,340,KRAS-SOS1 Interaction,8.15e-07
339,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1-methyl-1H-pyrazol-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C1=CC=NN1C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,340,KRAS-Activation by SOS high GTP,1.38e-06
339,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1-methyl-1H-pyrazol-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C1=CC=NN1C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,340,KRAS-Activation by SOS no GTP,1.99e-06
339,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1-methyl-1H-pyrazol-5-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C1=CC=NN1C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,340,EGFR kinase inhibition IC50,>2.00E-5
340,"N-{(1R)-1-[3-(1H-imidazol-1-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1(C=NC=C1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,341,KRAS-SOS1 Interaction,3.44e-07
340,"N-{(1R)-1-[3-(1H-imidazol-1-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1(C=NC=C1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,341,KRAS-Activation by SOS high GTP,9.09e-07
340,"N-{(1R)-1-[3-(1H-imidazol-1-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1(C=NC=C1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,341,KRAS-Activation by SOS no GTP,1.39e-06
340,"N-{(1R)-1-[3-(1H-imidazol-1-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1(C=NC=C1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,341,EGFR kinase inhibition IC50,>2.00E-5
341,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-1-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)N1N=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,342,KRAS-SOS1 Interaction,2.83e-06
341,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-1-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)N1N=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,342,KRAS-Activation by SOS high GTP,3.73e-06
341,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-1-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)N1N=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,342,KRAS-Activation by SOS no GTP,1.22e-05
341,"6,7-dimethoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-1-yl)phenyl]ethyl}quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)N1N=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,342,EGFR kinase inhibition IC50,>2.00E-5
342,"N-{(1R)-1-[3-(1H-imidazol-4-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=NC(=C1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,343,KRAS-SOS1 Interaction,5.44e-07
342,"N-{(1R)-1-[3-(1H-imidazol-4-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=NC(=C1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,343,KRAS-Activation by SOS high GTP,9.93e-07
342,"N-{(1R)-1-[3-(1H-imidazol-4-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=NC(=C1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,343,KRAS-Activation by SOS no GTP,1.13e-06
342,"N-{(1R)-1-[3-(1H-imidazol-4-yl)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1C=NC(=C1)C=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,343,EGFR kinase inhibition IC50,>2.00E-5
343,6-(benzyloxy)-N-[(1R)-1-(3-bromophenyl)ethyl]-7-methoxy-2-methylquinazolin-4-amine,C(C1=CC=CC=C1)OC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)Br,data/bronze/artifacts/2018_raw.xlsx,Sheet1,344,KRAS-SOS1 Interaction,1.88e-06
343,6-(benzyloxy)-N-[(1R)-1-(3-bromophenyl)ethyl]-7-methoxy-2-methylquinazolin-4-amine,C(C1=CC=CC=C1)OC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)Br,data/bronze/artifacts/2018_raw.xlsx,Sheet1,344,KRAS-Activation by SOS high GTP,1.81e-06
343,6-(benzyloxy)-N-[(1R)-1-(3-bromophenyl)ethyl]-7-methoxy-2-methylquinazolin-4-amine,C(C1=CC=CC=C1)OC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)Br,data/bronze/artifacts/2018_raw.xlsx,Sheet1,344,KRAS-Activation by SOS no GTP,4.33e-06
343,6-(benzyloxy)-N-[(1R)-1-(3-bromophenyl)ethyl]-7-methoxy-2-methylquinazolin-4-amine,C(C1=CC=CC=C1)OC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)Br,data/bronze/artifacts/2018_raw.xlsx,Sheet1,344,EGFR kinase inhibition IC50,>2.00E-5
344,6-(benzyloxy)-7-methoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,C(C1=CC=CC=C1)OC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,345,KRAS-SOS1 Interaction,9.31e-07
344,6-(benzyloxy)-7-methoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,C(C1=CC=CC=C1)OC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,345,KRAS-Activation by SOS high GTP,1.19e-06
344,6-(benzyloxy)-7-methoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,C(C1=CC=CC=C1)OC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,345,KRAS-Activation by SOS no GTP,1.86e-06
344,6-(benzyloxy)-7-methoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,C(C1=CC=CC=C1)OC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,345,EGFR kinase inhibition IC50,>2.00E-5
345,7-methoxy-2-methyl-4-({(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}amino)quinazolin-6-ol,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,346,KRAS-SOS1 Interaction,1.46e-05
345,7-methoxy-2-methyl-4-({(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}amino)quinazolin-6-ol,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,346,KRAS-Activation by SOS high GTP,7.84e-06
345,7-methoxy-2-methyl-4-({(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}amino)quinazolin-6-ol,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,346,KRAS-Activation by SOS no GTP,2.94e-05
345,7-methoxy-2-methyl-4-({(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}amino)quinazolin-6-ol,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,346,EGFR kinase inhibition IC50,>2.00E-5
346,6-(cyclopropylmethoxy)-7-methoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,C1(CC1)COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,347,KRAS-SOS1 Interaction,3.42e-07
346,6-(cyclopropylmethoxy)-7-methoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,C1(CC1)COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,347,KRAS-Activation by SOS high GTP,3.95e-07
346,6-(cyclopropylmethoxy)-7-methoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,C1(CC1)COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,347,KRAS-Activation by SOS no GTP,5.76e-07
346,6-(cyclopropylmethoxy)-7-methoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,C1(CC1)COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,347,EGFR kinase inhibition IC50,>2.00E-5
347,"6,7-dimethoxy-2-methyl-N-[1-(thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,348,KRAS-SOS1 Interaction,1.58e-05
347,"6,7-dimethoxy-2-methyl-N-[1-(thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,348,KRAS-Activation by SOS high GTP,9.95e-06
347,"6,7-dimethoxy-2-methyl-N-[1-(thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,348,KRAS-Activation by SOS no GTP,0.48
347,"6,7-dimethoxy-2-methyl-N-[1-(thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=CC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,348,EGFR kinase inhibition IC50,>2.00E-5
348,7-methoxy-6-(2-methoxyethoxy)-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)OCCOC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,349,KRAS-SOS1 Interaction,8.93e-07
348,7-methoxy-6-(2-methoxyethoxy)-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)OCCOC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,349,KRAS-Activation by SOS high GTP,8.18e-07
348,7-methoxy-6-(2-methoxyethoxy)-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)OCCOC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,349,KRAS-Activation by SOS no GTP,7.53e-07
348,7-methoxy-6-(2-methoxyethoxy)-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)OCCOC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,349,EGFR kinase inhibition IC50,>2.00E-5
349,"(1R)-1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]propan-1-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)[C@@H](CC)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,350,KRAS-SOS1 Interaction,2.31e-07
349,"(1R)-1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]propan-1-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)[C@@H](CC)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,350,KRAS-Activation by SOS high GTP,6.49e-07
349,"(1R)-1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]propan-1-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)[C@@H](CC)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,350,KRAS-Activation by SOS no GTP,7.4e-07
349,"(1R)-1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]propan-1-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)[C@@H](CC)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,350,EGFR kinase inhibition IC50,>2.00E-5
350,6-butoxy-7-methoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,C(CCC)OC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,351,KRAS-SOS1 Interaction,8.88e-07
350,6-butoxy-7-methoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,C(CCC)OC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,351,KRAS-Activation by SOS high GTP,7.38e-07
350,6-butoxy-7-methoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,C(CCC)OC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,351,KRAS-Activation by SOS no GTP,8.5e-07
350,6-butoxy-7-methoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,C(CCC)OC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,351,EGFR kinase inhibition IC50,>2.00E-5
351,7-methoxy-2-methyl-6-(3-methylbutoxy)-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)OCCC(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,352,KRAS-SOS1 Interaction,1.71e-06
351,7-methoxy-2-methyl-6-(3-methylbutoxy)-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)OCCC(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,352,KRAS-Activation by SOS high GTP,1.29e-06
351,7-methoxy-2-methyl-6-(3-methylbutoxy)-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)OCCC(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,352,KRAS-Activation by SOS no GTP,1.31e-06
351,7-methoxy-2-methyl-6-(3-methylbutoxy)-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)OCCC(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,352,EGFR kinase inhibition IC50,>2.00E-5
352,"tert-butyl{2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethyl}carbamate",C(C)(C)(C)OC(NCCC1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,353,KRAS-SOS1 Interaction,1.6e-05
352,"tert-butyl{2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethyl}carbamate",C(C)(C)(C)OC(NCCC1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,353,KRAS-Activation by SOS high GTP,1.22e-05
352,"tert-butyl{2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethyl}carbamate",C(C)(C)(C)OC(NCCC1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,353,KRAS-Activation by SOS no GTP,1.82e-05
352,"tert-butyl{2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethyl}carbamate",C(C)(C)(C)OC(NCCC1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,353,EGFR kinase inhibition IC50,>2.00E-5
353,7-methoxy-2-methyl-6-(propan-2-yloxy)-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)OC(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,354,KRAS-SOS1 Interaction,3.8e-07
353,7-methoxy-2-methyl-6-(propan-2-yloxy)-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)OC(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,354,KRAS-Activation by SOS high GTP,4.29e-07
353,7-methoxy-2-methyl-6-(propan-2-yloxy)-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)OC(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,354,KRAS-Activation by SOS no GTP,4.53e-07
353,7-methoxy-2-methyl-6-(propan-2-yloxy)-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)OC(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,354,EGFR kinase inhibition IC50,>2.00E-5
354,7-methoxy-2-methyl-6-(oxetan-3-ylmethoxy)-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)OCC1COC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,355,KRAS-SOS1 Interaction,3.13e-07
354,7-methoxy-2-methyl-6-(oxetan-3-ylmethoxy)-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)OCC1COC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,355,KRAS-Activation by SOS high GTP,5.18e-07
354,7-methoxy-2-methyl-6-(oxetan-3-ylmethoxy)-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)OCC1COC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,355,KRAS-Activation by SOS no GTP,8.77e-07
354,7-methoxy-2-methyl-6-(oxetan-3-ylmethoxy)-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)OCC1COC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,355,EGFR kinase inhibition IC50,>2.00E-5
355,6-ethoxy-7-methoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,C(C)OC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,356,KRAS-SOS1 Interaction,4.85e-07
355,6-ethoxy-7-methoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,C(C)OC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,356,KRAS-Activation by SOS high GTP,5.71e-07
355,6-ethoxy-7-methoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,C(C)OC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,356,KRAS-Activation by SOS no GTP,7.14e-07
355,6-ethoxy-7-methoxy-2-methyl-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,C(C)OC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,356,EGFR kinase inhibition IC50,>2.00E-5
356,6-ethoxy-N-{(1R)-1-[3-(1-ethyl-1H-pyrazol-4-yl)phenyl]ethyl}-7-methoxy-2-methylquinazolin-4-amine,C(C)OC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NN(C1)CC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,357,KRAS-SOS1 Interaction,6.55e-07
356,6-ethoxy-N-{(1R)-1-[3-(1-ethyl-1H-pyrazol-4-yl)phenyl]ethyl}-7-methoxy-2-methylquinazolin-4-amine,C(C)OC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NN(C1)CC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,357,KRAS-Activation by SOS high GTP,7.77e-07
356,6-ethoxy-N-{(1R)-1-[3-(1-ethyl-1H-pyrazol-4-yl)phenyl]ethyl}-7-methoxy-2-methylquinazolin-4-amine,C(C)OC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NN(C1)CC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,357,KRAS-Activation by SOS no GTP,9.33e-07
356,6-ethoxy-N-{(1R)-1-[3-(1-ethyl-1H-pyrazol-4-yl)phenyl]ethyl}-7-methoxy-2-methylquinazolin-4-amine,C(C)OC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NN(C1)CC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,357,EGFR kinase inhibition IC50,>2.00E-5
357,"N-[1-{5-[2-(2-aminoethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,358,KRAS-SOS1 Interaction,5.12e-08
357,"N-[1-{5-[2-(2-aminoethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,358,KRAS-Activation by SOS high GTP,4.88e-08
357,"N-[1-{5-[2-(2-aminoethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,358,KRAS-Activation by SOS no GTP,6.92e-08
357,"N-[1-{5-[2-(2-aminoethyl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,358,EGFR kinase inhibition IC50,>2.00E-5
358,"tert-butyl{1-[2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethyl}carbamate",C(C)(C)(C)OC(NC(C)C1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,359,KRAS-SOS1 Interaction,1.44e-06
358,"tert-butyl{1-[2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethyl}carbamate",C(C)(C)(C)OC(NC(C)C1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,359,KRAS-Activation by SOS high GTP,1.53e-06
358,"tert-butyl{1-[2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethyl}carbamate",C(C)(C)(C)OC(NC(C)C1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,359,KRAS-Activation by SOS no GTP,2.45e-06
358,"tert-butyl{1-[2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethyl}carbamate",C(C)(C)(C)OC(NC(C)C1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,359,EGFR kinase inhibition IC50,>2.00E-5
359,"N-[1-(5-{2-[1-aminoethyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NC(C)C1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,360,KRAS-SOS1 Interaction,2.34e-07
359,"N-[1-(5-{2-[1-aminoethyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NC(C)C1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,360,KRAS-Activation by SOS high GTP,2.09e-07
359,"N-[1-(5-{2-[1-aminoethyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NC(C)C1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,360,KRAS-Activation by SOS no GTP,2.99e-07
359,"N-[1-(5-{2-[1-aminoethyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NC(C)C1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,360,EGFR kinase inhibition IC50,>2.00E-5
360,"N-[1-(5-{2-[1-aminoethyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NC(C)C1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,361,KRAS-SOS1 Interaction,1.95e-07
360,"N-[1-(5-{2-[1-aminoethyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NC(C)C1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,361,KRAS-Activation by SOS high GTP,1.41e-07
360,"N-[1-(5-{2-[1-aminoethyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NC(C)C1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,361,KRAS-Activation by SOS no GTP,1.99e-07
360,"N-[1-(5-{2-[1-aminoethyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NC(C)C1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,361,EGFR kinase inhibition IC50,>2.00E-5
361,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(1H-pyrazol-4-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,362,KRAS-SOS1 Interaction,2.48e-06
361,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(1H-pyrazol-4-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,362,KRAS-Activation by SOS high GTP,4.95e-06
361,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(1H-pyrazol-4-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,362,KRAS-Activation by SOS no GTP,8.8e-06
361,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(1H-pyrazol-4-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)C=1C=NNC1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,362,EGFR kinase inhibition IC50,>2.00E-5
362,"6,7-dimethoxy-2-methyl-N-[1-(5-(2-[(phenylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,363,KRAS-SOS1 Interaction,0.28
362,"6,7-dimethoxy-2-methyl-N-[1-(5-(2-[(phenylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,363,KRAS-Activation by SOS high GTP,0.27
362,"6,7-dimethoxy-2-methyl-N-[1-(5-(2-[(phenylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,363,KRAS-Activation by SOS no GTP,0.3
362,"6,7-dimethoxy-2-methyl-N-[1-(5-(2-[(phenylamino)methyl]phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNC1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,363,EGFR kinase inhibition IC50,>2.00E-5
363,6-bromo-N-[(1R)-1-(3-chlorophenyl)ethyl]-2-methylquinazolin-4-amine,BrC=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC(=CC=C1)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,364,KRAS-SOS1 Interaction,1.24e-05
363,6-bromo-N-[(1R)-1-(3-chlorophenyl)ethyl]-2-methylquinazolin-4-amine,BrC=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC(=CC=C1)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,364,KRAS-Activation by SOS high GTP,1.13e-05
363,6-bromo-N-[(1R)-1-(3-chlorophenyl)ethyl]-2-methylquinazolin-4-amine,BrC=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC(=CC=C1)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,364,KRAS-Activation by SOS no GTP,1.72e-05
363,6-bromo-N-[(1R)-1-(3-chlorophenyl)ethyl]-2-methylquinazolin-4-amine,BrC=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC(=CC=C1)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,364,EGFR kinase inhibition IC50,>2.00E-5
364,"N-[1-(5-(2-[(cyclopentylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CCCC1)NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,365,KRAS-SOS1 Interaction,1.29e-07
364,"N-[1-(5-(2-[(cyclopentylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CCCC1)NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,365,KRAS-Activation by SOS high GTP,1.58e-07
364,"N-[1-(5-(2-[(cyclopentylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CCCC1)NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,365,KRAS-Activation by SOS no GTP,2.17e-07
364,"N-[1-(5-(2-[(cyclopentylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CCCC1)NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,365,EGFR kinase inhibition IC50,>2.00E-5
365,"N-[1-(5-(2-[(benzylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,366,KRAS-SOS1 Interaction,4.89e-07
365,"N-[1-(5-(2-[(benzylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,366,KRAS-Activation by SOS high GTP,2.99e-07
365,"N-[1-(5-(2-[(benzylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,366,KRAS-Activation by SOS no GTP,3.53e-07
365,"N-[1-(5-(2-[(benzylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,366,EGFR kinase inhibition IC50,>2.00E-5
366,"N-[1-(5-(2-[(butylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(CCC)NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,367,KRAS-SOS1 Interaction,9.76e-08
366,"N-[1-(5-(2-[(butylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(CCC)NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,367,KRAS-Activation by SOS high GTP,9.69e-08
366,"N-[1-(5-(2-[(butylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(CCC)NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,367,KRAS-Activation by SOS no GTP,1.36e-07
366,"N-[1-(5-(2-[(butylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(CCC)NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,367,EGFR kinase inhibition IC50,>2.00E-5
367,"N-[1-(5-(2-[(ethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C)NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,368,KRAS-SOS1 Interaction,7.16e-08
367,"N-[1-(5-(2-[(ethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C)NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,368,KRAS-Activation by SOS high GTP,6.13e-08
367,"N-[1-(5-(2-[(ethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C)NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,368,KRAS-Activation by SOS no GTP,9.9e-08
367,"N-[1-(5-(2-[(ethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C)NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,368,EGFR kinase inhibition IC50,>2.00E-5
368,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(1H-tetrazol-5-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)C1=NN=NN1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,369,KRAS-SOS1 Interaction,0.41
368,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(1H-tetrazol-5-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)C1=NN=NN1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,369,KRAS-Activation by SOS high GTP,0.39
368,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(1H-tetrazol-5-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)C1=NN=NN1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,369,KRAS-Activation by SOS no GTP,0.08
368,"6,7-dimethoxy-2-methyl-N-[1-{5-[2-(1H-tetrazol-5-yl)phenyl]thiophen-2-yl}ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)C1=NN=NN1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,369,EGFR kinase inhibition IC50,>2.00E-5
369,"6,7-dimethoxy-N-{1-[5-(2-{[(2-methoxyethyl)amino]methyl}phenyl)thiophen-2-yl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNCCOC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,370,KRAS-SOS1 Interaction,9.95e-06
369,"6,7-dimethoxy-N-{1-[5-(2-{[(2-methoxyethyl)amino]methyl}phenyl)thiophen-2-yl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNCCOC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,370,KRAS-Activation by SOS high GTP,1.52e-07
369,"6,7-dimethoxy-N-{1-[5-(2-{[(2-methoxyethyl)amino]methyl}phenyl)thiophen-2-yl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNCCOC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,370,KRAS-Activation by SOS no GTP,1.89e-07
369,"6,7-dimethoxy-N-{1-[5-(2-{[(2-methoxyethyl)amino]methyl}phenyl)thiophen-2-yl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CNCCOC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,370,EGFR kinase inhibition IC50,>2.00E-5
370,"N-[1-(5-{2-[(cyclopropylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,371,KRAS-SOS1 Interaction,2.7e-07
370,"N-[1-(5-{2-[(cyclopropylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,371,KRAS-Activation by SOS high GTP,3.52e-07
370,"N-[1-(5-{2-[(cyclopropylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,371,KRAS-Activation by SOS no GTP,3.83e-07
370,"N-[1-(5-{2-[(cyclopropylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)NCC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,371,EGFR kinase inhibition IC50,>2.00E-5
371,methyl4-{[(1R)-1-(3-chlorophenyl)ethyl]amino}-2-methylquinazoline-6-carboxylate,COC(=O)C=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC(=CC=C1)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,372,KRAS-SOS1 Interaction,1.89e-06
371,methyl4-{[(1R)-1-(3-chlorophenyl)ethyl]amino}-2-methylquinazoline-6-carboxylate,COC(=O)C=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC(=CC=C1)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,372,KRAS-Activation by SOS high GTP,2.42e-06
371,methyl4-{[(1R)-1-(3-chlorophenyl)ethyl]amino}-2-methylquinazoline-6-carboxylate,COC(=O)C=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC(=CC=C1)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,372,KRAS-Activation by SOS no GTP,3.35e-06
371,methyl4-{[(1R)-1-(3-chlorophenyl)ethyl]amino}-2-methylquinazoline-6-carboxylate,COC(=O)C=1C=C2C(=NC(=NC2=CC1)C)N[C@H](C)C1=CC(=CC=C1)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,372,EGFR kinase inhibition IC50,>2.00E-5
372,4-{[(1R)-1-(3-chlorophenyl)ethyl]amino}-2-methylquinazoline-6-carboxylicacid,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C(=O)O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,373,KRAS-SOS1 Interaction,0.28
372,4-{[(1R)-1-(3-chlorophenyl)ethyl]amino}-2-methylquinazoline-6-carboxylicacid,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C(=O)O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,373,KRAS-Activation by SOS high GTP,0.33
372,4-{[(1R)-1-(3-chlorophenyl)ethyl]amino}-2-methylquinazoline-6-carboxylicacid,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C(=O)O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,373,KRAS-Activation by SOS no GTP,0.19
372,4-{[(1R)-1-(3-chlorophenyl)ethyl]amino}-2-methylquinazoline-6-carboxylicacid,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C(=O)O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,373,EGFR kinase inhibition IC50,>2.00E-5
373,(4-{[(1R)-1-(3-chlorophenyl)ethyl]amino}-2-methylquinazolin-6-yl)methanol,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)CO)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,374,KRAS-SOS1 Interaction,1.52e-06
373,(4-{[(1R)-1-(3-chlorophenyl)ethyl]amino}-2-methylquinazolin-6-yl)methanol,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)CO)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,374,KRAS-Activation by SOS high GTP,8.28e-06
373,(4-{[(1R)-1-(3-chlorophenyl)ethyl]amino}-2-methylquinazolin-6-yl)methanol,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)CO)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,374,KRAS-Activation by SOS no GTP,9.21e-06
373,(4-{[(1R)-1-(3-chlorophenyl)ethyl]amino}-2-methylquinazolin-6-yl)methanol,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)CO)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,374,EGFR kinase inhibition IC50,>2.00E-5
374,"[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl](phenyl)methanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(O)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,375,KRAS-SOS1 Interaction,1.8e-06
374,"[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl](phenyl)methanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(O)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,375,KRAS-Activation by SOS high GTP,2.55e-06
374,"[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl](phenyl)methanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(O)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,375,KRAS-Activation by SOS no GTP,8.5e-06
374,"[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl](phenyl)methanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(O)C1=CC=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,375,EGFR kinase inhibition IC50,>2.00E-5
375,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]-3-phenylpropan-1-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(CCC1=CC=CC=C1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,376,KRAS-SOS1 Interaction,0.46
375,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]-3-phenylpropan-1-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(CCC1=CC=CC=C1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,376,KRAS-Activation by SOS high GTP,0.17
375,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]-3-phenylpropan-1-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(CCC1=CC=CC=C1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,376,KRAS-Activation by SOS no GTP,0.35
375,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]-3-phenylpropan-1-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(CCC1=CC=CC=C1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,376,EGFR kinase inhibition IC50,>2.00E-5
376,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]-2-phenylethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(CC1=CC=CC=C1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,377,KRAS-SOS1 Interaction,5.48e-06
376,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]-2-phenylethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(CC1=CC=CC=C1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,377,KRAS-Activation by SOS high GTP,1.84e-05
376,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]-2-phenylethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(CC1=CC=CC=C1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,377,KRAS-Activation by SOS no GTP,1.79e-05
376,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]-2-phenylethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(CC1=CC=CC=C1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,377,EGFR kinase inhibition IC50,>2.00E-5
377,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]pentan-1-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(CCCC)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,378,KRAS-SOS1 Interaction,5.14e-06
377,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]pentan-1-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(CCCC)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,378,KRAS-Activation by SOS high GTP,9.75e-06
377,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]pentan-1-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(CCCC)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,378,KRAS-Activation by SOS no GTP,1.51e-05
377,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]pentan-1-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(CCCC)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,378,EGFR kinase inhibition IC50,>2.00E-5
378,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]prop-2-yn-1-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(C#C)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,379,KRAS-SOS1 Interaction,4.3e-07
378,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]prop-2-yn-1-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(C#C)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,379,KRAS-Activation by SOS high GTP,1.05e-06
378,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]prop-2-yn-1-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(C#C)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,379,KRAS-Activation by SOS no GTP,1.45e-06
378,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]prop-2-yn-1-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(C#C)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,379,EGFR kinase inhibition IC50,>2.00E-5
379,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]-2-methylpropan-1-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(C(C)C)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,380,KRAS-SOS1 Interaction,5.88e-07
379,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]-2-methylpropan-1-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(C(C)C)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,380,KRAS-Activation by SOS high GTP,1.35e-06
379,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]-2-methylpropan-1-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(C(C)C)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,380,KRAS-Activation by SOS no GTP,1.83e-06
379,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]-2-methylpropan-1-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(C(C)C)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,380,EGFR kinase inhibition IC50,>2.00E-5
380,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]-2,2,2-trifluoroethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(C(F)(F)F)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,381,KRAS-SOS1 Interaction,9.37e-07
380,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]-2,2,2-trifluoroethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(C(F)(F)F)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,381,KRAS-Activation by SOS high GTP,1.68e-06
380,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]-2,2,2-trifluoroethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(C(F)(F)F)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,381,KRAS-Activation by SOS no GTP,2.74e-06
380,"1-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]-2,2,2-trifluoroethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(C(F)(F)F)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,381,EGFR kinase inhibition IC50,>2.00E-5
381,"N-{1-[5-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)-4-methylthiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1=C2N(C(=C1)C1=C(C=C(S1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,382,KRAS-SOS1 Interaction,4.9e-07
381,"N-{1-[5-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)-4-methylthiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1=C2N(C(=C1)C1=C(C=C(S1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,382,KRAS-Activation by SOS high GTP,1.98e-06
381,"N-{1-[5-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)-4-methylthiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1=C2N(C(=C1)C1=C(C=C(S1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,382,KRAS-Activation by SOS no GTP,2.33e-06
381,"N-{1-[5-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-3-yl)-4-methylthiophen-2-yl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",N1=C2N(C(=C1)C1=C(C=C(S1)C(C)NC1=NC(=NC3=CC(=C(C=C13)OC)OC)C)C)CCC2,data/bronze/artifacts/2018_raw.xlsx,Sheet1,382,EGFR kinase inhibition IC50,>2.00E-5
382,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-2-hydroxyacetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(CO)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,383,KRAS-SOS1 Interaction,2.53e-07
382,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-2-hydroxyacetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(CO)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,383,KRAS-Activation by SOS high GTP,9.31e-07
382,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-2-hydroxyacetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(CO)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,383,KRAS-Activation by SOS no GTP,7.48e-07
382,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-2-hydroxyacetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(CO)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,383,EGFR kinase inhibition IC50,>2.00E-5
383,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-2-methoxyacetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(COC)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,384,KRAS-SOS1 Interaction,9.84e-07
383,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-2-methoxyacetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(COC)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,384,KRAS-Activation by SOS high GTP,3.62e-06
383,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-2-methoxyacetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(COC)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,384,KRAS-Activation by SOS no GTP,5.11e-06
383,"N-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-5-fluorobenzyl]-2-methoxyacetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CNC(COC)=O)C=C(C=C1)F,data/bronze/artifacts/2018_raw.xlsx,Sheet1,384,EGFR kinase inhibition IC50,>2.00E-5
384,"N-(1-(5-(4-bromo-2-((dimethylamino)methyl)phenyl)thiophen-2-yl)ethyl)-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC(=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)CN(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,385,KRAS-SOS1 Interaction,1.23e-07
384,"N-(1-(5-(4-bromo-2-((dimethylamino)methyl)phenyl)thiophen-2-yl)ethyl)-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC(=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)CN(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,385,KRAS-Activation by SOS high GTP,6.65e-08
384,"N-(1-(5-(4-bromo-2-((dimethylamino)methyl)phenyl)thiophen-2-yl)ethyl)-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC(=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)CN(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,385,KRAS-Activation by SOS no GTP,8.46e-08
384,"N-(1-(5-(4-bromo-2-((dimethylamino)methyl)phenyl)thiophen-2-yl)ethyl)-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC(=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)CN(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,385,EGFR kinase inhibition IC50,
385,"thiophen-2-yl)ethyl)-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1=C(C=CC(=C1)C(F)(F)F)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,386,KRAS-SOS1 Interaction,7.32e-07
385,"thiophen-2-yl)ethyl)-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1=C(C=CC(=C1)C(F)(F)F)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,386,KRAS-Activation by SOS high GTP,3.29e-07
385,"thiophen-2-yl)ethyl)-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1=C(C=CC(=C1)C(F)(F)F)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,386,KRAS-Activation by SOS no GTP,3.88e-07
385,"thiophen-2-yl)ethyl)-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1=C(C=CC(=C1)C(F)(F)F)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,386,EGFR kinase inhibition IC50,
386,"6,7-dimethoxy-2-methyl-N-(1-{5-[2-methyl-4-(trifluoromethyl)phenyl]-2-thienyl}ethyl)quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=C(C=C1)C(F)(F)F)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,387,KRAS-SOS1 Interaction,8.77e-06
386,"6,7-dimethoxy-2-methyl-N-(1-{5-[2-methyl-4-(trifluoromethyl)phenyl]-2-thienyl}ethyl)quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=C(C=C1)C(F)(F)F)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,387,KRAS-Activation by SOS high GTP,3.86e-06
386,"6,7-dimethoxy-2-methyl-N-(1-{5-[2-methyl-4-(trifluoromethyl)phenyl]-2-thienyl}ethyl)quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=C(C=C1)C(F)(F)F)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,387,KRAS-Activation by SOS no GTP,1.01e-05
386,"6,7-dimethoxy-2-methyl-N-(1-{5-[2-methyl-4-(trifluoromethyl)phenyl]-2-thienyl}ethyl)quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=C(C=C1)C(F)(F)F)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,387,EGFR kinase inhibition IC50,
387,"tert-butyl[4-chloro-2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]carbamate",C(C)(C)(C)OC(NCC1=C(C=C(C=C1)Cl)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,388,KRAS-SOS1 Interaction,1.17e-06
387,"tert-butyl[4-chloro-2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]carbamate",C(C)(C)(C)OC(NCC1=C(C=C(C=C1)Cl)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,388,KRAS-Activation by SOS high GTP,1.86e-06
387,"tert-butyl[4-chloro-2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]carbamate",C(C)(C)(C)OC(NCC1=C(C=C(C=C1)Cl)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,388,KRAS-Activation by SOS no GTP,8.32e-06
387,"tert-butyl[4-chloro-2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]carbamate",C(C)(C)(C)OC(NCC1=C(C=C(C=C1)Cl)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,388,EGFR kinase inhibition IC50,>2.00E-5
388,"4-(3-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)pyridin-2-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=NC=C1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,389,KRAS-SOS1 Interaction,2.05e-07
388,"4-(3-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)pyridin-2-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=NC=C1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,389,KRAS-Activation by SOS high GTP,8.01e-07
388,"4-(3-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)pyridin-2-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=NC=C1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,389,KRAS-Activation by SOS no GTP,7.57e-07
388,"4-(3-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}phenyl)pyridin-2-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=CC(=NC=C1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,389,EGFR kinase inhibition IC50,>2.00E-5
389,"N-{1-[3-(benzyloxy)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)OC=1C=C(C=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,390,KRAS-SOS1 Interaction,8.89e-06
389,"N-{1-[3-(benzyloxy)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)OC=1C=C(C=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,390,KRAS-Activation by SOS high GTP,1.49e-05
389,"N-{1-[3-(benzyloxy)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)OC=1C=C(C=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,390,KRAS-Activation by SOS no GTP,1.89e-05
389,"N-{1-[3-(benzyloxy)phenyl]ethyl}-6,7-dimethoxy-2-methylquinazolin-4-amine",C(C1=CC=CC=C1)OC=1C=C(C=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,390,EGFR kinase inhibition IC50,>2.00E-5
390,"N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine,enantiomer1",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,391,KRAS-SOS1 Interaction,5.09e-06
390,"N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine,enantiomer1",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,391,KRAS-Activation by SOS high GTP,8.25e-06
390,"N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine,enantiomer1",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,391,KRAS-Activation by SOS no GTP,1.29e-05
390,"N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine,enantiomer1",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,391,EGFR kinase inhibition IC50,>2.00E-5
391,"N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine,enantiomer2",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,392,KRAS-SOS1 Interaction,1.55e-08
391,"N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine,enantiomer2",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,392,KRAS-Activation by SOS high GTP,3.87e-08
391,"N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine,enantiomer2",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,392,KRAS-Activation by SOS no GTP,3.79e-08
391,"N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine,enantiomer2",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,392,EGFR kinase inhibition IC50,>2.00E-5
392,2-(4-{[(1R)-1-(3-chlorophenyl)ethyl]amino}-2-methylquinazolin-6-yl)propan-2-ol,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C(C)(C)O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,393,KRAS-SOS1 Interaction,3.38e-07
392,2-(4-{[(1R)-1-(3-chlorophenyl)ethyl]amino}-2-methylquinazolin-6-yl)propan-2-ol,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C(C)(C)O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,393,KRAS-Activation by SOS high GTP,1.19e-06
392,2-(4-{[(1R)-1-(3-chlorophenyl)ethyl]amino}-2-methylquinazolin-6-yl)propan-2-ol,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C(C)(C)O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,393,KRAS-Activation by SOS no GTP,1.52e-06
392,2-(4-{[(1R)-1-(3-chlorophenyl)ethyl]amino}-2-methylquinazolin-6-yl)propan-2-ol,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C(C)(C)O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,393,EGFR kinase inhibition IC50,>2.00E-5
393,"2-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-2-yl)acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)CC(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,394,KRAS-SOS1 Interaction,2.44e-07
393,"2-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-2-yl)acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)CC(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,394,KRAS-Activation by SOS high GTP,9.75e-07
393,"2-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-2-yl)acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)CC(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,394,KRAS-Activation by SOS no GTP,1.04e-06
393,"2-(3'-{(1R)-1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}biphenyl-2-yl)acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)N[C@H](C)C=1C=C(C=CC1)C1=C(C=CC=C1)CC(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,394,EGFR kinase inhibition IC50,>2.00E-5
394,"2-(2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)CC(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,395,KRAS-SOS1 Interaction,4.05e-07
394,"2-(2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)CC(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,395,KRAS-Activation by SOS high GTP,1.82e-06
394,"2-(2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)CC(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,395,KRAS-Activation by SOS no GTP,2.29e-06
394,"2-(2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]acetamide",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)CC(=O)N,data/bronze/artifacts/2018_raw.xlsx,Sheet1,395,EGFR kinase inhibition IC50,>2.00E-5
395,"5-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)pyridin-2-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=CC(=NC1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,396,KRAS-SOS1 Interaction,9.84e-07
395,"5-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)pyridin-2-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=CC(=NC1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,396,KRAS-Activation by SOS high GTP,1.88e-06
395,"5-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)pyridin-2-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=CC(=NC1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,396,KRAS-Activation by SOS no GTP,1.02e-06
395,"5-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)pyridin-2-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C=1C=CC(=NC1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,396,EGFR kinase inhibition IC50,7.07e-06
396,"N-[(1R)-1-(3-chlorophenyl)ethyl]-6-methoxy-2,8-dimethylquinazolin-4-amine",ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=C(C=C(C=C12)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,397,KRAS-SOS1 Interaction,2.24e-06
396,"N-[(1R)-1-(3-chlorophenyl)ethyl]-6-methoxy-2,8-dimethylquinazolin-4-amine",ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=C(C=C(C=C12)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,397,KRAS-Activation by SOS high GTP,1.15e-06
396,"N-[(1R)-1-(3-chlorophenyl)ethyl]-6-methoxy-2,8-dimethylquinazolin-4-amine",ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=C(C=C(C=C12)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,397,KRAS-Activation by SOS no GTP,3.13e-06
396,"N-[(1R)-1-(3-chlorophenyl)ethyl]-6-methoxy-2,8-dimethylquinazolin-4-amine",ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=C(C=C(C=C12)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,397,EGFR kinase inhibition IC50,>2.00E-5
397,"N-[1-{5-[2-(aminomethyl)-3-chlorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1Cl)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,398,KRAS-SOS1 Interaction,2.97e-07
397,"N-[1-{5-[2-(aminomethyl)-3-chlorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1Cl)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,398,KRAS-Activation by SOS high GTP,2.09e-07
397,"N-[1-{5-[2-(aminomethyl)-3-chlorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1Cl)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,398,KRAS-Activation by SOS no GTP,2.49e-07
397,"N-[1-{5-[2-(aminomethyl)-3-chlorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1Cl)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,398,EGFR kinase inhibition IC50,>2.00E-5
398,"N-[1-{5-[2-(aminomethyl)-4-chlorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)Cl)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,399,KRAS-SOS1 Interaction,1.04e-07
398,"N-[1-{5-[2-(aminomethyl)-4-chlorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)Cl)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,399,KRAS-Activation by SOS high GTP,6.34e-08
398,"N-[1-{5-[2-(aminomethyl)-4-chlorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)Cl)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,399,KRAS-Activation by SOS no GTP,7.21e-08
398,"N-[1-{5-[2-(aminomethyl)-4-chlorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)Cl)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,399,EGFR kinase inhibition IC50,>2.00E-5
399,"N-(1-{5-[2-(aminomethyl)-4-fluorophenyl]-4-methyl-2-thienyl}ethyl)-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)F)C1=C(C=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,400,KRAS-SOS1 Interaction,3.33e-07
399,"N-(1-{5-[2-(aminomethyl)-4-fluorophenyl]-4-methyl-2-thienyl}ethyl)-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)F)C1=C(C=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,400,KRAS-Activation by SOS high GTP,1.92e-07
399,"N-(1-{5-[2-(aminomethyl)-4-fluorophenyl]-4-methyl-2-thienyl}ethyl)-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)F)C1=C(C=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,400,KRAS-Activation by SOS no GTP,2.96e-07
399,"N-(1-{5-[2-(aminomethyl)-4-fluorophenyl]-4-methyl-2-thienyl}ethyl)-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC(=C1)F)C1=C(C=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,400,EGFR kinase inhibition IC50,>2.00E-5
400,"N-[1-(5-{2-[(dimethylamino)methyl]phenyl}-4-methyl-2-thienyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1=C(C=CC=C1)C1=C(C=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,401,KRAS-SOS1 Interaction,7.87e-08
400,"N-[1-(5-{2-[(dimethylamino)methyl]phenyl}-4-methyl-2-thienyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1=C(C=CC=C1)C1=C(C=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,401,KRAS-Activation by SOS high GTP,6.88e-08
400,"N-[1-(5-{2-[(dimethylamino)methyl]phenyl}-4-methyl-2-thienyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1=C(C=CC=C1)C1=C(C=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,401,KRAS-Activation by SOS no GTP,7.68e-08
400,"N-[1-(5-{2-[(dimethylamino)methyl]phenyl}-4-methyl-2-thienyl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1=C(C=CC=C1)C1=C(C=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,401,EGFR kinase inhibition IC50,>2.00E-5
401,"2-((2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-3-methyl-2-thienyl)benzyl](methyl)amino}ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC(=C(S1)C1=C(CN(CCO)C)C=CC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,402,KRAS-SOS1 Interaction,7.63e-08
401,"2-((2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-3-methyl-2-thienyl)benzyl](methyl)amino}ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC(=C(S1)C1=C(CN(CCO)C)C=CC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,402,KRAS-Activation by SOS high GTP,6.52e-08
401,"2-((2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-3-methyl-2-thienyl)benzyl](methyl)amino}ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC(=C(S1)C1=C(CN(CCO)C)C=CC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,402,KRAS-Activation by SOS no GTP,8.23e-08
401,"2-((2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-3-methyl-2-thienyl)benzyl](methyl)amino}ethanol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC(=C(S1)C1=C(CN(CCO)C)C=CC=C1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,402,EGFR kinase inhibition IC50,>2.00E-5
402,"6,7-dimethoxy-2-methyl-N-[1-(4-methyl-5-(2-[(methylamino)methyl]-phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=C(C1)C)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,403,KRAS-SOS1 Interaction,8.28e-08
402,"6,7-dimethoxy-2-methyl-N-[1-(4-methyl-5-(2-[(methylamino)methyl]-phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=C(C1)C)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,403,KRAS-Activation by SOS high GTP,7.52e-08
402,"6,7-dimethoxy-2-methyl-N-[1-(4-methyl-5-(2-[(methylamino)methyl]-phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=C(C1)C)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,403,KRAS-Activation by SOS no GTP,9.81e-08
402,"6,7-dimethoxy-2-methyl-N-[1-(4-methyl-5-(2-[(methylamino)methyl]-phenyl}thiophen-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=C(C1)C)C1=C(C=CC=C1)CNC,data/bronze/artifacts/2018_raw.xlsx,Sheet1,403,EGFR kinase inhibition IC50,>2.00E-5
403,"1-(2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethane-1,2-diol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(CO)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,404,KRAS-SOS1 Interaction,4.42e-07
403,"1-(2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethane-1,2-diol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(CO)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,404,KRAS-Activation by SOS high GTP,5.48e-07
403,"1-(2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethane-1,2-diol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(CO)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,404,KRAS-Activation by SOS no GTP,6.32e-07
403,"1-(2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]ethane-1,2-diol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C(CO)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,404,EGFR kinase inhibition IC50,>2.00E-5
404,"N-[(1R)-1-(3-chlorophenyl)ethyl]-2,6-dimethylquinazolin-4-amine",ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,405,KRAS-SOS1 Interaction,4.68e-06
404,"N-[(1R)-1-(3-chlorophenyl)ethyl]-2,6-dimethylquinazolin-4-amine",ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,405,KRAS-Activation by SOS high GTP,1.45e-06
404,"N-[(1R)-1-(3-chlorophenyl)ethyl]-2,6-dimethylquinazolin-4-amine",ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,405,KRAS-Activation by SOS no GTP,9.3e-06
404,"N-[(1R)-1-(3-chlorophenyl)ethyl]-2,6-dimethylquinazolin-4-amine",ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,405,EGFR kinase inhibition IC50,>2.00E-5
405,N-[(1R)-1-(3-chlorophenyl)ethyl]-2-methyl-6-(1H-pyrazol-4-yl)quinazolin-4-amine,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C=1C=NNC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,406,KRAS-SOS1 Interaction,1.11e-06
405,N-[(1R)-1-(3-chlorophenyl)ethyl]-2-methyl-6-(1H-pyrazol-4-yl)quinazolin-4-amine,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C=1C=NNC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,406,KRAS-Activation by SOS high GTP,4.48e-07
405,N-[(1R)-1-(3-chlorophenyl)ethyl]-2-methyl-6-(1H-pyrazol-4-yl)quinazolin-4-amine,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C=1C=NNC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,406,KRAS-Activation by SOS no GTP,1.31e-06
405,N-[(1R)-1-(3-chlorophenyl)ethyl]-2-methyl-6-(1H-pyrazol-4-yl)quinazolin-4-amine,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C=1C=NNC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,406,EGFR kinase inhibition IC50,>2.00E-5
406,N-[(1R)-1-(3-chlorophenyl)ethyl]-2-methyl-6-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-amine,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C=1C=NN(C1)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,407,KRAS-SOS1 Interaction,7.27e-07
406,N-[(1R)-1-(3-chlorophenyl)ethyl]-2-methyl-6-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-amine,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C=1C=NN(C1)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,407,KRAS-Activation by SOS high GTP,4e-07
406,N-[(1R)-1-(3-chlorophenyl)ethyl]-2-methyl-6-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-amine,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C=1C=NN(C1)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,407,KRAS-Activation by SOS no GTP,8.55e-07
406,N-[(1R)-1-(3-chlorophenyl)ethyl]-2-methyl-6-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-amine,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C=1C=NN(C1)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,407,EGFR kinase inhibition IC50,>2.00E-5
407,N-[(1R)-1-(3-chlorophenyl)ethyl]-6-cyclopropyl-2-methylquinazolin-4-amine,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C1CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,408,KRAS-SOS1 Interaction,1.25e-06
407,N-[(1R)-1-(3-chlorophenyl)ethyl]-6-cyclopropyl-2-methylquinazolin-4-amine,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C1CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,408,KRAS-Activation by SOS high GTP,1.06e-06
407,N-[(1R)-1-(3-chlorophenyl)ethyl]-6-cyclopropyl-2-methylquinazolin-4-amine,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C1CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,408,KRAS-Activation by SOS no GTP,2.14e-06
407,N-[(1R)-1-(3-chlorophenyl)ethyl]-6-cyclopropyl-2-methylquinazolin-4-amine,ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)C1CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,408,EGFR kinase inhibition IC50,>2.00E-5
408,"tert-butyl[3-chloro-2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]carbamate",C(C)(C)(C)OC(NCC1=C(C(=CC=C1)Cl)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,409,KRAS-SOS1 Interaction,5.33e-07
408,"tert-butyl[3-chloro-2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]carbamate",C(C)(C)(C)OC(NCC1=C(C(=CC=C1)Cl)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,409,KRAS-Activation by SOS high GTP,5.6e-07
408,"tert-butyl[3-chloro-2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]carbamate",C(C)(C)(C)OC(NCC1=C(C(=CC=C1)Cl)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,409,KRAS-Activation by SOS no GTP,1.02e-06
408,"tert-butyl[3-chloro-2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]carbamate",C(C)(C)(C)OC(NCC1=C(C(=CC=C1)Cl)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,409,EGFR kinase inhibition IC50,>2.00E-5
409,"N-[1-{5-[2-(aminomethyl)-6-chlorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C(=CC=C1)Cl)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,410,KRAS-SOS1 Interaction,4.92e-08
409,"N-[1-{5-[2-(aminomethyl)-6-chlorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C(=CC=C1)Cl)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,410,KRAS-Activation by SOS high GTP,2.8e-08
409,"N-[1-{5-[2-(aminomethyl)-6-chlorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C(=CC=C1)Cl)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,410,KRAS-Activation by SOS no GTP,3.16e-08
409,"N-[1-{5-[2-(aminomethyl)-6-chlorophenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C(=CC=C1)Cl)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,410,EGFR kinase inhibition IC50,>2.00E-5
410,"4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2-thienyl)pyridin-2-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC(=NC=C1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,411,KRAS-SOS1 Interaction,4.23e-06
410,"4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2-thienyl)pyridin-2-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC(=NC=C1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,411,KRAS-Activation by SOS high GTP,2.79e-06
410,"4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2-thienyl)pyridin-2-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC(=NC=C1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,411,KRAS-Activation by SOS no GTP,>2.00E-5
410,"4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2-thienyl)pyridin-2-ol",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=CC(=NC=C1)O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,411,EGFR kinase inhibition IC50,>2.00E-5
411,"4-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]azetidin-2-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C1CC(N1)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,412,KRAS-SOS1 Interaction,1.45e-05
411,"4-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]azetidin-2-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C1CC(N1)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,412,KRAS-Activation by SOS high GTP,>2.09E-5
411,"4-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]azetidin-2-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C1CC(N1)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,412,KRAS-Activation by SOS no GTP,>2.00E-5
411,"4-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)phenyl]azetidin-2-one",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=CC=C1)C1CC(N1)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,412,EGFR kinase inhibition IC50,>2.00E-5
412,"N-[(1R)-1-(3-chlorophenyl)ethyl]-6-methoxy-2,7-dimethylquinazolin-4-amine",ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,413,KRAS-SOS1 Interaction,
412,"N-[(1R)-1-(3-chlorophenyl)ethyl]-6-methoxy-2,7-dimethylquinazolin-4-amine",ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,413,KRAS-Activation by SOS high GTP,
412,"N-[(1R)-1-(3-chlorophenyl)ethyl]-6-methoxy-2,7-dimethylquinazolin-4-amine",ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,413,KRAS-Activation by SOS no GTP,
412,"N-[(1R)-1-(3-chlorophenyl)ethyl]-6-methoxy-2,7-dimethylquinazolin-4-amine",ClC=1C=C(C=CC1)[C@@H](C)NC1=NC(=NC2=CC(=C(C=C12)OC)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,413,EGFR kinase inhibition IC50,
413,"4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-3-[(dimethylamino)methyl]benzonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=C(C#N)C=C1)CN(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,414,KRAS-SOS1 Interaction,2.23e-07
413,"4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-3-[(dimethylamino)methyl]benzonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=C(C#N)C=C1)CN(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,414,KRAS-Activation by SOS high GTP,2.62e-07
413,"4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-3-[(dimethylamino)methyl]benzonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=C(C#N)C=C1)CN(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,414,KRAS-Activation by SOS no GTP,2.13e-07
413,"4-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-3-[(dimethylamino)methyl]benzonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(C=C(C#N)C=C1)CN(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,414,EGFR kinase inhibition IC50,>2.00E-5
414,N-[1-(5-bromothiophen-2-yl)ethyl]-6-[3-(dimethylamino)pyrrolidin-1-yl]-2-methylquinazolin-4-amine,BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CC(CC1)N(C)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,415,KRAS-SOS1 Interaction,1.38e-06
414,N-[1-(5-bromothiophen-2-yl)ethyl]-6-[3-(dimethylamino)pyrrolidin-1-yl]-2-methylquinazolin-4-amine,BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CC(CC1)N(C)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,415,KRAS-Activation by SOS high GTP,1.24e-06
414,N-[1-(5-bromothiophen-2-yl)ethyl]-6-[3-(dimethylamino)pyrrolidin-1-yl]-2-methylquinazolin-4-amine,BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CC(CC1)N(C)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,415,KRAS-Activation by SOS no GTP,1.48e-06
414,N-[1-(5-bromothiophen-2-yl)ethyl]-6-[3-(dimethylamino)pyrrolidin-1-yl]-2-methylquinazolin-4-amine,BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CC(CC1)N(C)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,415,EGFR kinase inhibition IC50,>2.00E-5
415,N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-2-methyl-6-(pyrrolidin-1-yl)quinazolin-4-amine,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CCCC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,416,KRAS-SOS1 Interaction,1.15e-07
415,N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-2-methyl-6-(pyrrolidin-1-yl)quinazolin-4-amine,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CCCC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,416,KRAS-Activation by SOS high GTP,8.85e-08
415,N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-2-methyl-6-(pyrrolidin-1-yl)quinazolin-4-amine,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CCCC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,416,KRAS-Activation by SOS no GTP,9.42e-08
415,N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-2-methyl-6-(pyrrolidin-1-yl)quinazolin-4-amine,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CCCC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,416,EGFR kinase inhibition IC50,nan
416,N-[1-(5-bromothiophen-2-yl)ethyl]-2-methyl-6-(4-methylpiperazin-1-yl)quinazolin-4-amine,BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CCN(CC1)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,417,KRAS-SOS1 Interaction,8.67e-07
416,N-[1-(5-bromothiophen-2-yl)ethyl]-2-methyl-6-(4-methylpiperazin-1-yl)quinazolin-4-amine,BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CCN(CC1)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,417,KRAS-Activation by SOS high GTP,6.97e-07
416,N-[1-(5-bromothiophen-2-yl)ethyl]-2-methyl-6-(4-methylpiperazin-1-yl)quinazolin-4-amine,BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CCN(CC1)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,417,KRAS-Activation by SOS no GTP,1.14e-06
416,N-[1-(5-bromothiophen-2-yl)ethyl]-2-methyl-6-(4-methylpiperazin-1-yl)quinazolin-4-amine,BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CCN(CC1)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,417,EGFR kinase inhibition IC50,>2.00E-5
417,N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-2-methyl-6-(4-methylpiperazin-1-yl)quinazolin-4-amine,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CCN(CC1)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,418,KRAS-SOS1 Interaction,4.55e-08
417,N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-2-methyl-6-(4-methylpiperazin-1-yl)quinazolin-4-amine,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CCN(CC1)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,418,KRAS-Activation by SOS high GTP,2.89e-08
417,N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-2-methyl-6-(4-methylpiperazin-1-yl)quinazolin-4-amine,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CCN(CC1)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,418,KRAS-Activation by SOS no GTP,3.53e-06
417,N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-2-methyl-6-(4-methylpiperazin-1-yl)quinazolin-4-amine,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CCN(CC1)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,418,EGFR kinase inhibition IC50,>2.00E-5
418,N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6-[3-(dimethylamino)pyrrolidin-1-yl]-2-methylquinazolin-4-amine,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CC(CC1)N(C)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,419,KRAS-SOS1 Interaction,8.66e-08
418,N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6-[3-(dimethylamino)pyrrolidin-1-yl]-2-methylquinazolin-4-amine,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CC(CC1)N(C)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,419,KRAS-Activation by SOS high GTP,3.98e-08
418,N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6-[3-(dimethylamino)pyrrolidin-1-yl]-2-methylquinazolin-4-amine,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CC(CC1)N(C)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,419,KRAS-Activation by SOS no GTP,4.51e-08
418,N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6-[3-(dimethylamino)pyrrolidin-1-yl]-2-methylquinazolin-4-amine,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CC(CC1)N(C)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,419,EGFR kinase inhibition IC50,>2.00E-5
419,N-[(1R)-1-(5-bromothiophen-2-yl)ethyl]-2-methyl-6-(pyrrolidin-1-yl)quinazolin-4-amine,BrC1=CC=C(S1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)N1CCCC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,420,KRAS-SOS1 Interaction,6.45e-06
419,N-[(1R)-1-(5-bromothiophen-2-yl)ethyl]-2-methyl-6-(pyrrolidin-1-yl)quinazolin-4-amine,BrC1=CC=C(S1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)N1CCCC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,420,KRAS-Activation by SOS high GTP,3.74e-06
419,N-[(1R)-1-(5-bromothiophen-2-yl)ethyl]-2-methyl-6-(pyrrolidin-1-yl)quinazolin-4-amine,BrC1=CC=C(S1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)N1CCCC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,420,KRAS-Activation by SOS no GTP,1.43e-05
419,N-[(1R)-1-(5-bromothiophen-2-yl)ethyl]-2-methyl-6-(pyrrolidin-1-yl)quinazolin-4-amine,BrC1=CC=C(S1)[C@@H](C)NC1=NC(=NC2=CC=C(C=C12)N1CCCC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,420,EGFR kinase inhibition IC50,>2.00E-5
420,N-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)acetamide,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NC(C)=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,421,KRAS-SOS1 Interaction,3.03e-07
420,N-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)acetamide,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NC(C)=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,421,KRAS-Activation by SOS high GTP,3.84e-07
420,N-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)acetamide,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NC(C)=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,421,KRAS-Activation by SOS no GTP,5.79e-07
420,N-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)acetamide,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NC(C)=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,421,EGFR kinase inhibition IC50,>2.00E-5
421,N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-2-methyl-6-nitroquinazolin-4-amine,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)[N+](=O)[O-])C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,422,KRAS-SOS1 Interaction,1.45e-07
421,N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-2-methyl-6-nitroquinazolin-4-amine,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)[N+](=O)[O-])C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,422,KRAS-Activation by SOS high GTP,2.22e-07
421,N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-2-methyl-6-nitroquinazolin-4-amine,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)[N+](=O)[O-])C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,422,KRAS-Activation by SOS no GTP,
421,N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-2-methyl-6-nitroquinazolin-4-amine,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)[N+](=O)[O-])C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,422,EGFR kinase inhibition IC50,>2.00E-5
422,"6,7-dimethoxy-N-{1-[5-(4-methoxy-2-methylphenyl)thiophen-2-yl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=C(C=C1)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,423,KRAS-SOS1 Interaction,1.47e-06
422,"6,7-dimethoxy-N-{1-[5-(4-methoxy-2-methylphenyl)thiophen-2-yl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=C(C=C1)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,423,KRAS-Activation by SOS high GTP,9.14e-07
422,"6,7-dimethoxy-N-{1-[5-(4-methoxy-2-methylphenyl)thiophen-2-yl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=C(C=C1)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,423,KRAS-Activation by SOS no GTP,3.6e-06
422,"6,7-dimethoxy-N-{1-[5-(4-methoxy-2-methylphenyl)thiophen-2-yl]ethyl}-2-methylquinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC(=CC1)C1=C(C=C(C=C1)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,423,EGFR kinase inhibition IC50,>2.00E-5
423,"N4-[1-(5-{2-[(dimethylamino)methyl]phenyl}-2-thienyl)ethyl]-2-methyl-quinazoline-4,6-diamine",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,424,KRAS-SOS1 Interaction,2.04e-07
423,"N4-[1-(5-{2-[(dimethylamino)methyl]phenyl}-2-thienyl)ethyl]-2-methyl-quinazoline-4,6-diamine",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,424,KRAS-Activation by SOS high GTP,1.87e-07
423,"N4-[1-(5-{2-[(dimethylamino)methyl]phenyl}-2-thienyl)ethyl]-2-methyl-quinazoline-4,6-diamine",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,424,KRAS-Activation by SOS no GTP,3.03e-07
423,"N4-[1-(5-{2-[(dimethylamino)methyl]phenyl}-2-thienyl)ethyl]-2-methyl-quinazoline-4,6-diamine",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,424,EGFR kinase inhibition IC50,>2.00E-5
424,N-[1-(5-bromothiophen-2-yl)ethyl]-2-methyl-6-[4-(pyridin-3-ylmethyl)piperazin-1-yl]quinazolin-4-amine,BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CCN(CC1)CC=1C=NC=CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,425,KRAS-SOS1 Interaction,1.59e-06
424,N-[1-(5-bromothiophen-2-yl)ethyl]-2-methyl-6-[4-(pyridin-3-ylmethyl)piperazin-1-yl]quinazolin-4-amine,BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CCN(CC1)CC=1C=NC=CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,425,KRAS-Activation by SOS high GTP,1.41e-06
424,N-[1-(5-bromothiophen-2-yl)ethyl]-2-methyl-6-[4-(pyridin-3-ylmethyl)piperazin-1-yl]quinazolin-4-amine,BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CCN(CC1)CC=1C=NC=CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,425,KRAS-Activation by SOS no GTP,3.76e-06
424,N-[1-(5-bromothiophen-2-yl)ethyl]-2-methyl-6-[4-(pyridin-3-ylmethyl)piperazin-1-yl]quinazolin-4-amine,BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CCN(CC1)CC=1C=NC=CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,425,EGFR kinase inhibition IC50,>2.00E-5
425,"N4-[1-(5-bromo-2-thienyl)ethyl]-2-methyl-N6-[2-(morpholin-4-yl)ethyl]-quinazoline-4,6-diamine",BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NCCN1CCOCC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,426,KRAS-SOS1 Interaction,5.82e-06
425,"N4-[1-(5-bromo-2-thienyl)ethyl]-2-methyl-N6-[2-(morpholin-4-yl)ethyl]-quinazoline-4,6-diamine",BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NCCN1CCOCC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,426,KRAS-Activation by SOS high GTP,2.56e-06
425,"N4-[1-(5-bromo-2-thienyl)ethyl]-2-methyl-N6-[2-(morpholin-4-yl)ethyl]-quinazoline-4,6-diamine",BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NCCN1CCOCC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,426,KRAS-Activation by SOS no GTP,1.12e-05
425,"N4-[1-(5-bromo-2-thienyl)ethyl]-2-methyl-N6-[2-(morpholin-4-yl)ethyl]-quinazoline-4,6-diamine",BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NCCN1CCOCC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,426,EGFR kinase inhibition IC50,>2.00E-5
426,N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-2-methyl-6-[4-(pyridin-3-ylmethyl)piperazin-1-yl]quinazolin-4-amine,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CCN(CC1)CC=1C=NC=CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,427,KRAS-SOS1 Interaction,3.32e-08
426,N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-2-methyl-6-[4-(pyridin-3-ylmethyl)piperazin-1-yl]quinazolin-4-amine,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CCN(CC1)CC=1C=NC=CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,427,KRAS-Activation by SOS high GTP,2.3e-08
426,N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-2-methyl-6-[4-(pyridin-3-ylmethyl)piperazin-1-yl]quinazolin-4-amine,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CCN(CC1)CC=1C=NC=CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,427,KRAS-Activation by SOS no GTP,3.15e-08
426,N-[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-2-methyl-6-[4-(pyridin-3-ylmethyl)piperazin-1-yl]quinazolin-4-amine,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CCN(CC1)CC=1C=NC=CC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,427,EGFR kinase inhibition IC50,4.95e-06
427,N-{2-[(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)amino]ethyl}acetamide,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NCCNC(C)=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,428,KRAS-SOS1 Interaction,5.84e-08
427,N-{2-[(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)amino]ethyl}acetamide,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NCCNC(C)=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,428,KRAS-Activation by SOS high GTP,4.98e-08
427,N-{2-[(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)amino]ethyl}acetamide,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NCCNC(C)=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,428,KRAS-Activation by SOS no GTP,7.39e-08
427,N-{2-[(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)amino]ethyl}acetamide,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NCCNC(C)=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,428,EGFR kinase inhibition IC50,>2.00E-5
428,"N-[1-(5-bromo-3-chlorothiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC(=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,429,KRAS-SOS1 Interaction,9.16e-07
428,"N-[1-(5-bromo-3-chlorothiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC(=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,429,KRAS-Activation by SOS high GTP,7.05e-07
428,"N-[1-(5-bromo-3-chlorothiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC(=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,429,KRAS-Activation by SOS no GTP,1.02e-06
428,"N-[1-(5-bromo-3-chlorothiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=CC(=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,429,EGFR kinase inhibition IC50,>2.00E-5
429,"tert-butyl[2-(4-chloro-5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]carbamate",C(C)(C)(C)OC(NCC1=C(C=CC=C1)C=1SC(=C(C1)Cl)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,430,KRAS-SOS1 Interaction,6.09e-06
429,"tert-butyl[2-(4-chloro-5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]carbamate",C(C)(C)(C)OC(NCC1=C(C=CC=C1)C=1SC(=C(C1)Cl)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,430,KRAS-Activation by SOS high GTP,3.05e-06
429,"tert-butyl[2-(4-chloro-5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]carbamate",C(C)(C)(C)OC(NCC1=C(C=CC=C1)C=1SC(=C(C1)Cl)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,430,KRAS-Activation by SOS no GTP,5.94e-06
429,"tert-butyl[2-(4-chloro-5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]carbamate",C(C)(C)(C)OC(NCC1=C(C=CC=C1)C=1SC(=C(C1)Cl)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,430,EGFR kinase inhibition IC50,>2.00E-5
430,"N-[1-{5-[2-(aminomethyl)phenyl]-4-chlorothiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C1=C(C=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,431,KRAS-SOS1 Interaction,5.94e-07
430,"N-[1-{5-[2-(aminomethyl)phenyl]-4-chlorothiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C1=C(C=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,431,KRAS-Activation by SOS high GTP,3.78e-07
430,"N-[1-{5-[2-(aminomethyl)phenyl]-4-chlorothiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C1=C(C=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,431,KRAS-Activation by SOS no GTP,5.84e-07
430,"N-[1-{5-[2-(aminomethyl)phenyl]-4-chlorothiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C1=C(C=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,431,EGFR kinase inhibition IC50,>2.00E-5
431,"N-[1-(4-chloro-5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=C(SC1C1=C(C=CC=C1)CN(C)C)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,432,KRAS-SOS1 Interaction,3.24e-07
431,"N-[1-(4-chloro-5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=C(SC1C1=C(C=CC=C1)CN(C)C)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,432,KRAS-Activation by SOS high GTP,2.15e-07
431,"N-[1-(4-chloro-5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=C(SC1C1=C(C=CC=C1)CN(C)C)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,432,KRAS-Activation by SOS no GTP,3.02e-07
431,"N-[1-(4-chloro-5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",ClC=1C=C(SC1C1=C(C=CC=C1)CN(C)C)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,432,EGFR kinase inhibition IC50,>2.00E-5
432,"N-[1-(5-bromo-4-chlorothiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=C(C=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,433,KRAS-SOS1 Interaction,1.67e-05
432,"N-[1-(5-bromo-4-chlorothiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=C(C=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,433,KRAS-Activation by SOS high GTP,1.57e-05
432,"N-[1-(5-bromo-4-chlorothiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=C(C=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,433,KRAS-Activation by SOS no GTP,>2.00E-5
432,"N-[1-(5-bromo-4-chlorothiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",BrC1=C(C=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,433,EGFR kinase inhibition IC50,>2.00E-5
433,"N4-[1-(5-{2-[(dimethylamino)methyl]phenyl}-2-thienyl)ethyl]-2-methyl-N6-[2-(morpholin-4-yl)ethyl]quinazoline-4,6-diamine",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NCCN1CCOCC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,434,KRAS-SOS1 Interaction,7.71e-08
433,"N4-[1-(5-{2-[(dimethylamino)methyl]phenyl}-2-thienyl)ethyl]-2-methyl-N6-[2-(morpholin-4-yl)ethyl]quinazoline-4,6-diamine",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NCCN1CCOCC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,434,KRAS-Activation by SOS high GTP,7.01e-08
433,"N4-[1-(5-{2-[(dimethylamino)methyl]phenyl}-2-thienyl)ethyl]-2-methyl-N6-[2-(morpholin-4-yl)ethyl]quinazoline-4,6-diamine",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NCCN1CCOCC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,434,KRAS-Activation by SOS no GTP,7.69e-08
433,"N4-[1-(5-{2-[(dimethylamino)methyl]phenyl}-2-thienyl)ethyl]-2-methyl-N6-[2-(morpholin-4-yl)ethyl]quinazoline-4,6-diamine",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NCCN1CCOCC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,434,EGFR kinase inhibition IC50,>2.00E-5
434,4-(4-{[1-(5-bromothiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)-1-methylpiperazin-2-one,BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CC(N(CC1)C)=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,435,KRAS-SOS1 Interaction,2.84e-06
434,4-(4-{[1-(5-bromothiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)-1-methylpiperazin-2-one,BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CC(N(CC1)C)=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,435,KRAS-Activation by SOS high GTP,2.39e-06
434,4-(4-{[1-(5-bromothiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)-1-methylpiperazin-2-one,BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CC(N(CC1)C)=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,435,KRAS-Activation by SOS no GTP,2.81e-06
434,4-(4-{[1-(5-bromothiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)-1-methylpiperazin-2-one,BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CC(N(CC1)C)=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,435,EGFR kinase inhibition IC50,1.68e-05
435,4-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)-1-methylpiperazin-2-one,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CC(N(CC1)C)=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,436,KRAS-SOS1 Interaction,8.44e-08
435,4-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)-1-methylpiperazin-2-one,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CC(N(CC1)C)=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,436,KRAS-Activation by SOS high GTP,5.19e-08
435,4-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)-1-methylpiperazin-2-one,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CC(N(CC1)C)=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,436,KRAS-Activation by SOS no GTP,6.86e-08
435,4-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)-1-methylpiperazin-2-one,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)N1CC(N(CC1)C)=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,436,EGFR kinase inhibition IC50,>2.00E-5
436,"methyl2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-thiophen-2-yl)phenyl]-2-methylpropanoate",COC(C(C)(C)C1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,437,KRAS-SOS1 Interaction,2.39e-06
436,"methyl2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-thiophen-2-yl)phenyl]-2-methylpropanoate",COC(C(C)(C)C1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,437,KRAS-Activation by SOS high GTP,1.47e-06
436,"methyl2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-thiophen-2-yl)phenyl]-2-methylpropanoate",COC(C(C)(C)C1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,437,KRAS-Activation by SOS no GTP,1.77e-06
436,"methyl2-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-thiophen-2-yl)phenyl]-2-methylpropanoate",COC(C(C)(C)C1=C(C=CC=C1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,437,EGFR kinase inhibition IC50,>2.00E-5
437,"N-[1-{5-[2-(aminomethyl)phenyl]-3-chlorothiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C1=CC(=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,438,KRAS-SOS1 Interaction,1.45e-07
437,"N-[1-{5-[2-(aminomethyl)phenyl]-3-chlorothiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C1=CC(=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,438,KRAS-Activation by SOS high GTP,9.53e-08
437,"N-[1-{5-[2-(aminomethyl)phenyl]-3-chlorothiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C1=CC(=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,438,KRAS-Activation by SOS no GTP,1.6e-07
437,"N-[1-{5-[2-(aminomethyl)phenyl]-3-chlorothiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NCC1=C(C=CC=C1)C1=CC(=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,438,EGFR kinase inhibition IC50,>2.00E-5
438,N-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)methanesulfonamide,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NS(=O)(=O)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,439,KRAS-SOS1 Interaction,9.02e-08
438,N-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)methanesulfonamide,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NS(=O)(=O)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,439,KRAS-Activation by SOS high GTP,6.55e-08
438,N-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)methanesulfonamide,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NS(=O)(=O)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,439,KRAS-Activation by SOS no GTP,1.16e-07
438,N-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)methanesulfonamide,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NS(=O)(=O)C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,439,EGFR kinase inhibition IC50,>2.00E-5
439,"N-[1-(5-{2-[(dimethylamino)methyl]-4-methoxyphenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1=C(C=CC(=C1)OC)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,440,KRAS-SOS1 Interaction,2.77e-07
439,"N-[1-(5-{2-[(dimethylamino)methyl]-4-methoxyphenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1=C(C=CC(=C1)OC)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,440,KRAS-Activation by SOS high GTP,1.45e-07
439,"N-[1-(5-{2-[(dimethylamino)methyl]-4-methoxyphenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1=C(C=CC(=C1)OC)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,440,KRAS-Activation by SOS no GTP,2.29e-07
439,"N-[1-(5-{2-[(dimethylamino)methyl]-4-methoxyphenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1=C(C=CC(=C1)OC)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,440,EGFR kinase inhibition IC50,>2.00E-5
440,"3-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)-1,1-dimethylurea",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NC(N(C)C)=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,441,KRAS-SOS1 Interaction,7.06e-07
440,"3-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)-1,1-dimethylurea",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NC(N(C)C)=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,441,KRAS-Activation by SOS high GTP,5.76e-07
440,"3-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)-1,1-dimethylurea",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NC(N(C)C)=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,441,KRAS-Activation by SOS no GTP,9.21e-07
440,"3-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)-1,1-dimethylurea",CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NC(N(C)C)=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,441,EGFR kinase inhibition IC50,>2.00E-5
441,1-benzyl-4-(4-{[1-(5-bromothiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)piperazin-2-one,C(C1=CC=CC=C1)N1C(CN(CC1)C=1C=C2C(=NC(=NC2=CC1)C)NC(C)C=1SC(=CC1)Br)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,442,KRAS-SOS1 Interaction,1.61e-06
441,1-benzyl-4-(4-{[1-(5-bromothiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)piperazin-2-one,C(C1=CC=CC=C1)N1C(CN(CC1)C=1C=C2C(=NC(=NC2=CC1)C)NC(C)C=1SC(=CC1)Br)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,442,KRAS-Activation by SOS high GTP,3.95e-06
441,1-benzyl-4-(4-{[1-(5-bromothiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)piperazin-2-one,C(C1=CC=CC=C1)N1C(CN(CC1)C=1C=C2C(=NC(=NC2=CC1)C)NC(C)C=1SC(=CC1)Br)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,442,KRAS-Activation by SOS no GTP,1.51e-05
441,1-benzyl-4-(4-{[1-(5-bromothiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)piperazin-2-one,C(C1=CC=CC=C1)N1C(CN(CC1)C=1C=C2C(=NC(=NC2=CC1)C)NC(C)C=1SC(=CC1)Br)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,442,EGFR kinase inhibition IC50,>2.00E-5
442,"N-[1-(5-{2-[(dimethylamino)methyl]-4-methylphenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1=C(C=CC(=C1)C)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,443,KRAS-SOS1 Interaction,4.53e-08
442,"N-[1-(5-{2-[(dimethylamino)methyl]-4-methylphenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1=C(C=CC(=C1)C)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,443,KRAS-Activation by SOS high GTP,3.94e-08
442,"N-[1-(5-{2-[(dimethylamino)methyl]-4-methylphenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1=C(C=CC(=C1)C)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,443,KRAS-Activation by SOS no GTP,4.51e-08
442,"N-[1-(5-{2-[(dimethylamino)methyl]-4-methylphenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",CN(C)CC1=C(C=CC(=C1)C)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,443,EGFR kinase inhibition IC50,>2.00E-5
443,"N-[1-(5-{4-cyclopropyl-2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)C1=CC(=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)CN(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,444,KRAS-SOS1 Interaction,1.12e-07
443,"N-[1-(5-{4-cyclopropyl-2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)C1=CC(=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)CN(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,444,KRAS-Activation by SOS high GTP,6.05e-08
443,"N-[1-(5-{4-cyclopropyl-2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)C1=CC(=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)CN(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,444,KRAS-Activation by SOS no GTP,6.9e-08
443,"N-[1-(5-{4-cyclopropyl-2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",C1(CC1)C1=CC(=C(C=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)CN(C)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,444,EGFR kinase inhibition IC50,>2.00E-5
444,"6,7-dimethoxy-2-methyl-N-[1-(2-methyl-1,3-thiazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1N=C(SC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,445,KRAS-SOS1 Interaction,0.1379
444,"6,7-dimethoxy-2-methyl-N-[1-(2-methyl-1,3-thiazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1N=C(SC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,445,KRAS-Activation by SOS high GTP,>2.00E-5
444,"6,7-dimethoxy-2-methyl-N-[1-(2-methyl-1,3-thiazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1N=C(SC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,445,KRAS-Activation by SOS no GTP,>2.00E-5
444,"6,7-dimethoxy-2-methyl-N-[1-(2-methyl-1,3-thiazol-4-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1N=C(SC1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,445,EGFR kinase inhibition IC50,>2.00E-5
445,"6,7-dimethoxy-2-methyl-N-[1-(4-methyl-1,3-thiazol-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=C(N1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,446,KRAS-SOS1 Interaction,0.1413
445,"6,7-dimethoxy-2-methyl-N-[1-(4-methyl-1,3-thiazol-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=C(N1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,446,KRAS-Activation by SOS high GTP,>2.00E-5
445,"6,7-dimethoxy-2-methyl-N-[1-(4-methyl-1,3-thiazol-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=C(N1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,446,KRAS-Activation by SOS no GTP,>2.00E-5
445,"6,7-dimethoxy-2-methyl-N-[1-(4-methyl-1,3-thiazol-2-yl)ethyl]quinazolin-4-amine",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C=1SC=C(N1)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,446,EGFR kinase inhibition IC50,>2.00E-5
446,"3-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1-methyl-1H-pyrazole-5-carboxylicacid",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=NN(C(=C1)C(=O)O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,447,KRAS-SOS1 Interaction,0.2442
446,"3-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1-methyl-1H-pyrazole-5-carboxylicacid",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=NN(C(=C1)C(=O)O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,447,KRAS-Activation by SOS high GTP,>2.00E-5
446,"3-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1-methyl-1H-pyrazole-5-carboxylicacid",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=NN(C(=C1)C(=O)O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,447,KRAS-Activation by SOS no GTP,>2.00E-5
446,"3-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)-1-methyl-1H-pyrazole-5-carboxylicacid",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=NN(C(=C1)C(=O)O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,447,EGFR kinase inhibition IC50,>2.00E-5
447,"tert-butyl[(5'-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2,2'-bithiophen-5-yl)methyl]carbamate",C(C)(C)(C)OC(NCC1=CC=C(S1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,448,KRAS-SOS1 Interaction,0.1916
447,"tert-butyl[(5'-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2,2'-bithiophen-5-yl)methyl]carbamate",C(C)(C)(C)OC(NCC1=CC=C(S1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,448,KRAS-Activation by SOS high GTP,>2.00E-5
447,"tert-butyl[(5'-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2,2'-bithiophen-5-yl)methyl]carbamate",C(C)(C)(C)OC(NCC1=CC=C(S1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,448,KRAS-Activation by SOS no GTP,>2.00E-5
447,"tert-butyl[(5'-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-2,2'-bithiophen-5-yl)methyl]carbamate",C(C)(C)(C)OC(NCC1=CC=C(S1)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,448,EGFR kinase inhibition IC50,>2.00E-5
448,7-methoxy-2-methyl-6-[2-(methylsulfonyl)ethoxy]-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)OCCS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,449,KRAS-SOS1 Interaction,0.2236
448,7-methoxy-2-methyl-6-[2-(methylsulfonyl)ethoxy]-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)OCCS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,449,KRAS-Activation by SOS high GTP,>2.00E-5
448,7-methoxy-2-methyl-6-[2-(methylsulfonyl)ethoxy]-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)OCCS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,449,KRAS-Activation by SOS no GTP,>2.00E-5
448,7-methoxy-2-methyl-6-[2-(methylsulfonyl)ethoxy]-N-{(1R)-1-[3-(1H-pyrazol-4-yl)phenyl]ethyl}quinazolin-4-amine,COC1=C(C=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)C=1C=NNC1)OCCS(=O)(=O)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,449,EGFR kinase inhibition IC50,>2.00E-5
449,"tert-butyl[5-chloro-2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]carbamate",C(C)(C)(C)OC(NCC1=C(C=CC(=C1)Cl)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,450,KRAS-SOS1 Interaction,0.5043
449,"tert-butyl[5-chloro-2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]carbamate",C(C)(C)(C)OC(NCC1=C(C=CC(=C1)Cl)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,450,KRAS-Activation by SOS high GTP,>2.00E-5
449,"tert-butyl[5-chloro-2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]carbamate",C(C)(C)(C)OC(NCC1=C(C=CC(=C1)Cl)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,450,KRAS-Activation by SOS no GTP,>2.00E-5
449,"tert-butyl[5-chloro-2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]carbamate",C(C)(C)(C)OC(NCC1=C(C=CC(=C1)Cl)C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,450,EGFR kinase inhibition IC50,>2.00E-5
450,"tert-butyl[2-chloro-6-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]carbamate",C(C)(C)(C)OC(NCC1=C(C=CC=C1C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)Cl)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,451,KRAS-SOS1 Interaction,0.4584
450,"tert-butyl[2-chloro-6-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]carbamate",C(C)(C)(C)OC(NCC1=C(C=CC=C1C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)Cl)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,451,KRAS-Activation by SOS high GTP,>2.00E-5
450,"tert-butyl[2-chloro-6-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]carbamate",C(C)(C)(C)OC(NCC1=C(C=CC=C1C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)Cl)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,451,KRAS-Activation by SOS no GTP,>2.00E-5
450,"tert-butyl[2-chloro-6-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl]carbamate",C(C)(C)(C)OC(NCC1=C(C=CC=C1C=1SC(=CC1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C)Cl)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,451,EGFR kinase inhibition IC50,>2.00E-5
451,7-bromo-N-[(1R)-1-(3-chlorophenyl)ethyl]-2-methylquinazolin-4-amine,BrC1=CC=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,452,KRAS-SOS1 Interaction,0.2988
451,7-bromo-N-[(1R)-1-(3-chlorophenyl)ethyl]-2-methylquinazolin-4-amine,BrC1=CC=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,452,KRAS-Activation by SOS high GTP,>2.00E-5
451,7-bromo-N-[(1R)-1-(3-chlorophenyl)ethyl]-2-methylquinazolin-4-amine,BrC1=CC=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,452,KRAS-Activation by SOS no GTP,>2.00E-5
451,7-bromo-N-[(1R)-1-(3-chlorophenyl)ethyl]-2-methylquinazolin-4-amine,BrC1=CC=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,452,EGFR kinase inhibition IC50,>2.00E-5
452,N-[1-(5-bromothiophen-2-yl)ethyl]-2-methyl-6-nitroquinazolin-4-amine,BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)[N+](=O)[O-])C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,453,KRAS-SOS1 Interaction,0.2399
452,N-[1-(5-bromothiophen-2-yl)ethyl]-2-methyl-6-nitroquinazolin-4-amine,BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)[N+](=O)[O-])C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,453,KRAS-Activation by SOS high GTP,>2.00E-5
452,N-[1-(5-bromothiophen-2-yl)ethyl]-2-methyl-6-nitroquinazolin-4-amine,BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)[N+](=O)[O-])C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,453,KRAS-Activation by SOS no GTP,>2.00E-5
452,N-[1-(5-bromothiophen-2-yl)ethyl]-2-methyl-6-nitroquinazolin-4-amine,BrC1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)[N+](=O)[O-])C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,453,EGFR kinase inhibition IC50,>2.00E-5
453,methyl4-{[(1R)-1-(3-chlorophenyl)ethyl]amino}-2-methylquinazoline-7-carboxylate,COC(=O)C1=CC=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,454,KRAS-SOS1 Interaction,0.276
453,methyl4-{[(1R)-1-(3-chlorophenyl)ethyl]amino}-2-methylquinazoline-7-carboxylate,COC(=O)C1=CC=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,454,KRAS-Activation by SOS high GTP,>2.00E-5
453,methyl4-{[(1R)-1-(3-chlorophenyl)ethyl]amino}-2-methylquinazoline-7-carboxylate,COC(=O)C1=CC=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,454,KRAS-Activation by SOS no GTP,>2.00E-5
453,methyl4-{[(1R)-1-(3-chlorophenyl)ethyl]amino}-2-methylquinazoline-7-carboxylate,COC(=O)C1=CC=C2C(=NC(=NC2=C1)C)N[C@H](C)C1=CC(=CC=C1)Cl,data/bronze/artifacts/2018_raw.xlsx,Sheet1,454,EGFR kinase inhibition IC50,>2.00E-5
454,"3-amino-3-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-3-thienyl)phenyl]propanoicacid",NC(CC(=O)O)C1=C(C=CC=C1)C1=CSC(=C1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,455,KRAS-SOS1 Interaction,
454,"3-amino-3-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-3-thienyl)phenyl]propanoicacid",NC(CC(=O)O)C1=C(C=CC=C1)C1=CSC(=C1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,455,KRAS-Activation by SOS high GTP,
454,"3-amino-3-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-3-thienyl)phenyl]propanoicacid",NC(CC(=O)O)C1=C(C=CC=C1)C1=CSC(=C1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,455,KRAS-Activation by SOS no GTP,
454,"3-amino-3-[2-(5-{1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}-3-thienyl)phenyl]propanoicacid",NC(CC(=O)O)C1=C(C=CC=C1)C1=CSC(=C1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,455,EGFR kinase inhibition IC50,
455,"N-[1-{5-[2-(2-aminopropan-2-yl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NC(C)(C)C1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,456,KRAS-SOS1 Interaction,3.97e-07
455,"N-[1-{5-[2-(2-aminopropan-2-yl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NC(C)(C)C1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,456,KRAS-Activation by SOS high GTP,1.94e-06
455,"N-[1-{5-[2-(2-aminopropan-2-yl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NC(C)(C)C1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,456,KRAS-Activation by SOS no GTP,7.89e-07
455,"N-[1-{5-[2-(2-aminopropan-2-yl)phenyl]thiophen-2-yl}ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine",NC(C)(C)C1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC(=C(C=C12)OC)OC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,456,EGFR kinase inhibition IC50,>2.00E-5
456,"{[2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl](methyl)amino}acetonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN(C)CC#N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,457,KRAS-SOS1 Interaction,1.62e-07
456,"{[2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl](methyl)amino}acetonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN(C)CC#N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,457,KRAS-Activation by SOS high GTP,2.92e-07
456,"{[2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl](methyl)amino}acetonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN(C)CC#N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,457,KRAS-Activation by SOS no GTP,2.87e-07
456,"{[2-(5-(1-[(6,7-dimethoxy-2-methylquinazolin-4-yl)amino]ethyl}thiophen-2-yl)benzyl](methyl)amino}acetonitrile",COC=1C=C2C(=NC(=NC2=CC1OC)C)NC(C)C1=CC=C(S1)C1=C(CN(C)CC#N)C=CC=C1,data/bronze/artifacts/2018_raw.xlsx,Sheet1,457,EGFR kinase inhibition IC50,>2.00E-5
457,1-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)-3-methylurea,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NC(=O)NC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,458,KRAS-SOS1 Interaction,2.95e-07
457,1-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)-3-methylurea,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NC(=O)NC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,458,KRAS-Activation by SOS high GTP,6.82e-07
457,1-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)-3-methylurea,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NC(=O)NC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,458,KRAS-Activation by SOS no GTP,6.38e-07
457,1-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)-3-methylurea,CN(C)CC1=C(C=CC=C1)C1=CC=C(S1)C(C)NC1=NC(=NC2=CC=C(C=C12)NC(=O)NC)C,data/bronze/artifacts/2018_raw.xlsx,Sheet1,458,EGFR kinase inhibition IC50,>2.00E-5
458,1-benzyl-4-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)piperazin-2-one,C(C1=CC=CC=C1)N1C(CN(CC1)C=1C=C2C(=NC(=NC2=CC1)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN(C)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,459,KRAS-SOS1 Interaction,4.8e-08
458,1-benzyl-4-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)piperazin-2-one,C(C1=CC=CC=C1)N1C(CN(CC1)C=1C=C2C(=NC(=NC2=CC1)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN(C)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,459,KRAS-Activation by SOS high GTP,4e-08
458,1-benzyl-4-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)piperazin-2-one,C(C1=CC=CC=C1)N1C(CN(CC1)C=1C=C2C(=NC(=NC2=CC1)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN(C)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,459,KRAS-Activation by SOS no GTP,4.55e-08
458,1-benzyl-4-(4-{[1-(5-{2-[(dimethylamino)methyl]phenyl}thiophen-2-yl)ethyl]amino}-2-methylquinazolin-6-yl)piperazin-2-one,C(C1=CC=CC=C1)N1C(CN(CC1)C=1C=C2C(=NC(=NC2=CC1)C)NC(C)C=1SC(=CC1)C1=C(C=CC=C1)CN(C)C)=O,data/bronze/artifacts/2018_raw.xlsx,Sheet1,459,EGFR kinase inhibition IC50,>2.00E-5
